ID,Description,GeneRatio,BgRatio,pvalue,p.adjust,qvalue,geneID,Count
R-HSA-8939236,RUNX1 regulates transcription of genes involved in differentiation of HSCs,3/14,130/10899,5.482369422357375e-4,0.032792553765325895,0.021178667560747277,H4C8/PSMC5/H2BC11,3
R-HSA-68867,Assembly of the pre-replicative complex,3/14,143/10899,7.24068971061204e-4,0.032792553765325895,0.021178667560747277,H4C8/PSMC5/H2BC11,3
R-HSA-69002,DNA Replication Pre-Initiation,3/14,160/10899,0.0010034608887081202,0.032792553765325895,0.021178667560747277,H4C8/PSMC5/H2BC11,3
R-HSA-69481,G2/M Checkpoints,3/14,167/10899,0.0011358582054568657,0.032792553765325895,0.021178667560747277,H4C8/PSMC5/H2BC11,3
R-HSA-5633008,TP53 Regulates Transcription of Cell Death Genes,2/14,44/10899,0.0014055279579304766,0.032792553765325895,0.021178667560747277,BNIP3L/NDRG1,2
R-HSA-69306,DNA Replication,3/14,188/10899,0.001598063941722531,0.032792553765325895,0.021178667560747277,H4C8/PSMC5/H2BC11,3
R-HSA-171306,Packaging Of Telomere Ends,2/14,52/10899,0.0019585876606113073,0.032792553765325895,0.021178667560747277,H4C8/H2BC11,2
R-HSA-110330,Recognition and association of DNA glycosylase with site containing an affected purine,2/14,56/10899,0.0022680152395077144,0.032792553765325895,0.021178667560747277,H4C8/H2BC11,2
R-HSA-110331,Cleavage of the damaged purine,2/14,56/10899,0.0022680152395077144,0.032792553765325895,0.021178667560747277,H4C8/H2BC11,2
R-HSA-73927,Depurination,2/14,56/10899,0.0022680152395077144,0.032792553765325895,0.021178667560747277,H4C8/H2BC11,2
R-HSA-110328,Recognition and association of DNA glycosylase with site containing an affected pyrimidine,2/14,61/10899,0.002685243738644776,0.032792553765325895,0.021178667560747277,H4C8/H2BC11,2
R-HSA-110329,Cleavage of the damaged pyrimidine ,2/14,61/10899,0.002685243738644776,0.032792553765325895,0.021178667560747277,H4C8/H2BC11,2
R-HSA-73928,Depyrimidination,2/14,61/10899,0.002685243738644776,0.032792553765325895,0.021178667560747277,H4C8/H2BC11,2
R-HSA-73728,RNA Polymerase I Promoter Opening,2/14,63/10899,0.0028615271579248095,0.032792553765325895,0.021178667560747277,H4C8/H2BC11,2
R-HSA-73929,"Base-Excision Repair, AP Site Formation",2/14,63/10899,0.0028615271579248095,0.032792553765325895,0.021178667560747277,H4C8/H2BC11,2
R-HSA-201681,TCF dependent signaling in response to WNT,3/14,233/10899,0.002948965848808309,0.032792553765325895,0.021178667560747277,H4C8/PSMC5/H2BC11,3
R-HSA-5334118,DNA methylation,2/14,65/10899,0.0030431404834877574,0.032792553765325895,0.021178667560747277,H4C8/H2BC11,2
R-HSA-157118,Signaling by NOTCH,3/14,236/10899,0.003057862341580668,0.032792553765325895,0.021178667560747277,H4C8/PSMC5/H2BC11,3
R-HSA-8878171,Transcriptional regulation by RUNX1,3/14,239/10899,0.003169229620074899,0.032792553765325895,0.021178667560747277,H4C8/PSMC5/H2BC11,3
R-HSA-5625886,Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3,2/14,67/10899,0.003230059178320727,0.032792553765325895,0.021178667560747277,H4C8/H2BC11,2
R-HSA-427359,SIRT1 negatively regulates rRNA expression,2/14,68/10899,0.0033255003920906927,0.032792553765325895,0.021178667560747277,H4C8/H2BC11,2
R-HSA-5693571,Nonhomologous End-Joining (NHEJ),2/14,68/10899,0.0033255003920906927,0.032792553765325895,0.021178667560747277,H4C8/H2BC11,2
R-HSA-9670095,Inhibition of DNA recombination at telomere,2/14,68/10899,0.0033255003920906927,0.032792553765325895,0.021178667560747277,H4C8/H2BC11,2
R-HSA-68616,Assembly of the ORC complex at the origin of replication,2/14,69/10899,0.003422258781072096,0.032792553765325895,0.021178667560747277,H4C8/H2BC11,2
R-HSA-212300,PRC2 methylates histones and DNA,2/14,73/10899,0.0038224032421060546,0.032792553765325895,0.021178667560747277,H4C8/H2BC11,2
R-HSA-9710421,Defective pyroptosis,2/14,73/10899,0.0038224032421060546,0.032792553765325895,0.021178667560747277,H4C8/H2BC11,2
R-HSA-2299718,Condensation of Prophase Chromosomes,2/14,74/10899,0.00392570191300142,0.032792553765325895,0.021178667560747277,H4C8/H2BC11,2
R-HSA-606279,Deposition of new CENPA-containing nucleosomes at the centromere,2/14,74/10899,0.00392570191300142,0.032792553765325895,0.021178667560747277,H4C8/H2BC11,2
R-HSA-774815,Nucleosome assembly,2/14,74/10899,0.00392570191300142,0.032792553765325895,0.021178667560747277,H4C8/H2BC11,2
R-HSA-1234174,Cellular response to hypoxia,2/14,75/10899,0.004030299554307352,0.032792553765325895,0.021178667560747277,VEGFA/PSMC5,2
R-HSA-427389,ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression,2/14,76/10899,0.00413619314829142,0.032792553765325895,0.021178667560747277,H4C8/H2BC11,2
R-HSA-5693565,Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks,2/14,77/10899,0.004243379681891701,0.032792553765325895,0.021178667560747277,H4C8/H2BC11,2
R-HSA-5693606,DNA Double Strand Break Response,2/14,78/10899,0.004351856146711011,0.032792553765325895,0.021178667560747277,H4C8/H2BC11,2
R-HSA-1221632,Meiotic synapsis,2/14,79/10899,0.004461619539011085,0.032792553765325895,0.021178667560747277,H4C8/H2BC11,2
R-HSA-2559586,DNA Damage/Telomere Stress Induced Senescence,2/14,80/10899,0.004572666859706798,0.032792553765325895,0.021178667560747277,H4C8/H2BC11,2
R-HSA-912446,Meiotic recombination,2/14,86/10899,0.005265745916263798,0.03408492236974202,0.022013327930133247,H4C8/H2BC11,2
R-HSA-69620,Cell Cycle Checkpoints,3/14,293/10899,0.0056171218490143875,0.03408492236974202,0.022013327930133247,H4C8/PSMC5/H2BC11,3
R-HSA-9616222,Transcriptional regulation of granulopoiesis,2/14,90/10899,0.005753099645143359,0.03408492236974202,0.022013327930133247,H4C8/H2BC11,2
R-HSA-201722,Formation of the beta-catenin:TCF transactivating complex,2/14,91/10899,0.005878073563599243,0.03408492236974202,0.022013327930133247,H4C8/H2BC11,2
R-HSA-5250924,B-WICH complex positively regulates rRNA expression,2/14,91/10899,0.005878073563599243,0.03408492236974202,0.022013327930133247,H4C8/H2BC11,2
R-HSA-73772,RNA Polymerase I Promoter Escape,2/14,91/10899,0.005878073563599243,0.03408492236974202,0.022013327930133247,H4C8/H2BC11,2
R-HSA-9006931,Signaling by Nuclear Receptors,3/14,299/10899,0.0059433150133924645,0.03408492236974202,0.022013327930133247,ARL4C/H4C8/H2BC11,3
R-HSA-73884,Base Excision Repair,2/14,92/10899,0.006004295782276896,0.03408492236974202,0.022013327930133247,H4C8/H2BC11,2
R-HSA-1912408,Pre-NOTCH Transcription and Translation,2/14,93/10899,0.006131763362058337,0.03408492236974202,0.022013327930133247,H4C8/H2BC11,2
R-HSA-3214815,HDACs deacetylate histones,2/14,94/10899,0.00626047336839837,0.03408492236974202,0.022013327930133247,H4C8/H2BC11,2
R-HSA-69473,G2/M DNA damage checkpoint,2/14,94/10899,0.00626047336839837,0.03408492236974202,0.022013327930133247,H4C8/H2BC11,2
R-HSA-5625740,RHO GTPases activate PKNs,2/14,95/10899,0.006390422871318898,0.03408492236974202,0.022013327930133247,H4C8/H2BC11,2
R-HSA-5693607,Processing of DNA double-strand break ends,2/14,97/10899,0.0066540286697902755,0.03408492236974202,0.022013327930133247,H4C8/H2BC11,2
R-HSA-8936459,RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function,2/14,97/10899,0.0066540286697902755,0.03408492236974202,0.022013327930133247,H4C8/H2BC11,2
R-HSA-9645723,Diseases of programmed cell death,2/14,105/10899,0.007757448871361748,0.036756399258851075,0.023738668424672118,H4C8/H2BC11,2
R-HSA-5250913,Positive epigenetic regulation of rRNA expression,2/14,106/10899,0.007900840758616105,0.036756399258851075,0.023738668424672118,H4C8/H2BC11,2
R-HSA-5578749,Transcriptional regulation by small RNAs,2/14,106/10899,0.007900840758616105,0.036756399258851075,0.023738668424672118,H4C8/H2BC11,2
R-HSA-195721,Signaling by WNT,3/14,332/10899,0.007942197532698245,0.036756399258851075,0.023738668424672118,H4C8/PSMC5/H2BC11,3
R-HSA-427413,NoRC negatively regulates rRNA expression,2/14,107/10899,0.008045437336881418,0.036756399258851075,0.023738668424672118,H4C8/H2BC11,2
R-HSA-1912422,Pre-NOTCH Expression and Processing,2/14,109/10899,0.008338233086446763,0.036756399258851075,0.023738668424672118,H4C8/H2BC11,2
R-HSA-5250941,Negative epigenetic regulation of rRNA expression,2/14,110/10899,0.008486426528962018,0.036756399258851075,0.023738668424672118,H4C8/H2BC11,2
R-HSA-73854,RNA Polymerase I Promoter Clearance,2/14,110/10899,0.008486426528962018,0.036756399258851075,0.023738668424672118,H4C8/H2BC11,2
R-HSA-977225,Amyloid fiber formation,2/14,111/10899,0.008635813204907503,0.036756399258851075,0.023738668424672118,H4C8/H2BC11,2
R-HSA-2559582,Senescence-Associated Secretory Phenotype (SASP),2/14,112/10899,0.008786390261079937,0.036756399258851075,0.023738668424672118,H4C8/H2BC11,2
R-HSA-73864,RNA Polymerase I Transcription,2/14,112/10899,0.008786390261079937,0.036756399258851075,0.023738668424672118,H4C8/H2BC11,2
R-HSA-157579,Telomere Maintenance,2/14,113/10899,0.008938154848741683,0.03677830929564201,0.023752818752480056,H4C8/H2BC11,2
R-HSA-9610379,HCMV Late Events,2/14,116/10899,0.009400545380152675,0.03805704661965035,0.024578675527054533,H4C8/H2BC11,2
R-HSA-1500620,Meiosis,2/14,118/10899,0.009714691365459747,0.0387045640115936,0.024996866671358413,H4C8/H2BC11,2
R-HSA-5617472,Activation of anterior HOX genes in hindbrain development during early embryogenesis,2/14,121/10899,0.010194682304357928,0.03936715782144369,0.025424794734754997,H4C8/H2BC11,2
R-HSA-5619507,Activation of HOX genes during differentiation,2/14,121/10899,0.010194682304357928,0.03936715782144369,0.025424794734754997,H4C8/H2BC11,2
R-HSA-2559580,Oxidative Stress Induced Senescence,2/14,125/10899,0.010850926487524414,0.041266402248009516,0.026651398390410842,H4C8/H2BC11,2
R-HSA-5693567,HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA),2/14,132/10899,0.012043556654686307,0.04511839881083975,0.029139162997984157,H4C8/H2BC11,2
R-HSA-9609690,HCMV Early Events,2/14,135/10899,0.012571711522836168,0.04640440576811586,0.029969714775801393,H4C8/H2BC11,2
R-HSA-211000,Gene Silencing by RNA,2/14,138/10899,0.013109975489310047,0.047006407082143035,0.030358509920947907,H4C8/H2BC11,2
R-HSA-5693538,Homology Directed Repair,2/14,138/10899,0.013109975489310047,0.047006407082143035,0.030358509920947907,H4C8/H2BC11,2
R-HSA-73886,Chromosome Maintenance,2/14,141/10899,0.013658274603735388,0.047006407082143035,0.030358509920947907,H4C8/H2BC11,2
R-HSA-3214847,HATs acetylate histones,2/14,142/10899,0.013843258276931903,0.047006407082143035,0.030358509920947907,H4C8/H2BC11,2
R-HSA-68875,Mitotic Prophase,2/14,142/10899,0.013843258276931903,0.047006407082143035,0.030358509920947907,H4C8/H2BC11,2
R-HSA-1474165,Reproduction,2/14,143/10899,0.014029346068504544,0.047006407082143035,0.030358509920947907,H4C8/H2BC11,2
R-HSA-1234158,Regulation of gene expression by Hypoxia-inducible Factor,1/14,11/10899,0.014045739167971028,0.047006407082143035,0.030358509920947907,VEGFA,1
R-HSA-68886,M Phase,3/14,418/10899,0.01487198426377067,0.049116684871137344,0.031721406878402816,H4C8/PSMC5/H2BC11,3
R-HSA-212165,Epigenetic regulation of gene expression,2/14,149/10899,0.015168907673322947,0.04943621526411121,0.03192777165306407,H4C8/H2BC11,2
R-HSA-9018519,Estrogen-dependent gene expression,2/14,150/10899,0.015362648568130176,0.04943621526411121,0.03192777165306407,H4C8/H2BC11,2
R-HSA-9609646,HCMV Infection,2/14,160/10899,0.017359156261232328,0.0551537749565736,0.03562038726488713,H4C8/H2BC11,2
R-HSA-6803205,TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain,1/14,14/10899,0.01784447630819963,0.05598704441697634,0.036158544098193995,NDRG1,1
R-HSA-5693532,DNA Double-Strand Break Repair,2/14,168/10899,0.019032518526651963,0.05848820012834517,0.03777388475472911,H4C8/H2BC11,2
R-HSA-8866910,TFAP2 (AP-2) family regulates transcription of growth factors and their receptors,1/14,15/10899,0.019107698846710375,0.05848820012834517,0.03777388475472911,VEGFA,1
R-HSA-8866427,VLDLR internalisation and degradation,1/14,16/10899,0.020369412574764434,0.06159906694296232,0.039782999828962884,VLDLR,1
R-HSA-5619115,Disorders of transmembrane transporters,2/14,176/10899,0.020772119593896587,0.062069071643667185,0.040086546584712716,SLC2A1/PSMC5,2
R-HSA-6803204,TP53 Regulates Transcription of Genes Involved in Cytochrome C Release,1/14,20/10899,0.025401212630617676,0.07484484995714093,0.0483376258897031,BNIP3L,1
R-HSA-2559583,Cellular Senescence,2/14,197/10899,0.02564405217655028,0.07484484995714093,0.0483376258897031,H4C8/H2BC11,2
R-HSA-189200,Cellular hexose transport,1/14,21/10899,0.026655407227839212,0.0760284910703141,0.04910206594601961,SLC2A1,1
R-HSA-5218921,VEGFR2 mediated cell proliferation,1/14,21/10899,0.026655407227839212,0.0760284910703141,0.04910206594601961,VEGFA,1
R-HSA-379716,Cytosolic tRNA aminoacylation,1/14,24/10899,0.030409004510477122,0.08576022620370514,0.05538718739933149,YARS1,1
R-HSA-5689880,Ub-specific processing proteases,2/14,220/10899,0.03146555401671285,0.08775393397994362,0.056674799047646544,PSMC5/H2BC11,2
R-HSA-8939211,ESR-mediated signaling,2/14,223/10899,0.032260803542453705,0.08898309548522945,0.05746863788939122,H4C8/H2BC11,2
R-HSA-70263,Gluconeogenesis,1/14,34/10899,0.042824141552143646,0.11683542966943537,0.07545672538936066,GAPDH,1
R-HSA-8964043,Plasma lipoprotein clearance,1/14,37/10899,0.046519797169317645,0.12279357078664865,0.07930471755564644,VLDLR,1
R-HSA-9029569,NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux,1/14,37/10899,0.046519797169317645,0.12279357078664865,0.07930471755564644,ARL4C,1
R-HSA-3247509,Chromatin modifying enzymes,2/14,274/10899,0.04696487169529191,0.12279357078664865,0.07930471755564644,H4C8/H2BC11,2
R-HSA-4839726,Chromatin organization,2/14,274/10899,0.04696487169529191,0.12279357078664865,0.07930471755564644,H4C8/H2BC11,2
R-HSA-8864260,Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors,1/14,38/10899,0.04774873501130139,0.12355600502924381,0.07979712633467624,VEGFA,1
R-HSA-379724,tRNA Aminoacylation,1/14,42/10899,0.05264979293698102,0.13484793905287995,0.08708988305365283,YARS1,1
R-HSA-71387,Metabolism of carbohydrates,2/14,295/10899,0.05362705964386186,0.13596355525868006,0.08781039006012469,GAPDH/SLC2A1,2
R-HSA-5688426,Deubiquitination,2/14,298/10899,0.05460575359721089,0.13706044152899932,0.08851880056811029,PSMC5/H2BC11,2
R-HSA-9024446,NR1H2 and NR1H3-mediated signaling,1/14,47/10899,0.05874317669415319,0.13734143521660103,0.08870027688553808,ARL4C,1
R-HSA-1236978,Cross-presentation of soluble exogenous antigens (endosomes),1/14,49/10899,0.06117032410324674,0.13734143521660103,0.08870027688553808,PSMC5,1
R-HSA-211733,Regulation of activated PAK-2p34 by proteasome mediated degradation,1/14,50/10899,0.06238171723343633,0.13734143521660103,0.08870027688553808,PSMC5,1
R-HSA-3214842,HDMs demethylate histones,1/14,50/10899,0.06238171723343633,0.13734143521660103,0.08870027688553808,H4C8,1
R-HSA-350562,Regulation of ornithine decarboxylase (ODC),1/14,51/10899,0.06359165879106699,0.13734143521660103,0.08870027688553808,PSMC5,1
R-HSA-195258,RHO GTPase Effectors,2/14,327/10899,0.0643965914343951,0.13734143521660103,0.08870027688553808,H4C8/H2BC11,2
R-HSA-180534,Vpu mediated degradation of CD4,1/14,52/10899,0.06480015038185971,0.13734143521660103,0.08870027688553808,PSMC5,1
R-HSA-349425,Autodegradation of the E3 ubiquitin ligase COP1,1/14,52/10899,0.06480015038185971,0.13734143521660103,0.08870027688553808,PSMC5,1
R-HSA-69601,Ubiquitin Mediated Degradation of Phosphorylated Cdc25A,1/14,52/10899,0.06480015038185971,0.13734143521660103,0.08870027688553808,PSMC5,1
R-HSA-69610,p53-Independent DNA Damage Response,1/14,52/10899,0.06480015038185971,0.13734143521660103,0.08870027688553808,PSMC5,1
R-HSA-69613,p53-Independent G1/S DNA damage checkpoint,1/14,52/10899,0.06480015038185971,0.13734143521660103,0.08870027688553808,PSMC5,1
R-HSA-75815,Ubiquitin-dependent degradation of Cyclin D,1/14,52/10899,0.06480015038185971,0.13734143521660103,0.08870027688553808,PSMC5,1
R-HSA-9762114,GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2,1/14,52/10899,0.06480015038185971,0.13734143521660103,0.08870027688553808,PSMC5,1
R-HSA-169911,Regulation of Apoptosis,1/14,53/10899,0.06600719360990948,0.13734143521660103,0.08870027688553808,PSMC5,1
R-HSA-180585,Vif-mediated degradation of APOBEC3G,1/14,54/10899,0.067212790077682,0.13734143521660103,0.08870027688553808,PSMC5,1
R-HSA-8854050,FBXL7 down-regulates AURKA during mitotic entry and in early mitosis,1/14,54/10899,0.067212790077682,0.13734143521660103,0.08870027688553808,PSMC5,1
R-HSA-9604323,Negative regulation of NOTCH4 signaling,1/14,54/10899,0.067212790077682,0.13734143521660103,0.08870027688553808,PSMC5,1
R-HSA-73894,DNA Repair,2/14,336/10899,0.06755199624777364,0.13734143521660103,0.08870027688553808,H4C8/H2BC11,2
R-HSA-174113,SCF-beta-TrCP mediated degradation of Emi1,1/14,55/10899,0.06841694138601873,0.13734143521660103,0.08870027688553808,PSMC5,1
R-HSA-4641257,Degradation of AXIN,1/14,55/10899,0.06841694138601873,0.13734143521660103,0.08870027688553808,PSMC5,1
R-HSA-8941858,Regulation of RUNX3 expression and activity,1/14,55/10899,0.06841694138601873,0.13734143521660103,0.08870027688553808,PSMC5,1
R-HSA-9700206,Signaling by ALK in cancer,1/14,55/10899,0.06841694138601873,0.13734143521660103,0.08870027688553808,TFG,1
R-HSA-9725370,Signaling by ALK fusions and activated point mutants,1/14,55/10899,0.06841694138601873,0.13734143521660103,0.08870027688553808,TFG,1
R-HSA-450408,AUF1 (hnRNP D0) binds and destabilizes mRNA,1/14,56/10899,0.06961964913413721,0.13734143521660103,0.08870027688553808,PSMC5,1
R-HSA-5362768,Hh mutants are degraded by ERAD,1/14,56/10899,0.06961964913413721,0.13734143521660103,0.08870027688553808,PSMC5,1
R-HSA-4641258,Degradation of DVL,1/14,57/10899,0.07082091491963205,0.13734143521660103,0.08870027688553808,PSMC5,1
R-HSA-69541,Stabilization of p53,1/14,57/10899,0.07082091491963205,0.13734143521660103,0.08870027688553808,PSMC5,1
R-HSA-351202,Metabolism of polyamines,1/14,59/10899,0.07321912698502908,0.13734143521660103,0.08870027688553808,PSMC5,1
R-HSA-5387390,Hh mutants abrogate ligand secretion,1/14,59/10899,0.07321912698502908,0.13734143521660103,0.08870027688553808,PSMC5,1
R-HSA-5676590,NIK-->noncanonical NF-kB signaling,1/14,59/10899,0.07321912698502908,0.13734143521660103,0.08870027688553808,PSMC5,1
R-HSA-8866654,E3 ubiquitin ligases ubiquitinate target proteins,1/14,59/10899,0.07321912698502908,0.13734143521660103,0.08870027688553808,H2BC11,1
R-HSA-187577,SCF(Skp2)-mediated degradation of p27/p21,1/14,60/10899,0.07441607645202286,0.13734143521660103,0.08870027688553808,PSMC5,1
R-HSA-5607761,Dectin-1 mediated noncanonical NF-kB signaling,1/14,60/10899,0.07441607645202286,0.13734143521660103,0.08870027688553808,PSMC5,1
R-HSA-5610780,Degradation of GLI1 by the proteasome,1/14,60/10899,0.07441607645202286,0.13734143521660103,0.08870027688553808,PSMC5,1
R-HSA-5610783,Degradation of GLI2 by the proteasome,1/14,60/10899,0.07441607645202286,0.13734143521660103,0.08870027688553808,PSMC5,1
R-HSA-5610785,GLI3 is processed to GLI3R by the proteasome,1/14,60/10899,0.07441607645202286,0.13734143521660103,0.08870027688553808,PSMC5,1
R-HSA-5678895,Defective CFTR causes cystic fibrosis,1/14,61/10899,0.07561159033057896,0.1385292640363162,0.08946742152062359,PSMC5,1
R-HSA-3700989,Transcriptional Regulation by TP53,2/14,362/10899,0.07695921365107021,0.13997654077114946,0.09040212740095205,BNIP3L/NDRG1,2
R-HSA-174084,Autodegradation of Cdh1 by Cdh1:APC/C,1/14,64/10899,0.07918953432261455,0.1414024913034797,0.09132306001566734,PSMC5,1
R-HSA-4608870,Asymmetric localization of PCP proteins,1/14,64/10899,0.07918953432261455,0.1414024913034797,0.09132306001566734,PSMC5,1
R-HSA-5358346,Hedgehog ligand biogenesis,1/14,65/10899,0.08037932172635087,0.1414024913034797,0.09132306001566734,PSMC5,1
R-HSA-1234176,Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha,1/14,66/10899,0.0815676814730587,0.1414024913034797,0.09132306001566734,PSMC5,1
R-HSA-69563,p53-Dependent G1 DNA Damage Response,1/14,66/10899,0.0815676814730587,0.1414024913034797,0.09132306001566734,PSMC5,1
R-HSA-69580,p53-Dependent G1/S DNA damage checkpoint,1/14,66/10899,0.0815676814730587,0.1414024913034797,0.09132306001566734,PSMC5,1
R-HSA-1169091,Activation of NF-kappaB in B cells,1/14,67/10899,0.08275461514419091,0.1414024913034797,0.09132306001566734,PSMC5,1
R-HSA-174154,APC/C:Cdc20 mediated degradation of Securin,1/14,68/10899,0.08394012431959552,0.1414024913034797,0.09132306001566734,PSMC5,1
R-HSA-204005,COPII-mediated vesicle transport,1/14,68/10899,0.08394012431959552,0.1414024913034797,0.09132306001566734,TFG,1
R-HSA-5658442,Regulation of RAS by GAPs,1/14,68/10899,0.08394012431959552,0.1414024913034797,0.09132306001566734,PSMC5,1
R-HSA-69615,G1/S DNA Damage Checkpoints,1/14,68/10899,0.08394012431959552,0.1414024913034797,0.09132306001566734,PSMC5,1
R-HSA-8948751,Regulation of PTEN stability and activity,1/14,69/10899,0.08512421057751507,0.14244117903304188,0.09199388371184085,PSMC5,1
R-HSA-3214841,PKMTs methylate histone lysines,1/14,71/10899,0.08748812064585676,0.14259427455915616,0.09209275857458608,H4C8,1
R-HSA-4551638,SUMOylation of chromatin organization proteins,1/14,71/10899,0.08748812064585676,0.14259427455915616,0.09209275857458608,H4C8,1
R-HSA-68949,Orc1 removal from chromatin,1/14,71/10899,0.08748812064585676,0.14259427455915616,0.09209275857458608,PSMC5,1
R-HSA-70171,Glycolysis,1/14,71/10899,0.08748812064585676,0.14259427455915616,0.09209275857458608,GAPDH,1
R-HSA-174184,Cdc20:Phospho-APC/C mediated degradation of Cyclin A,1/14,73/10899,0.08984635794312612,0.1427928853814602,0.09222102893162036,PSMC5,1
R-HSA-69017,CDK-mediated phosphorylation and removal of Cdc6,1/14,73/10899,0.08984635794312612,0.1427928853814602,0.09222102893162036,PSMC5,1
R-HSA-8939902,Regulation of RUNX2 expression and activity,1/14,73/10899,0.08984635794312612,0.1427928853814602,0.09222102893162036,PSMC5,1
R-HSA-174178,APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1,1/14,74/10899,0.09102335323120969,0.1427928853814602,0.09222102893162036,PSMC5,1
R-HSA-174824,"Plasma lipoprotein assembly, remodeling, and clearance",1/14,74/10899,0.09102335323120969,0.1427928853814602,0.09222102893162036,VLDLR,1
R-HSA-179419,APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint,1/14,74/10899,0.09102335323120969,0.1427928853814602,0.09222102893162036,PSMC5,1
R-HSA-176409,APC/C:Cdc20 mediated degradation of mitotic proteins,1/14,76/10899,0.09337310492951245,0.14475402886796382,0.09348760933389151,PSMC5,1
R-HSA-176814,Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins,1/14,77/10899,0.09454586447224411,0.14475402886796382,0.09348760933389151,PSMC5,1
R-HSA-8852276,The role of GTSE1 in G2/M progression after G2 checkpoint,1/14,77/10899,0.09454586447224411,0.14475402886796382,0.09348760933389151,PSMC5,1
R-HSA-422356,Regulation of insulin secretion,1/14,78/10899,0.09571721522971866,0.14475402886796382,0.09348760933389151,SLC2A1,1
R-HSA-5619084,ABC transporter disorders,1/14,78/10899,0.09571721522971866,0.14475402886796382,0.09348760933389151,PSMC5,1
R-HSA-3214858,RMTs methylate histone arginines,1/14,79/10899,0.09688715876421483,0.14475402886796382,0.09348760933389151,H4C8,1
R-HSA-8852135,Protein ubiquitination,1/14,79/10899,0.09688715876421483,0.14475402886796382,0.09348760933389151,H2BC11,1
R-HSA-9759194,Nuclear events mediated by NFE2L2,1/14,79/10899,0.09688715876421483,0.14475402886796382,0.09348760933389151,PSMC5,1
R-HSA-176408,Regulation of APC/C activators between G1/S and early anaphase,1/14,81/10899,0.09922283040544988,0.14649296469812226,0.09461067965406093,PSMC5,1
R-HSA-2871837,FCERI mediated NF-kB activation,1/14,82/10899,0.10038856162881094,0.14649296469812226,0.09461067965406093,PSMC5,1
R-HSA-9013694,Signaling by NOTCH4,1/14,82/10899,0.10038856162881094,0.14649296469812226,0.09461067965406093,PSMC5,1
R-HSA-1168372,Downstream signaling events of B Cell Receptor (BCR),1/14,83/10899,0.10155289186244332,0.14649296469812226,0.09461067965406093,PSMC5,1
R-HSA-195253,Degradation of beta-catenin by the destruction complex,1/14,83/10899,0.10155289186244332,0.14649296469812226,0.09461067965406093,PSMC5,1
R-HSA-69202,Cyclin E associated events during G1/S transition ,1/14,83/10899,0.10155289186244332,0.14649296469812226,0.09461067965406093,PSMC5,1
R-HSA-5632684,Hedgehog 'on' state,1/14,85/10899,0.10387735557634792,0.14814327414581435,0.09567651171505732,PSMC5,1
R-HSA-69656,Cyclin A:Cdk2-associated events at S phase entry,1/14,85/10899,0.10387735557634792,0.14814327414581435,0.09567651171505732,PSMC5,1
R-HSA-5663202,Diseases of signal transduction by growth factor receptors and second messengers,2/14,433/10899,0.10462580937909122,0.14836767318729885,0.09582143707630122,TFG/PSMC5,2
R-HSA-174143,APC/C-mediated degradation of cell cycle proteins,1/14,88/10899,0.10735358253169647,0.1496986067525323,0.09668100415135239,PSMC5,1
R-HSA-450531,Regulation of mRNA stability by proteins that bind AU-rich elements,1/14,88/10899,0.10735358253169647,0.1496986067525323,0.09668100415135239,PSMC5,1
R-HSA-453276,Regulation of mitotic cell cycle,1/14,88/10899,0.10735358253169647,0.1496986067525323,0.09668100415135239,PSMC5,1
R-HSA-5687128,MAPK6/MAPK4 signaling,1/14,89/10899,0.10850953941307273,0.15047455465569753,0.09718214056186801,PSMC5,1
R-HSA-1236974,ER-Phagosome pathway,1/14,90/10899,0.10966410615203825,0.15109805332786388,0.09758481951139042,PSMC5,1
R-HSA-70326,Glucose metabolism,1/14,91/10899,0.11081728429190962,0.15109805332786388,0.09758481951139042,GAPDH,1
R-HSA-163125,Post-translational modification: synthesis of GPI-anchored proteins,1/14,92/10899,0.11196907537443301,0.15109805332786388,0.09758481951139042,NRN1,1
R-HSA-4086400,PCP/CE pathway,1/14,92/10899,0.11196907537443301,0.15109805332786388,0.09758481951139042,PSMC5,1
R-HSA-69052,Switching of origins to a post-replicative state,1/14,92/10899,0.11196907537443301,0.15109805332786388,0.09758481951139042,PSMC5,1
R-HSA-8878159,Transcriptional regulation by RUNX3,1/14,96/10899,0.1165623999110682,0.15645541378437497,0.1010448048764678,PSMC5,1
R-HSA-202424,Downstream TCR signaling,1/14,98/10899,0.1188507798054842,0.15768701065695448,0.10184021657022853,PSMC5,1
R-HSA-5619102,SLC transporter disorders,1/14,98/10899,0.1188507798054842,0.15768701065695448,0.10184021657022853,SLC2A1,1
R-HSA-4420097,VEGFA-VEGFR2 Pathway,1/14,99/10899,0.11999290452381794,0.15768701065695448,0.10184021657022853,VEGFA,1
R-HSA-9679191,Potential therapeutics for SARS,1/14,99/10899,0.11999290452381794,0.15768701065695448,0.10184021657022853,VEGFA,1
R-HSA-449147,Signaling by Interleukins,2/14,473/10899,0.12130819445517689,0.15804168399729296,0.10206927798525108,VEGFA/PSMC5,2
R-HSA-5607764,CLEC7A (Dectin-1) signaling,1/14,101/10899,0.12227303114889987,0.15804168399729296,0.10206927798525108,PSMC5,1
R-HSA-5668541,TNFR2 non-canonical NF-kB pathway,1/14,102/10899,0.12341103610943993,0.15804168399729296,0.10206927798525108,PSMC5,1
R-HSA-5689603,UCH proteinases,1/14,102/10899,0.12341103610943993,0.15804168399729296,0.10206927798525108,PSMC5,1
R-HSA-9755511,KEAP1-NFE2L2 pathway,1/14,102/10899,0.12341103610943993,0.15804168399729296,0.10206927798525108,PSMC5,1
R-HSA-382556,ABC-family proteins mediated transport,1/14,103/10899,0.1245476708685832,0.15868764156352477,0.10248646173530224,PSMC5,1
R-HSA-1236975,Antigen processing-Cross presentation,1/14,105/10899,0.1268168358731656,0.16076275658668976,0.10382664925288414,PSMC5,1
R-HSA-163685,Integration of energy metabolism,1/14,108/10899,0.13021034489440375,0.16260097795271314,0.10501384191536098,SLC2A1,1
R-HSA-194138,Signaling by VEGF,1/14,108/10899,0.13021034489440375,0.16260097795271314,0.10501384191536098,VEGFA,1
R-HSA-6785807,Interleukin-4 and Interleukin-13 signaling,1/14,108/10899,0.13021034489440375,0.16260097795271314,0.10501384191536098,VEGFA,1
R-HSA-983705,Signaling by the B Cell Receptor (BCR),1/14,112/10899,0.13471597542317892,0.16739460312484114,0.10810974577993518,PSMC5,1
R-HSA-5610787,Hedgehog 'off' state,1/14,113/10899,0.13583899167830826,0.16795855621308065,0.10847396794638049,PSMC5,1
R-HSA-9020702,Interleukin-1 signaling,1/14,115/10899,0.13808096509436585,0.16989373646414624,0.1097237803123444,PSMC5,1
R-HSA-202403,TCR signaling,1/14,120/10899,0.14366229075838177,0.17554784892771352,0.11337541931167074,PSMC5,1
R-HSA-69239,Synthesis of DNA,1/14,121/10899,0.14477452082883147,0.17554784892771352,0.11337541931167074,PSMC5,1
R-HSA-8878166,Transcriptional regulation by RUNX2,1/14,121/10899,0.14477452082883147,0.17554784892771352,0.11337541931167074,PSMC5,1
R-HSA-196849,Metabolism of water-soluble vitamins and cofactors,1/14,124/10899,0.14810316784454303,0.17872064965855913,0.11542453364402647,SLC2A1,1
R-HSA-114608,Platelet degranulation ,1/14,129/10899,0.15362419166188046,0.18449603879010523,0.11915449768788514,VEGFA,1
R-HSA-162909,Host Interactions of HIV factors,1/14,130/10899,0.15472440162629408,0.18493249908666579,0.11943638020275335,PSMC5,1
R-HSA-69206,G1/S Transition,1/14,131/10899,0.15582328345164742,0.18536324239982702,0.11971457047420157,PSMC5,1
R-HSA-2454202,Fc epsilon receptor (FCERI) signaling,1/14,134/10899,0.159111974886744,0.18749814881020066,0.12109337352388722,PSMC5,1
R-HSA-76005,Response to elevated platelet cytosolic Ca2+,1/14,134/10899,0.159111974886744,0.18749814881020066,0.12109337352388722,VEGFA,1
R-HSA-6807070,PTEN Regulation,1/14,140/10899,0.1656536973395385,0.194294757159926,0.12548287944067354,PSMC5,1
R-HSA-5621481,C-type lectin receptors (CLRs),1/14,142/10899,0.16782374858053373,0.1959244692730882,0.12653540896647342,PSMC5,1
R-HSA-3858494,Beta-catenin independent WNT signaling,1/14,146/10899,0.17214813701953025,0.20004251107362078,0.1291949956189457,PSMC5,1
R-HSA-453279,Mitotic G1 phase and G1/S transition,1/14,149/10899,0.17537772453314127,0.20192572870558928,0.1304112485664112,PSMC5,1
R-HSA-5358351,Signaling by Hedgehog,1/14,149/10899,0.17537772453314127,0.20192572870558928,0.1304112485664112,PSMC5,1
R-HSA-446652,Interleukin-1 family signaling,1/14,153/10899,0.17966564413230146,0.205918158343414,0.13298971014839908,PSMC5,1
R-HSA-199977,ER to Golgi Anterograde Transport,1/14,154/10899,0.18073438421997523,0.20620150199642628,0.13317270416208704,TFG,1
R-HSA-69242,S Phase,1/14,163/10899,0.1902950315938824,0.21612693633513338,0.13958292386500543,PSMC5,1
R-HSA-983231,Factors involved in megakaryocyte development and platelet production,1/14,168/10899,0.19556163225467904,0.22110797160326323,0.1427998642352801,MAFF,1
R-HSA-9010553,Regulation of expression of SLITs and ROBOs,1/14,171/10899,0.19870630586980775,0.2236559765619809,0.1444454619020552,PSMC5,1
R-HSA-109581,Apoptosis,1/14,180/10899,0.20807197093319263,0.23315207457246137,0.15057840001744205,PSMC5,1
R-HSA-3108232,SUMO E3 ligases SUMOylate target proteins,1/14,182/10899,0.21013937808481453,0.23442215066350422,0.15139866304122312,H4C8,1
R-HSA-948021,Transport to the Golgi and subsequent modification,1/14,185/10899,0.21323109370355775,0.23681860406899558,0.15294638300115462,TFG,1
R-HSA-2990846,SUMOylation,1/14,188/10899,0.2163115688279259,0.2391815144308784,0.15447243959888984,H4C8,1
R-HSA-196854,Metabolism of vitamins and cofactors,1/14,190/10899,0.21835899283050575,0.24038643508972343,0.1552506227880789,SLC2A1,1
R-HSA-2467813,Separation of Sister Chromatids,1/14,191/10899,0.21938084119173207,0.24045672986517358,0.15529602180430588,PSMC5,1
R-HSA-9711123,Cellular response to chemical stress,1/14,194/10899,0.22243894841264222,0.2427485915285791,0.1567761924738989,PSMC5,1
R-HSA-69275,G2/M Transition,1/14,196/10899,0.22447150222693701,0.24390626432450732,0.15752386121188564,PSMC5,1
R-HSA-453274,Mitotic G2-G2/M phases,1/14,198/10899,0.22649912150848828,0.24504861852857998,0.15826163662571327,PSMC5,1
R-HSA-5357801,Programmed Cell Death,1/14,210/10899,0.23856182980136031,0.256991499056401,0.16597479913896318,PSMC5,1
R-HSA-376176,Signaling by ROBO receptors,1/14,218/10899,0.24650633708367198,0.26441491712821225,0.17076912240614256,PSMC5,1
R-HSA-162906,HIV Infection,1/14,231/10899,0.25925218566932096,0.27690339831063643,0.17883465439227517,PSMC5,1
R-HSA-68882,Mitotic Anaphase,1/14,236/10899,0.26410090173389555,0.28072507366797617,0.18130283642217795,PSMC5,1
R-HSA-2555396,Mitotic Metaphase and Anaphase,1/14,237/10899,0.26506710143151535,0.28072507366797617,0.18130283642217795,PSMC5,1
R-HSA-8951664,Neddylation,1/14,240/10899,0.2679586373994207,0.2825950335598933,0.1825105270212773,PSMC5,1
R-HSA-425407,SLC-mediated transmembrane transport,1/14,250/10899,0.2775209743228868,0.2914550818202702,0.1882326802278114,SLC2A1,1
R-HSA-76002,"Platelet activation, signaling and aggregation",1/14,263/10899,0.28977864528819,0.3030601665305654,0.1957276814665845,VEGFA,1
R-HSA-1257604,PIP3 activates AKT signaling,1/14,267/10899,0.29351120690000365,0.30569009515311585,0.1974261885241344,PSMC5,1
R-HSA-5673001,RAF/MAP kinase cascade,1/14,280/10899,0.30551661062859103,0.316878798627175,0.20465227506221412,PSMC5,1
R-HSA-5684996,MAPK1/MAPK3 signaling,1/14,286/10899,0.31099342714348477,0.3212318938807189,0.2074636680965851,PSMC5,1
R-HSA-72766,Translation,1/14,291/10899,0.31552677551926867,0.32457877317760836,0.20962520892997147,YARS1,1
R-HSA-446203,Asparagine N-linked glycosylation,1/14,304/10899,0.32718418924927484,0.33519686327170606,0.2164827718341067,TFG,1
R-HSA-9006925,Intracellular signaling by second messengers,1/14,309/10899,0.3316185121366927,0.33698885241420995,0.2176401059835955,PSMC5,1
R-HSA-983168,Antigen processing: Ubiquitination & Proteasome degradation,1/14,309/10899,0.3316185121366927,0.33698885241420995,0.2176401059835955,PSMC5,1
R-HSA-5683057,MAPK family signaling cascades,1/14,325/10899,0.34562664917308283,0.34980761670340244,0.22591894725235473,PSMC5,1
R-HSA-71291,Metabolism of amino acids and derivatives,1/14,374/10899,0.38684910385680005,0.38995632557452536,0.25184849712089286,PSMC5,1
R-HSA-983169,Class I MHC mediated antigen processing & presentation,1/14,381/10899,0.3925371354628069,0.3941072840046581,0.254529342573778,PSMC5,1
R-HSA-9679506,SARS-CoV Infections,1/14,413/10899,0.41792107678977997,0.41792107678977997,0.2699091877778408,VEGFA,1
HALLMARK_HYPOXIA,HALLMARK_HYPOXIA,8/9,200/4383,1.4198093548273698e-10,2.8396187096547398e-9,2.2418042444642682e-9,KLF6/BNIP3L/GAPDH/SLC2A1/NDRG1/MAFF/VLDLR/VEGFA,8
HALLMARK_HEDGEHOG_SIGNALING,HALLMARK_HEDGEHOG_SIGNALING,2/9,36/4383,0.002277625698784191,0.022776256987841907,0.017981255516717295,VLDLR/VEGFA,2
HALLMARK_IL2_STAT5_SIGNALING,HALLMARK_IL2_STAT5_SIGNALING,3/9,199/4383,0.006320921110932765,0.025641759542735922,0.020243494375844148,KLF6/NDRG1/MAFF,3
HALLMARK_MTORC1_SIGNALING,HALLMARK_MTORC1_SIGNALING,3/9,200/4383,0.0064104398856839806,0.025641759542735922,0.020243494375844148,GAPDH/SLC2A1/VLDLR,3
HALLMARK_TNFA_SIGNALING_VIA_NFKB,HALLMARK_TNFA_SIGNALING_VIA_NFKB,3/9,200/4383,0.0064104398856839806,0.025641759542735922,0.020243494375844148,KLF6/MAFF/VEGFA,3
HALLMARK_GLYCOLYSIS,HALLMARK_GLYCOLYSIS,2/9,200/4383,0.060367138606587004,0.17247753887596287,0.1361664780599707,VLDLR/VEGFA,2
HALLMARK_HEME_METABOLISM,HALLMARK_HEME_METABOLISM,2/9,200/4383,0.060367138606587004,0.17247753887596287,0.1361664780599707,BNIP3L/SLC2A1,2
HALLMARK_ANGIOGENESIS,HALLMARK_ANGIOGENESIS,1/9,36/4383,0.07160253439996245,0.17900633599990612,0.14132079157887326,VEGFA,1
HALLMARK_PROTEIN_SECRETION,HALLMARK_PROTEIN_SECRETION,1/9,96/4383,0.18086000329858487,0.34343645249916344,0.271134041446708,BNIP3,1
HALLMARK_ANDROGEN_RESPONSE,HALLMARK_ANDROGEN_RESPONSE,1/9,100/4383,0.18771947751368945,0.34343645249916344,0.271134041446708,NDRG1,1
HALLMARK_PI3K_AKT_MTOR_SIGNALING,HALLMARK_PI3K_AKT_MTOR_SIGNALING,1/9,105/4383,0.19622199098222715,0.34343645249916344,0.271134041446708,SLC2A1,1
HALLMARK_UNFOLDED_PROTEIN_RESPONSE,HALLMARK_UNFOLDED_PROTEIN_RESPONSE,1/9,113/4383,0.2096615392246991,0.34343645249916344,0.271134041446708,VEGFA,1
HALLMARK_COAGULATION,HALLMARK_COAGULATION,1/9,138/4383,0.2503821828119722,0.34343645249916344,0.271134041446708,MAFF,1
HALLMARK_UV_RESPONSE_DN,HALLMARK_UV_RESPONSE_DN,1/9,144/4383,0.25987311823587833,0.34343645249916344,0.271134041446708,VLDLR,1
HALLMARK_APOPTOSIS,HALLMARK_APOPTOSIS,1/9,161/4383,0.2861867272291707,0.34343645249916344,0.271134041446708,BNIP3L,1
HALLMARK_COMPLEMENT,HALLMARK_COMPLEMENT,1/9,200/4383,0.34343645249916344,0.34343645249916344,0.271134041446708,MAFF,1
HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION,HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION,1/9,200/4383,0.34343645249916344,0.34343645249916344,0.271134041446708,VEGFA,1
HALLMARK_ESTROGEN_RESPONSE_EARLY,HALLMARK_ESTROGEN_RESPONSE_EARLY,1/9,200/4383,0.34343645249916344,0.34343645249916344,0.271134041446708,SLC2A1,1
HALLMARK_INFLAMMATORY_RESPONSE,HALLMARK_INFLAMMATORY_RESPONSE,1/9,200/4383,0.34343645249916344,0.34343645249916344,0.271134041446708,KLF6,1
HALLMARK_P53_PATHWAY,HALLMARK_P53_PATHWAY,1/9,200/4383,0.34343645249916344,0.34343645249916344,0.271134041446708,NDRG1,1
ELVIDGE_HYPOXIA_BY_DMOG_UP,ELVIDGE_HYPOXIA_BY_DMOG_UP,8/16,133/21728,1.9668750704296727e-14,1.825260065358736e-11,7.971020022267621e-12,KLF6/BNIP3L/BNIP3/SLC2A1/NDRG1/MAFF/VLDLR/VEGFA,8
ELVIDGE_HYPOXIA_UP,ELVIDGE_HYPOXIA_UP,8/16,172/21728,1.5961157661285373e-13,7.405977154836413e-11,3.2342345787341415e-11,KLF6/BNIP3L/BNIP3/SLC2A1/NDRG1/MAFF/VLDLR/VEGFA,8
ELVIDGE_HIF1A_TARGETS_DN,ELVIDGE_HIF1A_TARGETS_DN,6/16,92/21728,3.779271744809237e-11,1.1690547263943238e-8,5.105332006145812e-9,BNIP3L/BNIP3/SLC2A1/NDRG1/MAFF/VLDLR,6
MANALO_HYPOXIA_UP,MANALO_HYPOXIA_UP,7/16,205/21728,6.393344156620033e-11,1.4832558443358476e-8,6.4774671060492445e-9,BNIP3L/BNIP3/NDRG1/MAFF/ARL4C/VLDLR/VEGFA,7
ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN,ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN,6/16,105/21728,8.485765429095427e-11,1.5749580636401113e-8,6.877936189898401e-9,BNIP3L/BNIP3/SLC2A1/NDRG1/VLDLR/VEGFA,6
BUFFA_HYPOXIA_METAGENE,BUFFA_HYPOXIA_METAGENE,5/16,50/21728,2.2510917729067385e-10,3.481688608762422e-8,1.520474267665078e-8,GAPDH/BNIP3/SLC2A1/NDRG1/VEGFA,5
QI_HYPOXIA,QI_HYPOXIA,6/16,133/21728,3.5754675029981473e-10,4.74004834683183e-8,2.0700075017357698e-8,NRN1/BNIP3/SLC2A1/NDRG1/VLDLR/VEGFA,6
HARRIS_HYPOXIA,HARRIS_HYPOXIA,5/16,81/21728,2.686741656792113e-9,3.1166203218788513e-7,1.3610467603486364e-7,BNIP3L/GAPDH/BNIP3/SLC2A1/VEGFA,5
WINTER_HYPOXIA_UP,WINTER_HYPOXIA_UP,5/16,95/21728,6.039904651214843e-9,6.227812795919305e-7,2.719723147038263e-7,GAPDH/BNIP3/SLC2A1/NDRG1/VEGFA,5
FARDIN_HYPOXIA_11,FARDIN_HYPOXIA_11,4/16,32/21728,6.96252708792551e-9,6.461225137594873e-7,2.821655714580338e-7,BNIP3L/BNIP3/NDRG1/VEGFA,4
MENSE_HYPOXIA_UP,MENSE_HYPOXIA_UP,5/16,100/21728,7.831624806690438e-9,6.60704347328066e-7,2.8853354550964776e-7,BNIP3L/BNIP3/NDRG1/MAFF/VEGFA,5
SEMENZA_HIF1_TARGETS,SEMENZA_HIF1_TARGETS,4/16,36/21728,1.1384948814566471e-8,8.804360416598071e-7,3.8449169242176245e-7,GAPDH/BNIP3/SLC2A1/VEGFA,4
WP_PHOTODYNAMIC_THERAPYINDUCED_HIF1_SURVIVAL_SIGNALING,WP_PHOTODYNAMIC_THERAPYINDUCED_HIF1_SURVIVAL_SIGNALING,4/16,37/21728,1.2759298093397627e-8,8.89146035697596e-7,3.8829539898318337e-7,BNIP3L/BNIP3/SLC2A1/VEGFA,4
WINTER_HYPOXIA_METAGENE,WINTER_HYPOXIA_METAGENE,6/16,243/21728,1.3413841055782697e-8,8.89146035697596e-7,3.8829539898318337e-7,BNIP3L/GAPDH/BNIP3/SLC2A1/NDRG1/VEGFA,6
GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP,GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP,5/16,143/21728,4.742714039090951e-8,2.9341590855176014e-6,1.281364845649134e-6,KLF6/BNIP3/SLC2A1/NDRG1/VEGFA,5
PRAMOONJAGO_SOX4_TARGETS_UP,PRAMOONJAGO_SOX4_TARGETS_UP,4/16,52/21728,5.1955736300636e-8,3.013432705436888e-6,1.3159841102463724e-6,BNIP3/NDRG1/MAFF/VEGFA,4
GROSS_HYPOXIA_VIA_ELK3_DN,GROSS_HYPOXIA_VIA_ELK3_DN,5/16,157/21728,7.56889235452802e-8,4.131724767648236e-6,1.804348951389033e-6,KLF6/SLC2A1/NDRG1/VLDLR/VEGFA,5
PID_HIF1_TFPATHWAY,PID_HIF1_TFPATHWAY,4/16,66/21728,1.3746158840387077e-7,7.086908557710671e-6,3.0948954114321784e-6,BNIP3/SLC2A1/NDRG1/VEGFA,4
VANDESLUIS_COMMD1_TARGETS_GROUP_2_UP,VANDESLUIS_COMMD1_TARGETS_GROUP_2_UP,3/16,15/21728,1.4825586235614864e-7,7.24112843507926e-6,3.16224415551896e-6,BNIP3/MAFF/VEGFA,3
KIM_HYPOXIA,KIM_HYPOXIA,3/16,17/21728,2.2137035163549333e-7,1.027158431588689e-5,4.485662388403418e-6,BNIP3L/SLC2A1/VEGFA,3
JIANG_HYPOXIA_NORMAL,JIANG_HYPOXIA_NORMAL,5/16,200/21728,2.5282235706698356e-7,1.1172340350388607e-5,4.879027943397929e-6,BNIP3L/BNIP3/SLC2A1/NDRG1/TFG,5
IBRAHIM_NRF1_UP,IBRAHIM_NRF1_UP,6/16,419/21728,3.37375772506295e-7,1.4231123494810987e-5,6.2148168619580665e-6,GAPDH/BNIP3/SLC2A1/NDRG1/TFG/YARS1,6
MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP,MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP,5/16,239/21728,6.110226998063745e-7,2.4653437626970245e-5,1.0766303863865181e-5,NRN1/BNIP3L/BNIP3/NDRG1/VLDLR,5
WANG_ADIPOGENIC_GENES_REPRESSED_BY_SIRT1,WANG_ADIPOGENIC_GENES_REPRESSED_BY_SIRT1,3/16,27/21728,9.479526628666117e-7,3.6654169630842316e-5,1.6007095403668663e-5,GAPDH/SLC2A1/NDRG1,3
GROSS_HYPOXIA_VIA_HIF1A_DN,GROSS_HYPOXIA_VIA_HIF1A_DN,4/16,110/21728,1.0798663464606632e-6,4.0084638780619814e-5,1.750520182683602e-5,GAPDH/BNIP3/SLC2A1/VEGFA,4
BURTON_ADIPOGENESIS_1,BURTON_ADIPOGENESIS_1,3/16,31/21728,1.4541544440014191e-6,5.190212784743527e-5,2.266597007856463e-5,MAFF/ARL4C/VEGFA,3
GROSS_ELK3_TARGETS_DN,GROSS_ELK3_TARGETS_DN,3/16,33/21728,1.7634584106602303e-6,6.061071870713681e-5,2.6469063863711062e-5,BNIP3/MAFF/VLDLR,3
LEONARD_HYPOXIA,LEONARD_HYPOXIA,3/16,41/21728,3.433112994094297e-6,1.1378317351855385e-4,4.968979333557535e-5,BNIP3/SLC2A1/VEGFA,3
TIEN_INTESTINE_PROBIOTICS_24HR_DN,TIEN_INTESTINE_PROBIOTICS_24HR_DN,4/16,215/21728,1.545582755129395e-5,4.945864816414064e-4,2.1598887866599534e-4,BNIP3L/NDRG1/VEGFA/TFG,4
GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN,GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN,4/16,236/21728,2.2285763307027093e-5,6.893729449640381e-4,3.010532937966818e-4,BNIP3/SLC2A1/NDRG1/VEGFA,4
SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE,SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE,3/16,81/21728,2.698861919373998e-5,8.079173745738935e-4,3.5282235618301844e-4,NDRG1/VEGFA/YARS1,3
COATES_MACROPHAGE_M1_VS_M2_DN,COATES_MACROPHAGE_M1_VS_M2_DN,3/16,84/21728,3.0099871161003156e-5,8.728962636690915e-4,3.811990262166518e-4,BNIP3/SLC2A1/VEGFA,3
HOLLEMAN_PREDNISOLONE_RESISTANCE_B_ALL_DN,HOLLEMAN_PREDNISOLONE_RESISTANCE_B_ALL_DN,2/16,12/21728,3.3409480539165864e-5,8.865940113685483e-4,3.8718091467433203e-4,GAPDH/MAFF,2
WP_AEROBIC_GLYCOLYSIS,WP_AEROBIC_GLYCOLYSIS,2/16,12/21728,3.3409480539165864e-5,8.865940113685483e-4,3.8718091467433203e-4,GAPDH/SLC2A1,2
WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS,WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS,3/16,87/21728,3.3438351721874127e-5,8.865940113685483e-4,3.8718091467433203e-4,GAPDH/SLC2A1/VEGFA,3
MALIK_REPRESSED_BY_ESTROGEN,MALIK_REPRESSED_BY_ESTROGEN,2/16,13/21728,3.9466972799590344e-5,0.00101737085438944,4.442919452585464e-4,KLF6/NDRG1,2
FARMER_BREAST_CANCER_CLUSTER_3,FARMER_BREAST_CANCER_CLUSTER_3,2/16,16/21728,6.0640218792074236e-5,0.0014808979747117077,6.467170148185202e-4,NDRG1/VLDLR,2
MAINA_VHL_TARGETS_DN,MAINA_VHL_TARGETS_DN,2/16,16/21728,6.0640218792074236e-5,0.0014808979747117077,6.467170148185202e-4,BNIP3/VEGFA,2
VANTVEER_BREAST_CANCER_METASTASIS_DN,VANTVEER_BREAST_CANCER_METASTASIS_DN,3/16,109/21728,6.55768643990115e-5,0.001560393081084171,6.814330038763678e-4,BNIP3/NDRG1/VEGFA,3
WP_CORI_CYCLE,WP_CORI_CYCLE,2/16,17/21728,6.869606525079935e-5,0.0015937487138185447,6.959996084620461e-4,GAPDH/SLC2A1,2
SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP,SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP,3/16,112/21728,7.109925263401626e-5,0.001609270888887002,7.027782352784663e-4,BNIP3/SLC2A1/MAFF,3
SMIRNOV_RESPONSE_TO_IR_6HR_DN,SMIRNOV_RESPONSE_TO_IR_6HR_DN,3/16,114/21728,7.494496871466706e-5,0.0016292702545367976,7.115120780361469e-4,KLF6/BNIP3/MAFF,3
AMIT_DELAYED_EARLY_GENES,AMIT_DELAYED_EARLY_GENES,2/16,18/21728,7.724988275821023e-5,0.0016292702545367976,7.115120780361469e-4,KLF6/MAFF,2
KOBAYASHI_EGFR_SIGNALING_6HR_DN,KOBAYASHI_EGFR_SIGNALING_6HR_DN,2/16,18/21728,7.724988275821023e-5,0.0016292702545367976,7.115120780361469e-4,MAFF/VEGFA,2
FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL,FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL,4/16,327/21728,7.945227886129851e-5,0.0016384825507396671,7.155351429614019e-4,BNIP3/NDRG1/VLDLR/VEGFA,4
KAN_RESPONSE_TO_ARSENIC_TRIOXIDE,KAN_RESPONSE_TO_ARSENIC_TRIOXIDE,3/16,123/21728,9.393676286739526e-5,0.0018925049167510992,8.264682315666666e-4,BNIP3L/NDRG1/ARL4C,3
WP_HEREDITARY_LEIOMYOMATOSIS_AND_RENAL_CELL_CARCINOMA_PATHWAY,WP_HEREDITARY_LEIOMYOMATOSIS_AND_RENAL_CELL_CARCINOMA_PATHWAY,2/16,20/21728,9.58488481544199e-5,0.0018925049167510992,8.264682315666666e-4,SLC2A1/VEGFA,2
REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_HSCS,REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_HSCS,3/16,128/21728,1.0572896425858996e-4,0.002044093308999406,8.926677903411653e-4,H4C8/PSMC5/H2BC11,3
REACTOME_DNA_REPLICATION_PRE_INITIATION,REACTOME_DNA_REPLICATION_PRE_INITIATION,3/16,146/21728,0.00015609209745315339,0.002882787497824311,0.0012589305656333482,H4C8/PSMC5/H2BC11,3
PODAR_RESPONSE_TO_ADAPHOSTIN_UP,PODAR_RESPONSE_TO_ADAPHOSTIN_UP,3/16,148/21728,1.6249470234618553e-4,0.002882787497824311,0.0012589305656333482,KLF6/MAFF/VEGFA,3
BRACHAT_RESPONSE_TO_METHOTREXATE_DN,BRACHAT_RESPONSE_TO_METHOTREXATE_DN,2/16,26/21728,1.635300021370489e-4,0.002882787497824311,0.0012589305656333482,BNIP3L/GAPDH,2
GROSS_HIF1A_TARGETS_DN,GROSS_HIF1A_TARGETS_DN,2/16,26/21728,1.635300021370489e-4,0.002882787497824311,0.0012589305656333482,GAPDH/BNIP3,2
BASAKI_YBX1_TARGETS_DN,BASAKI_YBX1_TARGETS_DN,4/16,395/21728,1.6464195838867293e-4,0.002882787497824311,0.0012589305656333482,NDRG1/MAFF/VLDLR/VEGFA,4
WP_OREXIN_RECEPTOR_PATHWAY,WP_OREXIN_RECEPTOR_PATHWAY,3/16,154/21728,1.827225786170969e-4,0.0031401213510493693,0.001371309800537667,SLC2A1/MAFF/VEGFA,3
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_UP,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_UP,2/16,28/21728,1.900346688392818e-4,0.003206403139688245,0.0014002554546052343,KLF6/MAFF,2
SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP,SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP,3/16,159/21728,2.0077730471577097e-4,0.0033271667638613478,0.001452993652548343,MAFF/VEGFA/YARS1,3
HAN_SATB1_TARGETS_UP,HAN_SATB1_TARGETS_UP,4/16,425/21728,2.179575890165611e-4,0.0035485025018836616,0.001549652294946926,BNIP3/NDRG1/MAFF/VLDLR,4
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_WS,KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_WS,2/16,31/21728,2.3347181223665203e-4,0.0037139340949488993,0.0016218972624266407,BNIP3L/NDRG1,2
REACTOME_G2_M_CHECKPOINTS,REACTOME_G2_M_CHECKPOINTS,3/16,168/21728,2.3612296508834595e-4,0.0037139340949488993,0.0016218972624266407,H4C8/PSMC5/H2BC11,3
NAGASHIMA_NRG1_SIGNALING_UP,NAGASHIMA_NRG1_SIGNALING_UP,3/16,173/21728,2.573944905017707e-4,0.003981034786427386,0.0017385417340909073,KLF6/MAFF/VEGFA,3
MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP,MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP,3/16,178/21728,2.7987151122050197e-4,0.004143737972868378,0.0018095951900570844,BNIP3/SLC2A1/VEGFA,3
ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP,ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP,4/16,454/21728,2.804268541792999e-4,0.004143737972868378,0.0018095951900570844,KLF6/NDRG1/MAFF/VEGFA,4
PID_HIF2PATHWAY,PID_HIF2PATHWAY,2/16,34/21728,2.8130979772705584e-4,0.004143737972868378,0.0018095951900570844,SLC2A1/VEGFA,2
SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6,SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6,4/16,459/21728,0.00029237589741111395,0.004239450512461152,0.0018513934293302448,GAPDH/SLC2A1/VEGFA/TFG,4
WANG_METHYLATED_IN_BREAST_CANCER,WANG_METHYLATED_IN_BREAST_CANCER,2/16,35/21728,2.9823078302747757e-4,0.004257817948453834,0.0018594145986328566,KLF6/MAFF,2
WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA,WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA,2/16,36/21728,3.1563820289384027e-4,0.004438064428567936,0.0019381293160148092,SLC2A1/VEGFA,2
REACTOME_DNA_REPLICATION,REACTOME_DNA_REPLICATION,3/16,189/21728,3.3370836263015366e-4,0.004622109858519143,0.002018503057542956,H4C8/PSMC5/H2BC11,3
IVANOVA_HEMATOPOIESIS_STEM_CELL,IVANOVA_HEMATOPOIESIS_STEM_CELL,3/16,190/21728,3.38909624708481e-4,0.004625119584256917,0.002019817422798223,MAFF/ARL4C/VLDLR,3
PLASARI_TGFB1_TARGETS_10HR_UP,PLASARI_TGFB1_TARGETS_10HR_UP,3/16,195/21728,3.6570287268463113e-4,0.004915386894726337,0.002146578895723276,SLC2A1/MAFF/VEGFA,3
RASHI_RESPONSE_TO_IONIZING_RADIATION_1,RASHI_RESPONSE_TO_IONIZING_RADIATION_1,2/16,39/21728,3.7077271835220217e-4,0.004915386894726337,0.002146578895723276,SLC2A1/VEGFA,2
BRACHAT_RESPONSE_TO_CAMPTOTHECIN_DN,BRACHAT_RESPONSE_TO_CAMPTOTHECIN_DN,2/16,42/21728,4.3026230343947016e-4,0.0056237101069271595,0.0024559078847175096,BNIP3L/GAPDH,2
AMIT_EGF_RESPONSE_480_MCF10A,AMIT_EGF_RESPONSE_480_MCF10A,2/16,43/21728,4.5105700502484213e-4,0.005813623620320188,0.0025388442534293016,ARL4C/VEGFA,2
REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_CELL_DEATH_GENES,REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_CELL_DEATH_GENES,2/16,44/21728,4.7233307368809823e-4,0.005844334565100735,0.0025522559069462154,BNIP3L/NDRG1,2
SHIPP_DLBCL_CURED_VS_FATAL_DN,SHIPP_DLBCL_CURED_VS_FATAL_DN,2/16,44/21728,4.7233307368809823e-4,0.005844334565100735,0.0025522559069462154,GAPDH/VEGFA,2
WP_METABOLIC_REPROGRAMMING_IN_COLON_CANCER,WP_METABOLIC_REPROGRAMMING_IN_COLON_CANCER,2/16,44/21728,4.7233307368809823e-4,0.005844334565100735,0.0025522559069462154,GAPDH/SLC2A1,2
WP_GLYCOLYSIS_AND_GLUCONEOGENESIS,WP_GLYCOLYSIS_AND_GLUCONEOGENESIS,2/16,45/21728,4.940898785651711e-4,0.006033097464585247,0.002634689795673004,GAPDH/SLC2A1,2
OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP,OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP,3/16,222/21728,5.341117891730721e-4,0.006356821440590118,0.0027760619948130625,KLF6/MAFF/ARL4C,3
AMIT_EGF_RESPONSE_60_HELA,AMIT_EGF_RESPONSE_60_HELA,2/16,47/21728,5.390431763547479e-4,0.006356821440590118,0.0027760619948130625,KLF6/VEGFA,2
CHEN_HOXA5_TARGETS_9HR_UP,CHEN_HOXA5_TARGETS_9HR_UP,3/16,223/21728,5.411518252226501e-4,0.006356821440590118,0.0027760619948130625,KLF6/MAFF/VEGFA,3
GERHOLD_ADIPOGENESIS_UP,GERHOLD_ADIPOGENESIS_UP,2/16,48/21728,5.622384103880999e-4,0.006441447467162428,0.0028130186874518316,VLDLR/VEGFA,2
WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2586,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2586,2/16,48/21728,5.622384103880999e-4,0.006441447467162428,0.0028130186874518316,KLF6/VEGFA,2
REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT,REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT,3/16,232/21728,6.072112372985302e-4,0.006789060580879952,0.0029648234161056965,H4C8/PSMC5/H2BC11,3
ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF,ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF,3/16,232/21728,6.072112372985302e-4,0.006789060580879952,0.0029648234161056965,SLC2A1/NDRG1/MAFF,3
REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1,3/16,237/21728,6.460469077933127e-4,0.007137280124192787,0.0031168929761958074,H4C8/PSMC5/H2BC11,3
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP,KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP,2/16,53/21728,6.853753055405967e-4,0.007482685688725574,0.0032677336548994395,BNIP3L/NDRG1,2
REACTOME_RECOGNITION_AND_ASSOCIATION_OF_DNA_GLYCOSYLASE_WITH_SITE_CONTAINING_AN_AFFECTED_PURINE,REACTOME_RECOGNITION_AND_ASSOCIATION_OF_DNA_GLYCOSYLASE_WITH_SITE_CONTAINING_AN_AFFECTED_PURINE,2/16,54/21728,7.114304413920519e-4,0.007588655526692204,0.003314011317804559,H4C8/H2BC11,2
REACTOME_SIGNALING_BY_NOTCH,REACTOME_SIGNALING_BY_NOTCH,3/16,245/21728,7.114364556273942e-4,0.007588655526692204,0.003314011317804559,H4C8/PSMC5/H2BC11,3
BILD_HRAS_ONCOGENIC_SIGNATURE,BILD_HRAS_ONCOGENIC_SIGNATURE,3/16,250/21728,7.54377522734822e-4,0.007955253876112667,0.003474107012594575,KLF6/NDRG1/VEGFA,3
DANG_REGULATED_BY_MYC_DN,DANG_REGULATED_BY_MYC_DN,3/16,251/21728,7.631598809961477e-4,0.007957442354656463,0.00347506273428169,NDRG1/VLDLR/VEGFA,3
NAGASHIMA_EGF_SIGNALING_UP,NAGASHIMA_EGF_SIGNALING_UP,2/16,57/21728,7.924401042150239e-4,0.008170937963461581,0.003568297545295722,KLF6/MAFF,2
DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP,DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP,3/16,258/21728,8.264726334805722e-4,0.008428204438131548,0.003680647355581496,NDRG1/MAFF/ARL4C,3
REACTOME_BASE_EXCISION_REPAIR_AP_SITE_FORMATION,REACTOME_BASE_EXCISION_REPAIR_AP_SITE_FORMATION,2/16,61/21728,9.07066301541061e-4,0.009149538345979398,0.003995658193287283,H4C8/H2BC11,2
REACTOME_DNA_METHYLATION,REACTOME_DNA_METHYLATION,2/16,63/21728,9.672024775627447e-4,0.009651224722346528,0.004214747638502057,H4C8/H2BC11,2
REACTOME_ACTIVATED_PKN1_STIMULATES_TRANSCRIPTION_OF_AR_ANDROGEN_RECEPTOR_REGULATED_GENES_KLK2_AND_KLK3,REACTOME_ACTIVATED_PKN1_STIMULATES_TRANSCRIPTION_OF_AR_ANDROGEN_RECEPTOR_REGULATED_GENES_KLK2_AND_KLK3,2/16,65/21728,0.0010292140847165648,0.010160751815074172,0.004437261171510385,H4C8/H2BC11,2
REACTOME_INHIBITION_OF_DNA_RECOMBINATION_AT_TELOMERE,REACTOME_INHIBITION_OF_DNA_RECOMBINATION_AT_TELOMERE,2/16,66/21728,0.001060921626465924,0.010246396411684785,0.004474662679785211,H4C8/H2BC11,2
REACTOME_SIRT1_NEGATIVELY_REGULATES_RRNA_EXPRESSION,REACTOME_SIRT1_NEGATIVELY_REGULATES_RRNA_EXPRESSION,2/16,66/21728,0.001060921626465924,0.010246396411684785,0.004474662679785211,H4C8/H2BC11,2
REACTOME_ASSEMBLY_OF_THE_ORC_COMPLEX_AT_THE_ORIGIN_OF_REPLICATION,REACTOME_ASSEMBLY_OF_THE_ORC_COMPLEX_AT_THE_ORIGIN_OF_REPLICATION,2/16,67/21728,0.0010930961689189587,0.010246396411684785,0.004474662679785211,H4C8/H2BC11,2
SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE,SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE,2/16,67/21728,0.0010930961689189587,0.010246396411684785,0.004474662679785211,NDRG1/VEGFA,2
VANHARANTA_UTERINE_FIBROID_DN,VANHARANTA_UTERINE_FIBROID_DN,2/16,67/21728,0.0010930961689189587,0.010246396411684785,0.004474662679785211,NDRG1/MAFF,2
REACTOME_NONHOMOLOGOUS_END_JOINING_NHEJ,REACTOME_NONHOMOLOGOUS_END_JOINING_NHEJ,2/16,69/21728,0.0011588437850676987,0.010657134191670912,0.004654034328259189,H4C8/H2BC11,2
REACTOME_CELL_CYCLE_CHECKPOINTS,REACTOME_CELL_CYCLE_CHECKPOINTS,3/16,292/21728,0.0011815992101497463,0.010657134191670912,0.004654034328259189,H4C8/PSMC5/H2BC11,3
KEGG_RENAL_CELL_CARCINOMA,KEGG_RENAL_CELL_CARCINOMA,2/16,70/21728,0.0011924156247300577,0.010657134191670912,0.004654034328259189,SLC2A1/VEGFA,2
REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS,REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS,3/16,295/21728,0.0012168791232755527,0.010657134191670912,0.004654034328259189,ARL4C/H4C8/H2BC11,3
REACTOME_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE,REACTOME_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE,2/16,71/21728,0.0012264519970285736,0.010657134191670912,0.004654034328259189,H4C8/H2BC11,2
REACTOME_PRC2_METHYLATES_HISTONES_AND_DNA,REACTOME_PRC2_METHYLATES_HISTONES_AND_DNA,2/16,71/21728,0.0012264519970285736,0.010657134191670912,0.004654034328259189,H4C8/H2BC11,2
SESTO_RESPONSE_TO_UV_C8,SESTO_RESPONSE_TO_UV_C8,2/16,71/21728,0.0012264519970285736,0.010657134191670912,0.004654034328259189,SLC2A1/VEGFA,2
ENK_UV_RESPONSE_EPIDERMIS_UP,ENK_UV_RESPONSE_EPIDERMIS_UP,3/16,296/21728,0.0012287859466689522,0.010657134191670912,0.004654034328259189,BNIP3/SLC2A1/VLDLR,3
REACTOME_CONDENSATION_OF_PROPHASE_CHROMOSOMES,REACTOME_CONDENSATION_OF_PROPHASE_CHROMOSOMES,2/16,72/21728,0.0012609522863455413,0.010834849275265393,0.004731643569620209,H4C8/H2BC11,2
REACTOME_ERCC6_CSB_AND_EHMT2_G9A_POSITIVELY_REGULATE_RRNA_EXPRESSION,REACTOME_ERCC6_CSB_AND_EHMT2_G9A_POSITIVELY_REGULATE_RRNA_EXPRESSION,2/16,74/21728,0.0013313421563578062,0.011334729551376552,0.004949944280036267,H4C8/H2BC11,2
JAIN_NFKB_SIGNALING,JAIN_NFKB_SIGNALING,2/16,75/21728,0.0013672305086102367,0.011430539747660357,0.004991785166571277,BNIP3/VEGFA,2
REACTOME_CELLULAR_RESPONSE_TO_HYPOXIA,REACTOME_CELLULAR_RESPONSE_TO_HYPOXIA,2/16,75/21728,0.0013672305086102367,0.011430539747660357,0.004991785166571277,VEGFA/PSMC5,2
CARD_MIR302A_TARGETS,CARD_MIR302A_TARGETS,2/16,77/21728,0.0014403909806831362,0.011623328957164785,0.00507597736899778,VLDLR/VEGFA,2
FRASOR_RESPONSE_TO_ESTRADIOL_DN,FRASOR_RESPONSE_TO_ESTRADIOL_DN,2/16,77/21728,0.0014403909806831362,0.011623328957164785,0.00507597736899778,KLF6/NDRG1,2
LEE_AGING_NEOCORTEX_UP,LEE_AGING_NEOCORTEX_UP,2/16,77/21728,0.0014403909806831362,0.011623328957164785,0.00507597736899778,NDRG1/VEGFA,2
REACTOME_MEIOTIC_SYNAPSIS,REACTOME_MEIOTIC_SYNAPSIS,2/16,77/21728,0.0014403909806831362,0.011623328957164785,0.00507597736899778,H4C8/H2BC11,2
REACTOME_DNA_DAMAGE_TELOMERE_STRESS_INDUCED_SENESCENCE,REACTOME_DNA_DAMAGE_TELOMERE_STRESS_INDUCED_SENESCENCE,2/16,78/21728,0.001477661875405082,0.01172025829381125,0.005118306990831819,H4C8/H2BC11,2
REACTOME_DNA_DOUBLE_STRAND_BREAK_RESPONSE,REACTOME_DNA_DOUBLE_STRAND_BREAK_RESPONSE,2/16,78/21728,0.001477661875405082,0.01172025829381125,0.005118306990831819,H4C8/H2BC11,2
GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN,GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN,2/16,79/21728,0.0015153923934458796,0.011817513790905683,0.005160779048886897,GAPDH/VEGFA,2
PID_MYC_ACTIV_PATHWAY,PID_MYC_ACTIV_PATHWAY,2/16,79/21728,0.0015153923934458796,0.011817513790905683,0.005160779048886897,GAPDH/SLC2A1,2
WP_NUCLEAR_RECEPTORS_METAPATHWAY,WP_NUCLEAR_RECEPTORS_METAPATHWAY,3/16,321/21728,0.001550879890275219,0.011993471151461694,0.005237620682069818,SLC2A1/MAFF/PSMC5,3
SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN,SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN,3/16,324/21728,0.0015927584171666152,0.012215535629178669,0.005334597569457563,KLF6/ARL4C/VEGFA,3
KEGG_PATHWAYS_IN_CANCER,KEGG_PATHWAYS_IN_CANCER,3/16,325/21728,0.0016068749264239986,0.012222786325585825,0.005337763992003792,SLC2A1/VEGFA/TFG,3
REACTOME_SIGNALING_BY_WNT,REACTOME_SIGNALING_BY_WNT,3/16,329/21728,0.0016641304566729464,0.012555390762540605,0.005483014341626739,H4C8/PSMC5/H2BC11,3
REACTOME_MEIOTIC_RECOMBINATION,REACTOME_MEIOTIC_RECOMBINATION,2/16,85/21728,0.0017513934053704449,0.013107202259546554,0.005723993727229383,H4C8/H2BC11,2
ALCALA_APOPTOSIS,ALCALA_APOPTOSIS,2/16,87/21728,0.0018337097547795641,0.013613461219483486,0.005945080047074798,BNIP3L/GAPDH,2
REACTOME_TRANSCRIPTIONAL_REGULATION_OF_GRANULOPOIESIS,REACTOME_TRANSCRIPTIONAL_REGULATION_OF_GRANULOPOIESIS,2/16,88/21728,0.00187554944713132,0.013690446180628512,0.005978699840678287,H4C8/H2BC11,2
REACTOME_B_WICH_COMPLEX_POSITIVELY_REGULATES_RRNA_EXPRESSION,REACTOME_B_WICH_COMPLEX_POSITIVELY_REGULATES_RRNA_EXPRESSION,2/16,89/21728,0.001917842676165632,0.013690446180628512,0.005978699840678287,H4C8/H2BC11,2
REACTOME_BASE_EXCISION_REPAIR,REACTOME_BASE_EXCISION_REPAIR,2/16,89/21728,0.001917842676165632,0.013690446180628512,0.005978699840678287,H4C8/H2BC11,2
REACTOME_RNA_POLYMERASE_I_PROMOTER_ESCAPE,REACTOME_RNA_POLYMERASE_I_PROMOTER_ESCAPE,2/16,89/21728,0.001917842676165632,0.013690446180628512,0.005978699840678287,H4C8/H2BC11,2
SAFFORD_T_LYMPHOCYTE_ANERGY,SAFFORD_T_LYMPHOCYTE_ANERGY,2/16,89/21728,0.001917842676165632,0.013690446180628512,0.005978699840678287,BNIP3/NDRG1,2
REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX,REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX,2/16,90/21728,0.0019605888362607096,0.01388875145076289,0.006065300939818186,H4C8/H2BC11,2
REACTOME_HDACS_DEACETYLATE_HISTONES,REACTOME_HDACS_DEACETYLATE_HISTONES,2/16,92/21728,0.0020474375299026496,0.01428587990789217,0.0062387293154928395,H4C8/H2BC11,2
REACTOME_RHO_GTPASES_ACTIVATE_PKNS,REACTOME_RHO_GTPASES_ACTIVATE_PKNS,2/16,92/21728,0.0020474375299026496,0.01428587990789217,0.0062387293154928395,H4C8/H2BC11,2
REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT,REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT,2/16,95/21728,0.0021810924444610517,0.015104879018357133,0.00659639113210923,H4C8/H2BC11,2
REACTOME_RUNX1_REGULATES_GENES_INVOLVED_IN_MEGAKARYOCYTE_DIFFERENTIATION_AND_PLATELET_FUNCTION,REACTOME_RUNX1_REGULATES_GENES_INVOLVED_IN_MEGAKARYOCYTE_DIFFERENTIATION_AND_PLATELET_FUNCTION,2/16,96/21728,0.0022265435037137683,0.015305424973676866,0.006683970751889285,H4C8/H2BC11,2
REACTOME_PROCESSING_OF_DNA_DOUBLE_STRAND_BREAK_ENDS,REACTOME_PROCESSING_OF_DNA_DOUBLE_STRAND_BREAK_ENDS,2/16,98/21728,0.00231879114237223,0.015822339559716393,0.006909710447471429,H4C8/H2BC11,2
WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN,WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN,3/16,371/21728,0.002344052014824365,0.015877958173408837,0.006933999429176954,SLC2A1/NDRG1/ARL4C,3
REACTOME_DISEASES_OF_PROGRAMMED_CELL_DEATH,REACTOME_DISEASES_OF_PROGRAMMED_CELL_DEATH,2/16,101/21728,0.0024605173906336146,0.01642705135617262,0.007173791710669759,H4C8/H2BC11,2
SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE,SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE,2/16,101/21728,0.0024605173906336146,0.01642705135617262,0.007173791710669759,NDRG1/YARS1,2
MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN,MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN,3/16,382/21728,0.002546760337620141,0.016881382809367792,0.007372200977321461,KLF6/BNIP3L/BNIP3,3
RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN,RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN,3/16,383/21728,0.0025657118302307245,0.016886387081234838,0.007374386372816939,KLF6/SLC2A1/VLDLR,3
REACTOME_POSITIVE_EPIGENETIC_REGULATION_OF_RRNA_EXPRESSION,REACTOME_POSITIVE_EPIGENETIC_REGULATION_OF_RRNA_EXPRESSION,2/16,104/21728,0.002606255000609531,0.017032427046236937,0.007438162900182873,H4C8/H2BC11,2
LE_EGR2_TARGETS_DN,LE_EGR2_TARGETS_DN,2/16,105/21728,0.002655722825991313,0.017114658211944016,0.00747407374273871,SLC2A1/NDRG1,2
REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS,2/16,105/21728,0.002655722825991313,0.017114658211944016,0.00747407374273871,H4C8/H2BC11,2
REACTOME_NEGATIVE_EPIGENETIC_REGULATION_OF_RRNA_EXPRESSION,REACTOME_NEGATIVE_EPIGENETIC_REGULATION_OF_RRNA_EXPRESSION,2/16,107/21728,0.0027559878279322225,0.017638322098766226,0.0077027608983949595,H4C8/H2BC11,2
REACTOME_AMYLOID_FIBER_FORMATION,REACTOME_AMYLOID_FIBER_FORMATION,2/16,108/21728,0.0028067838124293423,0.01784037930092075,0.007791000488718795,H4C8/H2BC11,2
REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION,REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION,2/16,109/21728,0.002858021325476637,0.01804247476219265,0.007879256787028322,H4C8/H2BC11,2
REACTOME_SENESCENCE_ASSOCIATED_SECRETORY_PHENOTYPE_SASP,REACTOME_SENESCENCE_ASSOCIATED_SECRETORY_PHENOTYPE_SASP,2/16,110/21728,0.00290969977240311,0.018244603978311392,0.007967527826281632,H4C8/H2BC11,2
JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_DN,JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_DN,3/16,402/21728,0.002942651440444621,0.018323784152181256,0.008002106282429429,SLC2A1/NDRG1/VEGFA,3
REACTOME_TELOMERE_MAINTENANCE,REACTOME_TELOMERE_MAINTENANCE,2/16,111/21728,0.002961818559081022,0.018323784152181256,0.008002106282429429,H4C8/H2BC11,2
REACTOME_HCMV_LATE_EVENTS,REACTOME_HCMV_LATE_EVENTS,2/16,114/21728,0.003120811024486666,0.019179553845851828,0.008375826032954803,H4C8/H2BC11,2
REACTOME_M_PHASE,REACTOME_M_PHASE,3/16,415/21728,0.003219338751650025,0.01958502653808915,0.008552898386075683,H4C8/PSMC5/H2BC11,3
RICKMAN_HEAD_AND_NECK_CANCER_C,RICKMAN_HEAD_AND_NECK_CANCER_C,2/16,116/21728,0.003228996832249612,0.01958502653808915,0.008552898386075683,SLC2A1/H4C8,2
REACTOME_MEIOSIS,REACTOME_MEIOSIS,2/16,117/21728,0.003283745211126027,0.019787763350162035,0.008641434766121123,H4C8/H2BC11,2
REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING,REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING,2/16,118/21728,0.003338929786037387,0.019941807396969546,0.008708706723948816,H4C8/H2BC11,2
MOOTHA_PGC,MOOTHA_PGC,3/16,421/21728,0.003352286588283674,0.019941807396969546,0.008708706723948816,BNIP3L/GAPDH/VEGFA,3
ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_DN,ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_DN,2/16,119/21728,0.0033945499671875785,0.020064601079936767,0.008762331460725564,H4C8/H2BC11,2
REACTOME_ACTIVATION_OF_ANTERIOR_HOX_GENES_IN_HINDBRAIN_DEVELOPMENT_DURING_EARLY_EMBRYOGENESIS,REACTOME_ACTIVATION_OF_ANTERIOR_HOX_GENES_IN_HINDBRAIN_DEVELOPMENT_DURING_EARLY_EMBRYOGENESIS,2/16,120/21728,0.0034506051653201346,0.020266845527956233,0.008850652822440052,H4C8/H2BC11,2
LEE_NEURAL_CREST_STEM_CELL_DN,LEE_NEURAL_CREST_STEM_CELL_DN,2/16,122/21728,0.0035640182582022148,0.020801314110765128,0.00908405845354421,MAFF/ARL4C,2
REACTOME_OXIDATIVE_STRESS_INDUCED_SENESCENCE,REACTOME_OXIDATIVE_STRESS_INDUCED_SENESCENCE,2/16,124/21728,0.0036791643614093356,0.021334182709809798,0.009316765362156048,H4C8/H2BC11,2
BAELDE_DIABETIC_NEPHROPATHY_DN,BAELDE_DIABETIC_NEPHROPATHY_DN,3/16,437/21728,0.0037232844011246672,0.021334182709809798,0.009316765362156048,NDRG1/MAFF/VEGFA,3
LIU_VMYB_TARGETS_UP,LIU_VMYB_TARGETS_UP,2/16,125/21728,0.0037373858244658057,0.021334182709809798,0.009316765362156048,BNIP3L/ARL4C,2
WP_VEGFAVEGFR2_SIGNALING_PATHWAY,WP_VEGFAVEGFR2_SIGNALING_PATHWAY,3/16,438/21728,0.0037472756268308156,0.021334182709809798,0.009316765362156048,GAPDH/NDRG1/VEGFA,3
IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP,IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP,2/16,128/21728,0.003914636828731123,0.02215111571379562,0.009673524897698859,ARL4C/VEGFA,2
WP_MALIGNANT_PLEURAL_MESOTHELIOMA,WP_MALIGNANT_PLEURAL_MESOTHELIOMA,3/16,446/21728,0.00394264798288586,0.022174408049200473,0.009683696800070534,SLC2A1/NDRG1/VEGFA,3
FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN,FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN,3/16,453/21728,0.004118653819342011,0.023024763520177027,0.01005505212711905,KLF6/BNIP3/ARL4C,3
REACTOME_HCMV_EARLY_EVENTS,REACTOME_HCMV_EARLY_EVENTS,2/16,136/21728,0.004406171897170948,0.024484595931584672,0.010692569684278697,H4C8/H2BC11,2
PID_P53_DOWNSTREAM_PATHWAY,PID_P53_DOWNSTREAM_PATHWAY,2/16,137/21728,0.004469532748727577,0.024601866661362066,0.01074378251431987,BNIP3L/NDRG1,2
REACTOME_CHROMOSOME_MAINTENANCE,REACTOME_CHROMOSOME_MAINTENANCE,2/16,138/21728,0.004533318102470812,0.024601866661362066,0.01074378251431987,H4C8/H2BC11,2
REACTOME_GENE_SILENCING_BY_RNA,REACTOME_GENE_SILENCING_BY_RNA,2/16,138/21728,0.004533318102470812,0.024601866661362066,0.01074378251431987,H4C8/H2BC11,2
REACTOME_HOMOLOGY_DIRECTED_REPAIR,REACTOME_HOMOLOGY_DIRECTED_REPAIR,2/16,138/21728,0.004533318102470812,0.024601866661362066,0.01074378251431987,H4C8/H2BC11,2
KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS,KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS,2/16,139/21728,0.004597527379321142,0.024805264000058252,0.010832607350297674,H4C8/H2BC11,2
REACTOME_HATS_ACETYLATE_HISTONES,REACTOME_HATS_ACETYLATE_HISTONES,2/16,140/21728,0.004662160000730721,0.02493549120110971,0.01088947834894197,H4C8/H2BC11,2
GARY_CD5_TARGETS_UP,GARY_CD5_TARGETS_UP,3/16,474/21728,0.004675404600208071,0.02493549120110971,0.01088947834894197,BNIP3L/VLDLR/VEGFA,3
REACTOME_MITOTIC_PROPHASE,REACTOME_MITOTIC_PROPHASE,2/16,141/21728,0.004727215388682941,0.025067747889701536,0.010947235636949968,H4C8/H2BC11,2
PROVENZANI_METASTASIS_DN,PROVENZANI_METASTASIS_DN,2/16,142/21728,0.004792692965692051,0.02527056291001263,0.011035806171001434,SLC2A1/ARL4C,2
REACTOME_REPRODUCTION,REACTOME_REPRODUCTION,2/16,143/21728,0.004858592154802699,0.025393309804091296,0.011089410474790324,H4C8/H2BC11,2
ENK_UV_RESPONSE_KERATINOCYTE_DN,ENK_UV_RESPONSE_KERATINOCYTE_DN,3/16,481/21728,0.004870699509836477,0.025393309804091296,0.011089410474790324,BNIP3L/GAPDH/SLC2A1,3
SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN,SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN,2/16,145/21728,0.0049916530641573075,0.02573474468632212,0.011238517132751836,KLF6/BNIP3L,2
WP_NRF2_PATHWAY,WP_NRF2_PATHWAY,2/16,145/21728,0.0049916530641573075,0.02573474468632212,0.011238517132751836,SLC2A1/MAFF,2
REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,2/16,146/21728,0.005058813633139309,0.02593690083731093,0.011326799934624219,H4C8/H2BC11,2
REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION,REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION,2/16,148/21728,0.0051943921255249255,0.026485691716962256,0.011566460198537286,H4C8/H2BC11,2
GOLDRATH_HOMEOSTATIC_PROLIFERATION,GOLDRATH_HOMEOSTATIC_PROLIFERATION,2/16,150/21728,0.005331643264385949,0.02703696693633968,0.011807205388487724,ARL4C/PSMC5,2
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP,2/16,159/21728,0.005969849680734663,0.03010880708544439,0.013148696379192481,KLF6/NDRG1,2
REACTOME_HCMV_INFECTION,REACTOME_HCMV_INFECTION,2/16,160/21728,0.006042828513497507,0.030149165916804766,0.013166321322561066,H4C8/H2BC11,2
RODRIGUES_NTN1_TARGETS_DN,RODRIGUES_NTN1_TARGETS_DN,2/16,160/21728,0.006042828513497507,0.030149165916804766,0.013166321322561066,ARL4C/VEGFA,2
WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS,WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS,2/16,162/21728,0.006190019563557561,0.030718385855515597,0.013414903078917314,GAPDH/VEGFA,2
LIU_CMYB_TARGETS_UP,LIU_CMYB_TARGETS_UP,2/16,164/21728,0.006338851349263812,0.031124095513845592,0.013592078916550086,BNIP3L/ARL4C,2
PHONG_TNF_RESPONSE_VIA_P38_PARTIAL,PHONG_TNF_RESPONSE_VIA_P38_PARTIAL,2/16,164/21728,0.006338851349263812,0.031124095513845592,0.013592078916550086,KLF6/MAFF,2
REACTOME_DNA_DOUBLE_STRAND_BREAK_REPAIR,REACTOME_DNA_DOUBLE_STRAND_BREAK_REPAIR,2/16,167/21728,0.0065651655106315765,0.03206565049403212,0.014003261615474556,H4C8/H2BC11,2
MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP,MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP,2/16,168/21728,0.006641419035276665,0.03226825583631804,0.01409174058187664,SLC2A1/VEGFA,2
UEDA_PERIFERAL_CLOCK,UEDA_PERIFERAL_CLOCK,2/16,171/21728,0.006872618135548235,0.03321765432181646,0.01450634858654644,BNIP3/NDRG1,2
PID_VEGF_VEGFR_PATHWAY,PID_VEGF_VEGFR_PATHWAY,1/16,10/21728,0.007340932248729781,0.03495913610167319,0.015266864109737044,VEGFA,1
WP_ETHANOL_METABOLISM_PRODUCTION_OF_ROS_BY_CYP2E1,WP_ETHANOL_METABOLISM_PRODUCTION_OF_ROS_BY_CYP2E1,1/16,10/21728,0.007340932248729781,0.03495913610167319,0.015266864109737044,MAFF,1
REACTOME_DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS,REACTOME_DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS,2/16,177/21728,0.007345939159295552,0.03495913610167319,0.015266864109737044,SLC2A1/PSMC5,2
KYNG_DNA_DAMAGE_DN,KYNG_DNA_DAMAGE_DN,2/16,182/21728,0.007751426618827211,0.0367006321544472,0.016027385865996117,BNIP3L/NDRG1,2
LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP,LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP,2/16,183/21728,0.007833723229521387,0.036902005873075364,0.016115326974970527,VLDLR/VEGFA,2
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP,2/16,184/21728,0.007916418249004934,0.03708435080593853,0.01619495809923586,KLF6/BNIP3L,2
AGARWAL_AKT_PATHWAY_TARGETS,AGARWAL_AKT_PATHWAY_TARGETS,1/16,11/21728,0.008072240153878862,0.03708435080593853,0.01619495809923586,VEGFA,1
BIOCARTA_VITCB_PATHWAY,BIOCARTA_VITCB_PATHWAY,1/16,11/21728,0.008072240153878862,0.03708435080593853,0.01619495809923586,SLC2A1,1
REACTOME_REGULATION_OF_GENE_EXPRESSION_BY_HYPOXIA_INDUCIBLE_FACTOR,REACTOME_REGULATION_OF_GENE_EXPRESSION_BY_HYPOXIA_INDUCIBLE_FACTOR,1/16,11/21728,0.008072240153878862,0.03708435080593853,0.01619495809923586,VEGFA,1
WP_GLYCOLYSIS_IN_SENESCENCE,WP_GLYCOLYSIS_IN_SENESCENCE,1/16,11/21728,0.008072240153878862,0.03708435080593853,0.01619495809923586,GAPDH,1
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_OLD,KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_OLD,1/16,12/21728,0.008803042942364114,0.039275114665932205,0.017151677797622392,NDRG1,1
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_WS,KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_WS,1/16,12/21728,0.008803042942364114,0.039275114665932205,0.017151677797622392,NDRG1,1
MIZUKAMI_HYPOXIA_UP,MIZUKAMI_HYPOXIA_UP,1/16,12/21728,0.008803042942364114,0.039275114665932205,0.017151677797622392,VEGFA,1
PARK_TRETINOIN_RESPONSE,PARK_TRETINOIN_RESPONSE,1/16,12/21728,0.008803042942364114,0.039275114665932205,0.017151677797622392,NDRG1,1
REACTOME_VLDLR_INTERNALISATION_AND_DEGRADATION,REACTOME_VLDLR_INTERNALISATION_AND_DEGRADATION,1/16,12/21728,0.008803042942364114,0.039275114665932205,0.017151677797622392,VLDLR,1
SOUCEK_MYC_TARGETS,SOUCEK_MYC_TARGETS,1/16,12/21728,0.008803042942364114,0.039275114665932205,0.017151677797622392,KLF6,1
REACTOME_CELLULAR_SENESCENCE,REACTOME_CELLULAR_SENESCENCE,2/16,196/21728,0.008939632850353823,0.03969368079008779,0.01733446813087999,H4C8/H2BC11,2
WIERENGA_STAT5A_TARGETS_UP,WIERENGA_STAT5A_TARGETS_UP,2/16,201/21728,0.009382654286011028,0.04146239608294398,0.018106876692301987,KLF6/NDRG1,2
HASINA_NOL7_TARGETS_DN,HASINA_NOL7_TARGETS_DN,1/16,13/21728,0.009533340939828161,0.04153493141859405,0.01813855330780253,VEGFA,1
INAMURA_LUNG_CANCER_SCC_UP,INAMURA_LUNG_CANCER_SCC_UP,1/16,13/21728,0.009533340939828161,0.04153493141859405,0.01813855330780253,SLC2A1,1
WACKER_HYPOXIA_TARGETS_OF_VHL,WACKER_HYPOXIA_TARGETS_OF_VHL,1/16,13/21728,0.009533340939828161,0.04153493141859405,0.01813855330780253,VEGFA,1
REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_SEVERAL_ADDITIONAL_CELL_DEATH_GENES_WHOSE_SPECIFIC_ROLES_IN_P53_DEPENDENT_APOPTOSIS_REMAIN_UNCERTAIN,REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_SEVERAL_ADDITIONAL_CELL_DEATH_GENES_WHOSE_SPECIFIC_ROLES_IN_P53_DEPENDENT_APOPTOSIS_REMAIN_UNCERTAIN,1/16,14/21728,0.010263134471716562,0.04424225550083894,0.019320857948982525,NDRG1,1
WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_3,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_3,1/16,14/21728,0.010263134471716562,0.04424225550083894,0.019320857948982525,VLDLR,1
MANNE_COVID19_NONICU_VS_HEALTHY_DONOR_PLATELETS_DN,MANNE_COVID19_NONICU_VS_HEALTHY_DONOR_PLATELETS_DN,2/16,211/21728,0.01029776636657458,0.04424225550083894,0.019320857948982525,NRN1/VEGFA,2
BIOCARTA_HIF_PATHWAY,BIOCARTA_HIF_PATHWAY,1/16,15/21728,0.010992423863282252,0.04580948803896705,0.020005277784712245,VEGFA,1
MARKS_HDAC_TARGETS_DN,MARKS_HDAC_TARGETS_DN,1/16,15/21728,0.010992423863282252,0.04580948803896705,0.020005277784712245,VEGFA,1
NGO_MALIGNANT_GLIOMA_1P_LOH,NGO_MALIGNANT_GLIOMA_1P_LOH,1/16,15/21728,0.010992423863282252,0.04580948803896705,0.020005277784712245,GAPDH,1
REACTOME_TFAP2_AP_2_FAMILY_REGULATES_TRANSCRIPTION_OF_GROWTH_FACTORS_AND_THEIR_RECEPTORS,REACTOME_TFAP2_AP_2_FAMILY_REGULATES_TRANSCRIPTION_OF_GROWTH_FACTORS_AND_THEIR_RECEPTORS,1/16,15/21728,0.010992423863282252,0.04580948803896705,0.020005277784712245,VEGFA,1
TERAMOTO_OPN_TARGETS_CLUSTER_1,TERAMOTO_OPN_TARGETS_CLUSTER_1,1/16,15/21728,0.010992423863282252,0.04580948803896705,0.020005277784712245,BNIP3,1
AMUNDSON_RESPONSE_TO_ARSENITE,AMUNDSON_RESPONSE_TO_ARSENITE,2/16,219/21728,0.011057462630095494,0.04580948803896705,0.020005277784712245,MAFF/VEGFA,2
REACTOME_ESR_MEDIATED_SIGNALING,REACTOME_ESR_MEDIATED_SIGNALING,2/16,219/21728,0.011057462630095494,0.04580948803896705,0.020005277784712245,H4C8/H2BC11,2
REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES,REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES,2/16,219/21728,0.011057462630095494,0.04580948803896705,0.020005277784712245,PSMC5/H2BC11,2
ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN,ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN,2/16,222/21728,0.011348612880761548,0.04628630791460156,0.02021350788012886,H4C8/H2BC11,2
ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP,ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP,2/16,223/21728,0.011446417958187245,0.04628630791460156,0.02021350788012886,KLF6/MAFF,2
BROWNE_HCMV_INFECTION_16HR_UP,BROWNE_HCMV_INFECTION_16HR_UP,2/16,224/21728,0.011544599639993297,0.04628630791460156,0.02021350788012886,VLDLR/VEGFA,2
CAIRO_LIVER_DEVELOPMENT_DN,CAIRO_LIVER_DEVELOPMENT_DN,2/16,224/21728,0.011544599639993297,0.04628630791460156,0.02021350788012886,NRN1/NDRG1,2
VANTVEER_BREAST_CANCER_ESR1_DN,VANTVEER_BREAST_CANCER_ESR1_DN,2/16,224/21728,0.011544599639993297,0.04628630791460156,0.02021350788012886,GAPDH/NDRG1,2
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_UP,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_UP,1/16,16/21728,0.011721209439581215,0.04628630791460156,0.02021350788012886,VEGFA,1
GHO_ATF5_TARGETS_DN,GHO_ATF5_TARGETS_DN,1/16,16/21728,0.011721209439581215,0.04628630791460156,0.02021350788012886,SLC2A1,1
KANG_FLUOROURACIL_RESISTANCE_DN,KANG_FLUOROURACIL_RESISTANCE_DN,1/16,16/21728,0.011721209439581215,0.04628630791460156,0.02021350788012886,SLC2A1,1
VETTER_TARGETS_OF_PRKCA_AND_ETS1_UP,VETTER_TARGETS_OF_PRKCA_AND_ETS1_UP,1/16,16/21728,0.011721209439581215,0.04628630791460156,0.02021350788012886,ARL4C,1
WP_QUERCETIN_AND_NFKB_AP1_INDUCED_APOPTOSIS,WP_QUERCETIN_AND_NFKB_AP1_INDUCED_APOPTOSIS,1/16,16/21728,0.011721209439581215,0.04628630791460156,0.02021350788012886,VEGFA,1
WU_HBX_TARGETS_2_DN,WU_HBX_TARGETS_2_DN,1/16,16/21728,0.011721209439581215,0.04628630791460156,0.02021350788012886,KLF6,1
MANNE_COVID19_COMBINED_COHORT_VS_HEALTHY_DONOR_PLATELETS_DN,MANNE_COVID19_COMBINED_COHORT_VS_HEALTHY_DONOR_PLATELETS_DN,2/16,228/21728,0.011941081722804708,0.046954762028655804,0.020505425795182036,NRN1/VEGFA,2
MARKEY_RB1_ACUTE_LOF_DN,MARKEY_RB1_ACUTE_LOF_DN,2/16,230/21728,0.012141568509751606,0.04754166910147464,0.020761731628933463,BNIP3L/NDRG1,2
BOYAULT_LIVER_CANCER_SUBCLASS_G56_DN,BOYAULT_LIVER_CANCER_SUBCLASS_G56_DN,1/16,17/21728,0.012449491525477252,0.047543737183715594,0.02076263477283406,MAFF,1
CROONQUIST_IL6_DEPRIVATION_UP,CROONQUIST_IL6_DEPRIVATION_UP,1/16,17/21728,0.012449491525477252,0.047543737183715594,0.02076263477283406,ARL4C,1
KASLER_HDAC7_TARGETS_1_DN,KASLER_HDAC7_TARGETS_1_DN,1/16,17/21728,0.012449491525477252,0.047543737183715594,0.02076263477283406,SLC2A1,1
MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_DN,MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_DN,1/16,17/21728,0.012449491525477252,0.047543737183715594,0.02076263477283406,KLF6,1
VANDESLUIS_COMMD1_TARGETS_GROUP_4_UP,VANDESLUIS_COMMD1_TARGETS_GROUP_4_UP,1/16,17/21728,0.012449491525477252,0.047543737183715594,0.02076263477283406,SLC2A1,1
WP_AMPLIFICATION_AND_EXPANSION_OF_ONCOGENIC_PATHWAYS_AS_METASTATIC_TRAITS,WP_AMPLIFICATION_AND_EXPANSION_OF_ONCOGENIC_PATHWAYS_AS_METASTATIC_TRAITS,1/16,17/21728,0.012449491525477252,0.047543737183715594,0.02076263477283406,VEGFA,1
MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN,MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN,2/16,235/21728,0.012649301436464998,0.04810881857803081,0.021009409202066544,BNIP3/MAFF,2
AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN,AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN,2/16,237/21728,0.012854989854317765,0.04869155340737504,0.021263892992104575,VLDLR/YARS1,2
CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP,CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP,2/16,238/21728,0.012958388071333522,0.048719151289048725,0.021275945152318242,KLF6/MAFF,2
AMIT_EGF_RESPONSE_40_MCF10A,AMIT_EGF_RESPONSE_40_MCF10A,1/16,18/21728,0.013177270445637101,0.048719151289048725,0.021275945152318242,KLF6,1
BIOCARTA_MTA3_PATHWAY,BIOCARTA_MTA3_PATHWAY,1/16,18/21728,0.013177270445637101,0.048719151289048725,0.021275945152318242,GAPDH,1
KANG_AR_TARGETS_DN,KANG_AR_TARGETS_DN,1/16,18/21728,0.013177270445637101,0.048719151289048725,0.021275945152318242,VEGFA,1
SUH_COEXPRESSED_WITH_ID1_AND_ID2_UP,SUH_COEXPRESSED_WITH_ID1_AND_ID2_UP,1/16,18/21728,0.013177270445637101,0.048719151289048725,0.021275945152318242,NDRG1,1
WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION,WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION,1/16,18/21728,0.013177270445637101,0.048719151289048725,0.021275945152318242,VEGFA,1
SANSOM_APC_MYC_TARGETS,SANSOM_APC_MYC_TARGETS,2/16,241/21728,0.013270792422123581,0.04887021971321699,0.02134191763791804,KLF6/NDRG1,2
HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP,HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP,2/16,242/21728,0.013375662016117,0.04906171680219991,0.021425545563574143,BNIP3/VEGFA,2
REACTOME_VEGFR2_MEDIATED_CELL_PROLIFERATION,REACTOME_VEGFR2_MEDIATED_CELL_PROLIFERATION,1/16,19/21728,0.013904546524534989,0.050800862892789254,0.022185041077272982,VEGFA,1
VERHAAK_AML_WITH_NPM1_MUTATED_DN,VERHAAK_AML_WITH_NPM1_MUTATED_DN,2/16,250/21728,0.014227769718217669,0.051626863270817676,0.022545760389365708,VLDLR/VEGFA,2
BIOCARTA_ARENRF2_PATHWAY,BIOCARTA_ARENRF2_PATHWAY,1/16,20/21728,0.014631320086449406,0.051626863270817676,0.022545760389365708,MAFF,1
FOURNIER_ACINAR_DEVELOPMENT_EARLY_UP,FOURNIER_ACINAR_DEVELOPMENT_EARLY_UP,1/16,20/21728,0.014631320086449406,0.051626863270817676,0.022545760389365708,BNIP3L,1
IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_UP,IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_UP,1/16,20/21728,0.014631320086449406,0.051626863270817676,0.022545760389365708,BNIP3L,1
KORKOLA_YOLK_SAC_TUMOR_UP,KORKOLA_YOLK_SAC_TUMOR_UP,1/16,20/21728,0.014631320086449406,0.051626863270817676,0.022545760389365708,GAPDH,1
REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_CYTOCHROME_C_RELEASE,REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_CYTOCHROME_C_RELEASE,1/16,20/21728,0.014631320086449406,0.051626863270817676,0.022545760389365708,BNIP3L,1
WP_ASPIRIN_AND_MIRNAS,WP_ASPIRIN_AND_MIRNAS,1/16,20/21728,0.014631320086449406,0.051626863270817676,0.022545760389365708,VEGFA,1
WP_HYPERTROPHY_MODEL,WP_HYPERTROPHY_MODEL,1/16,20/21728,0.014631320086449406,0.051626863270817676,0.022545760389365708,VEGFA,1
ZHU_SKIL_TARGETS_UP,ZHU_SKIL_TARGETS_UP,1/16,20/21728,0.014631320086449406,0.051626863270817676,0.022545760389365708,VEGFA,1
KANG_CISPLATIN_RESISTANCE_UP,KANG_CISPLATIN_RESISTANCE_UP,1/16,21/21728,0.015357591455466335,0.05258983347111719,0.022966295243171644,MAFF,1
MACLACHLAN_BRCA1_TARGETS_UP,MACLACHLAN_BRCA1_TARGETS_UP,1/16,21/21728,0.015357591455466335,0.05258983347111719,0.022966295243171644,GAPDH,1
PID_S1P_S1P1_PATHWAY,PID_S1P_S1P1_PATHWAY,1/16,21/21728,0.015357591455466335,0.05258983347111719,0.022966295243171644,VEGFA,1
RAMPON_ENRICHED_LEARNING_ENVIRONMENT_LATE_UP,RAMPON_ENRICHED_LEARNING_ENVIRONMENT_LATE_UP,1/16,21/21728,0.015357591455466335,0.05258983347111719,0.022966295243171644,VLDLR,1
REACTOME_CELLULAR_HEXOSE_TRANSPORT,REACTOME_CELLULAR_HEXOSE_TRANSPORT,1/16,21/21728,0.015357591455466335,0.05258983347111719,0.022966295243171644,SLC2A1,1
SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_UP,SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_UP,1/16,21/21728,0.015357591455466335,0.05258983347111719,0.022966295243171644,VLDLR,1
SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_DN,SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_DN,1/16,21/21728,0.015357591455466335,0.05258983347111719,0.022966295243171644,ARL4C,1
WP_GALANIN_RECEPTOR_PATHWAY,WP_GALANIN_RECEPTOR_PATHWAY,1/16,21/21728,0.015357591455466335,0.05258983347111719,0.022966295243171644,VEGFA,1
RICKMAN_METASTASIS_DN,RICKMAN_METASTASIS_DN,2/16,262/21728,0.01554932902552188,0.05305065196942759,0.0231675374412768,SLC2A1/NDRG1,2
LU_AGING_BRAIN_UP,LU_AGING_BRAIN_UP,2/16,263/21728,0.015661786036202757,0.05323859868716541,0.023249614898546603,NDRG1/VEGFA,2
WP_ALZHEIMERS_DISEASE,WP_ALZHEIMERS_DISEASE,2/16,266/21728,0.016001288596512984,0.053688341606768886,0.023446020325097572,GAPDH/PSMC5,2
GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_DN,GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_DN,1/16,22/21728,0.016083360955476023,0.053688341606768886,0.023446020325097572,VLDLR,1
MULLIGAN_NTF3_SIGNALING_VIA_INSR_AND_IGF1R_UP,MULLIGAN_NTF3_SIGNALING_VIA_INSR_AND_IGF1R_UP,1/16,22/21728,0.016083360955476023,0.053688341606768886,0.023446020325097572,ARL4C,1
TIAN_TNF_SIGNALING_NOT_VIA_NFKB,TIAN_TNF_SIGNALING_NOT_VIA_NFKB,1/16,22/21728,0.016083360955476023,0.053688341606768886,0.023446020325097572,KLF6,1
WANG_METASTASIS_OF_BREAST_CANCER_ESR1_UP,WANG_METASTASIS_OF_BREAST_CANCER_ESR1_UP,1/16,22/21728,0.016083360955476023,0.053688341606768886,0.023446020325097572,H4C8,1
REACTOME_CHROMATIN_MODIFYING_ENZYMES,REACTOME_CHROMATIN_MODIFYING_ENZYMES,2/16,272/21728,0.01668983932961032,0.05453988681343743,0.023817895216848246,H4C8/H2BC11,2
CHEOK_RESPONSE_TO_HD_MTX_DN,CHEOK_RESPONSE_TO_HD_MTX_DN,1/16,23/21728,0.01680862891017576,0.05453988681343743,0.023817895216848246,BNIP3L,1
CHEOK_RESPONSE_TO_HD_MTX_UP,CHEOK_RESPONSE_TO_HD_MTX_UP,1/16,23/21728,0.01680862891017576,0.05453988681343743,0.023817895216848246,ARL4C,1
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_OLD,KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_OLD,1/16,23/21728,0.01680862891017576,0.05453988681343743,0.023817895216848246,BNIP3L,1
PARK_TRETINOIN_RESPONSE_AND_RARA_PLZF_FUSION,PARK_TRETINOIN_RESPONSE_AND_RARA_PLZF_FUSION,1/16,23/21728,0.01680862891017576,0.05453988681343743,0.023817895216848246,NDRG1,1
WILLERT_WNT_SIGNALING,WILLERT_WNT_SIGNALING,1/16,23/21728,0.01680862891017576,0.05453988681343743,0.023817895216848246,SLC2A1,1
WP_HIPPOYAP_SIGNALING_PATHWAY,WP_HIPPOYAP_SIGNALING_PATHWAY,1/16,23/21728,0.01680862891017576,0.05453988681343743,0.023817895216848246,NDRG1,1
WU_HBX_TARGETS_1_DN,WU_HBX_TARGETS_1_DN,1/16,23/21728,0.01680862891017576,0.05453988681343743,0.023817895216848246,KLF6,1
OISHI_CHOLANGIOMA_STEM_CELL_LIKE_DN,OISHI_CHOLANGIOMA_STEM_CELL_LIKE_DN,2/16,274/21728,0.016922169533834165,0.05471698023483661,0.023895232974605368,BNIP3L/NDRG1,2
FORTSCHEGGER_PHF8_TARGETS_UP,FORTSCHEGGER_PHF8_TARGETS_UP,2/16,278/21728,0.017391025363603943,0.055722572454683254,0.02433438111961554,VLDLR/VEGFA,2
WP_IL18_SIGNALING_PATHWAY,WP_IL18_SIGNALING_PATHWAY,2/16,279/21728,0.017509110396580006,0.055722572454683254,0.02433438111961554,NRN1/VEGFA,2
REACTOME_CYTOSOLIC_TRNA_AMINOACYLATION,REACTOME_CYTOSOLIC_TRNA_AMINOACYLATION,1/16,24/21728,0.01753339564306844,0.055722572454683254,0.02433438111961554,YARS1,1
WP_ANGIOGENESIS,WP_ANGIOGENESIS,1/16,24/21728,0.01753339564306844,0.055722572454683254,0.02433438111961554,VEGFA,1
WP_NAD_METABOLISM_IN_ONCOGENEINDUCED_SENESCENCE_AND_MITOCHONDRIAL_DYSFUNCTIONASSOCIATED_SENESCENCE,WP_NAD_METABOLISM_IN_ONCOGENEINDUCED_SENESCENCE_AND_MITOCHONDRIAL_DYSFUNCTIONASSOCIATED_SENESCENCE,1/16,24/21728,0.01753339564306844,0.055722572454683254,0.02433438111961554,SLC2A1,1
OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN,OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN,2/16,281/21728,0.017746322196024598,0.05620678156283559,0.024545838137127608,BNIP3/VLDLR,2
HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN,HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN,2/16,282/21728,0.01786544794807781,0.056391618012980295,0.024626557321911772,MAFF/VEGFA,2
LU_TUMOR_ANGIOGENESIS_UP,LU_TUMOR_ANGIOGENESIS_UP,1/16,25/21728,0.018257661477463882,0.05724023598340028,0.02499715387206115,VEGFA,1
PID_INTEGRIN_A9B1_PATHWAY,PID_INTEGRIN_A9B1_PATHWAY,1/16,25/21728,0.018257661477463882,0.05724023598340028,0.02499715387206115,VEGFA,1
PID_VEGFR1_PATHWAY,PID_VEGFR1_PATHWAY,1/16,26/21728,0.018981426736476514,0.059308969735522576,0.025900582291488422,VEGFA,1
REACTOME_METABOLISM_OF_CARBOHYDRATES,REACTOME_METABOLISM_OF_CARBOHYDRATES,2/16,293/21728,0.01919854905393345,0.059786085644463895,0.0261089416664231,GAPDH/SLC2A1,2
REACTOME_DEUBIQUITINATION,REACTOME_DEUBIQUITINATION,2/16,297/21728,0.01969355885540255,0.0599539473361697,0.026182247872533277,PSMC5/H2BC11,2
BIOCARTA_VEGF_PATHWAY,BIOCARTA_VEGF_PATHWAY,1/16,27/21728,0.019704691743029912,0.0599539473361697,0.026182247872533277,VEGFA,1
IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_UP,IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_UP,1/16,27/21728,0.019704691743029912,0.0599539473361697,0.026182247872533277,BNIP3,1
NICK_RESPONSE_TO_PROC_TREATMENT_DN,NICK_RESPONSE_TO_PROC_TREATMENT_DN,1/16,27/21728,0.019704691743029912,0.0599539473361697,0.026182247872533277,MAFF,1
PID_GLYPICAN_1PATHWAY,PID_GLYPICAN_1PATHWAY,1/16,27/21728,0.019704691743029912,0.0599539473361697,0.026182247872533277,VEGFA,1
VALK_AML_CLUSTER_7,VALK_AML_CLUSTER_7,1/16,27/21728,0.019704691743029912,0.0599539473361697,0.026182247872533277,SLC2A1,1
WP_INTRACELLULAR_TRAFFICKING_PROTEINS_INVOLVED_IN_CMT_NEUROPATHY,WP_INTRACELLULAR_TRAFFICKING_PROTEINS_INVOLVED_IN_CMT_NEUROPATHY,1/16,27/21728,0.019704691743029912,0.0599539473361697,0.026182247872533277,NDRG1,1
DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP,DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP,2/16,300/21728,0.020068370658687534,0.06086094108255566,0.026578337473665982,KLF6/H2BC11,2
BIOCARTA_NO1_PATHWAY,BIOCARTA_NO1_PATHWAY,1/16,28/21728,0.020427456819851586,0.06095395475505554,0.02661895710151586,VEGFA,1
HWANG_PROSTATE_CANCER_MARKERS,HWANG_PROSTATE_CANCER_MARKERS,1/16,28/21728,0.020427456819851586,0.06095395475505554,0.02661895710151586,NDRG1,1
PID_LIS1_PATHWAY,PID_LIS1_PATHWAY,1/16,28/21728,0.020427456819851586,0.06095395475505554,0.02661895710151586,VLDLR,1
PID_REELIN_PATHWAY,PID_REELIN_PATHWAY,1/16,28/21728,0.020427456819851586,0.06095395475505554,0.02661895710151586,VLDLR,1
PLASARI_NFIC_TARGETS_BASAL_UP,PLASARI_NFIC_TARGETS_BASAL_UP,1/16,28/21728,0.020427456819851586,0.06095395475505554,0.02661895710151586,NRN1,1
TARTE_PLASMA_CELL_VS_PLASMABLAST_DN,TARTE_PLASMA_CELL_VS_PLASMABLAST_DN,2/16,307/21728,0.02095469835399597,0.061511733914590166,0.026862542601085775,PSMC5/YARS1,2
BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_UP,BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_UP,1/16,29/21728,0.02114972228947798,0.061511733914590166,0.026862542601085775,NDRG1,1
BOYAULT_LIVER_CANCER_SUBCLASS_G5_DN,BOYAULT_LIVER_CANCER_SUBCLASS_G5_DN,1/16,29/21728,0.02114972228947798,0.061511733914590166,0.026862542601085775,ARL4C,1
KEGG_THYROID_CANCER,KEGG_THYROID_CANCER,1/16,29/21728,0.02114972228947798,0.061511733914590166,0.026862542601085775,TFG,1
KRIGE_AMINO_ACID_DEPRIVATION,KRIGE_AMINO_ACID_DEPRIVATION,1/16,29/21728,0.02114972228947798,0.061511733914590166,0.026862542601085775,VEGFA,1
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_OLD,KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_OLD,1/16,29/21728,0.02114972228947798,0.061511733914590166,0.026862542601085775,NDRG1,1
PID_S1P_S1P3_PATHWAY,PID_S1P_S1P3_PATHWAY,1/16,29/21728,0.02114972228947798,0.061511733914590166,0.026862542601085775,VEGFA,1
TAKADA_GASTRIC_CANCER_COPY_NUMBER_DN,TAKADA_GASTRIC_CANCER_COPY_NUMBER_DN,1/16,29/21728,0.02114972228947798,0.061511733914590166,0.026862542601085775,VLDLR,1
WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING_PATHWAY,WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING_PATHWAY,2/16,309/21728,0.021210942729169024,0.061511733914590166,0.026862542601085775,SLC2A1/VEGFA,2
LIU_SOX4_TARGETS_DN,LIU_SOX4_TARGETS_DN,2/16,310/21728,0.021339563758512547,0.06169194756355029,0.026941242980906156,BNIP3/VEGFA,2
CHIARETTI_T_ALL_REFRACTORY_TO_THERAPY,CHIARETTI_T_ALL_REFRACTORY_TO_THERAPY,1/16,30/21728,0.0218714884742498,0.06206954527248873,0.027106142161874052,ARL4C,1
DIRMEIER_LMP1_RESPONSE_LATE_DN,DIRMEIER_LMP1_RESPONSE_LATE_DN,1/16,30/21728,0.0218714884742498,0.06206954527248873,0.027106142161874052,GAPDH,1
PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION,PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION,1/16,30/21728,0.0218714884742498,0.06206954527248873,0.027106142161874052,NDRG1,1
SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_UP,SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_UP,1/16,30/21728,0.0218714884742498,0.06206954527248873,0.027106142161874052,SLC2A1,1
TIEN_INTESTINE_PROBIOTICS_2HR_UP,TIEN_INTESTINE_PROBIOTICS_2HR_UP,1/16,30/21728,0.0218714884742498,0.06206954527248873,0.027106142161874052,GAPDH,1
WP_GPR143_IN_MELANOCYTES_AND_RETINAL_PIGMENT_EPITHELIUM_CELLS,WP_GPR143_IN_MELANOCYTES_AND_RETINAL_PIGMENT_EPITHELIUM_CELLS,1/16,30/21728,0.0218714884742498,0.06206954527248873,0.027106142161874052,VEGFA,1
PASINI_SUZ12_TARGETS_DN,PASINI_SUZ12_TARGETS_DN,2/16,316/21728,0.02211824267244441,0.06257844268301345,0.027328380708893128,KLF6/ARL4C,2
BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_DN,BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_DN,1/16,31/21728,0.02259275569631669,0.06296119305159727,0.02749553008718801,KLF6,1
DANG_MYC_TARGETS_DN,DANG_MYC_TARGETS_DN,1/16,31/21728,0.02259275569631669,0.06296119305159727,0.02749553008718801,NDRG1,1
VALK_AML_CLUSTER_13,VALK_AML_CLUSTER_13,1/16,31/21728,0.02259275569631669,0.06296119305159727,0.02749553008718801,VLDLR,1
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_5,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_5,1/16,31/21728,0.02259275569631669,0.06296119305159727,0.02749553008718801,VEGFA,1
ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_DN,ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_DN,1/16,31/21728,0.02259275569631669,0.06296119305159727,0.02749553008718801,PSMC5,1
REACTOME_RHO_GTPASE_EFFECTORS,REACTOME_RHO_GTPASE_EFFECTORS,2/16,322/21728,0.022908763960553236,0.06363220744013409,0.0277885660894415,H4C8/H2BC11,2
GRESHOCK_CANCER_COPY_NUMBER_UP,GRESHOCK_CANCER_COPY_NUMBER_UP,2/16,323/21728,0.02304166142746789,0.06363220744013409,0.0277885660894415,KLF6/TFG,2
CAFFAREL_RESPONSE_TO_THC_UP,CAFFAREL_RESPONSE_TO_THC_UP,1/16,32/21728,0.023313524277635334,0.06363220744013409,0.0277885660894415,VEGFA,1
LIU_BREAST_CANCER,LIU_BREAST_CANCER,1/16,32/21728,0.023313524277635334,0.06363220744013409,0.0277885660894415,NRN1,1
MAYBURD_RESPONSE_TO_L663536_UP,MAYBURD_RESPONSE_TO_L663536_UP,1/16,32/21728,0.023313524277635334,0.06363220744013409,0.0277885660894415,YARS1,1
PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP,PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP,1/16,32/21728,0.023313524277635334,0.06363220744013409,0.0277885660894415,VEGFA,1
TSAI_RESPONSE_TO_RADIATION_THERAPY,TSAI_RESPONSE_TO_RADIATION_THERAPY,1/16,32/21728,0.023313524277635334,0.06363220744013409,0.0277885660894415,VEGFA,1
LINDGREN_BLADDER_CANCER_CLUSTER_3_UP,LINDGREN_BLADDER_CANCER_CLUSTER_3_UP,2/16,327/21728,0.023576501761261064,0.06372388952311282,0.027828604204172463,TFG/YARS1,2
REACTOME_DNA_REPAIR,REACTOME_DNA_REPAIR,2/16,330/21728,0.023981031397428132,0.06372388952311282,0.027828604204172463,H4C8/H2BC11,2
AMIT_SERUM_RESPONSE_40_MCF10A,AMIT_SERUM_RESPONSE_40_MCF10A,1/16,33/21728,0.024033794539967124,0.06372388952311282,0.027828604204172463,KLF6,1
DUTTA_APOPTOSIS_VIA_NFKB,DUTTA_APOPTOSIS_VIA_NFKB,1/16,33/21728,0.024033794539967124,0.06372388952311282,0.027828604204172463,BNIP3,1
KASLER_HDAC7_TARGETS_2_DN,KASLER_HDAC7_TARGETS_2_DN,1/16,33/21728,0.024033794539967124,0.06372388952311282,0.027828604204172463,VEGFA,1
REACTOME_PLASMA_LIPOPROTEIN_CLEARANCE,REACTOME_PLASMA_LIPOPROTEIN_CLEARANCE,1/16,33/21728,0.024033794539967124,0.06372388952311282,0.027828604204172463,VLDLR,1
SIMBULAN_UV_RESPONSE_NORMAL_DN,SIMBULAN_UV_RESPONSE_NORMAL_DN,1/16,33/21728,0.024033794539967124,0.06372388952311282,0.027828604204172463,VEGFA,1
WEIGEL_OXIDATIVE_STRESS_RESPONSE,WEIGEL_OXIDATIVE_STRESS_RESPONSE,1/16,33/21728,0.024033794539967124,0.06372388952311282,0.027828604204172463,BNIP3,1
WP_PREGNANE_X_RECEPTOR_PATHWAY,WP_PREGNANE_X_RECEPTOR_PATHWAY,1/16,33/21728,0.024033794539967124,0.06372388952311282,0.027828604204172463,PSMC5,1
WP_PROSTAGLANDIN_SIGNALING,WP_PROSTAGLANDIN_SIGNALING,1/16,33/21728,0.024033794539967124,0.06372388952311282,0.027828604204172463,VEGFA,1
DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN,DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN,1/16,34/21728,0.024753566804883498,0.06500921884603635,0.02838991521747277,VLDLR,1
REACTOME_GLUCONEOGENESIS,REACTOME_GLUCONEOGENESIS,1/16,34/21728,0.024753566804883498,0.06500921884603635,0.02838991521747277,GAPDH,1
WANG_RESPONSE_TO_BEXAROTENE_UP,WANG_RESPONSE_TO_BEXAROTENE_UP,1/16,34/21728,0.024753566804883498,0.06500921884603635,0.02838991521747277,BNIP3,1
WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS,WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS,2/16,336/21728,0.02479877529256128,0.06500921884603635,0.02838991521747277,GAPDH/PSMC5,2
GENTILE_UV_RESPONSE_CLUSTER_D6,GENTILE_UV_RESPONSE_CLUSTER_D6,1/16,35/21728,0.02547284139376149,0.06588803130375873,0.028773697881065236,ARL4C,1
GYORFFY_MITOXANTRONE_RESISTANCE,GYORFFY_MITOXANTRONE_RESISTANCE,1/16,35/21728,0.02547284139376149,0.06588803130375873,0.028773697881065236,MAFF,1
HONMA_DOCETAXEL_RESISTANCE,HONMA_DOCETAXEL_RESISTANCE,1/16,35/21728,0.02547284139376149,0.06588803130375873,0.028773697881065236,GAPDH,1
WP_PHOTODYNAMIC_THERAPYINDUCED_NFKB_SURVIVAL_SIGNALING,WP_PHOTODYNAMIC_THERAPYINDUCED_NFKB_SURVIVAL_SIGNALING,1/16,35/21728,0.02547284139376149,0.06588803130375873,0.028773697881065236,VEGFA,1
RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP,RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP,2/16,341/21728,0.025489012109967006,0.06588803130375873,0.028773697881065236,NDRG1/TFG,2
PACHER_TARGETS_OF_IGF1_AND_IGF2_UP,PACHER_TARGETS_OF_IGF1_AND_IGF2_UP,1/16,36/21728,0.026191618627786295,0.066774236501609,0.0291607089985475,VEGFA,1
RIZ_ERYTHROID_DIFFERENTIATION_12HR,RIZ_ERYTHROID_DIFFERENTIATION_12HR,1/16,36/21728,0.026191618627786295,0.066774236501609,0.0291607089985475,KLF6,1
SUBTIL_PROGESTIN_TARGETS,SUBTIL_PROGESTIN_TARGETS,1/16,36/21728,0.026191618627786295,0.066774236501609,0.0291607089985475,BNIP3,1
UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN,UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN,1/16,36/21728,0.026191618627786295,0.066774236501609,0.0291607089985475,NDRG1,1
WP_LEUKOCYTEINTRINSIC_HIPPO_PATHWAY_FUNCTIONS,WP_LEUKOCYTEINTRINSIC_HIPPO_PATHWAY_FUNCTIONS,1/16,36/21728,0.026191618627786295,0.066774236501609,0.0291607089985475,NDRG1,1
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_WS,KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_WS,1/16,37/21728,0.026909898827950585,0.06823056314846487,0.029796695567330965,NDRG1,1
REACTOME_NR1H3_NR1H2_REGULATE_GENE_EXPRESSION_LINKED_TO_CHOLESTEROL_TRANSPORT_AND_EFFLUX,REACTOME_NR1H3_NR1H2_REGULATE_GENE_EXPRESSION_LINKED_TO_CHOLESTEROL_TRANSPORT_AND_EFFLUX,1/16,37/21728,0.026909898827950585,0.06823056314846487,0.029796695567330965,ARL4C,1
MA_MYELOID_DIFFERENTIATION_UP,MA_MYELOID_DIFFERENTIATION_UP,1/16,38/21728,0.02762768231505308,0.0694810005104858,0.030342769052333296,BNIP3L,1
REACTOME_TRANSCRIPTIONAL_REGULATION_BY_THE_AP_2_TFAP2_FAMILY_OF_TRANSCRIPTION_FACTORS,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_THE_AP_2_TFAP2_FAMILY_OF_TRANSCRIPTION_FACTORS,1/16,38/21728,0.02762768231505308,0.0694810005104858,0.030342769052333296,VEGFA,1
VALK_AML_CLUSTER_11,VALK_AML_CLUSTER_11,1/16,38/21728,0.02762768231505308,0.0694810005104858,0.030342769052333296,VEGFA,1
YOSHIMURA_MAPK8_TARGETS_DN,YOSHIMURA_MAPK8_TARGETS_DN,2/16,357/21728,0.027750705713054255,0.06960177000463338,0.03039550981372941,VEGFA/PSMC5,2
GRUETZMANN_PANCREATIC_CANCER_UP,GRUETZMANN_PANCREATIC_CANCER_UP,2/16,359/21728,0.028039023494352167,0.07013534717724747,0.030628526160662747,SLC2A1/NDRG1,2
WANG_LMO4_TARGETS_DN,WANG_LMO4_TARGETS_DN,2/16,361/21728,0.02832857446847035,0.07033190270642992,0.030714363137449546,H4C8/PSMC5,2
GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_UP,GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_UP,1/16,39/21728,0.028344969409703435,0.07033190270642992,0.030714363137449546,MAFF,1
GEISS_RESPONSE_TO_DSRNA_UP,GEISS_RESPONSE_TO_DSRNA_UP,1/16,39/21728,0.028344969409703435,0.07033190270642992,0.030714363137449546,BNIP3,1
REACTOME_TRANSCRIPTIONAL_REGULATION_BY_TP53,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_TP53,2/16,366/21728,0.029057822458157533,0.07122174147549123,0.031102961057241526,BNIP3L/NDRG1,2
DELPUECH_FOXO3_TARGETS_DN,DELPUECH_FOXO3_TARGETS_DN,1/16,40/21728,0.02906176043231601,0.07122174147549123,0.031102961057241526,VEGFA,1
FIGUEROA_AML_METHYLATION_CLUSTER_3_DN,FIGUEROA_AML_METHYLATION_CLUSTER_3_DN,1/16,40/21728,0.02906176043231601,0.07122174147549123,0.031102961057241526,H2BC11,1
TRAYNOR_RETT_SYNDROM_UP,TRAYNOR_RETT_SYNDROM_UP,1/16,40/21728,0.02906176043231601,0.07122174147549123,0.031102961057241526,GAPDH,1
DELACROIX_RARG_BOUND_MEF,DELACROIX_RARG_BOUND_MEF,2/16,367/21728,0.02920458897318353,0.07122174147549123,0.031102961057241526,NRN1/VEGFA,2
DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP,DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP,2/16,367/21728,0.02920458897318353,0.07122174147549123,0.031102961057241526,KLF6/H4C8,2
WANG_LMO4_TARGETS_UP,WANG_LMO4_TARGETS_UP,2/16,369/21728,0.029499035179904126,0.07122174147549123,0.031102961057241526,SLC2A1/NDRG1,2
AMIT_EGF_RESPONSE_120_MCF10A,AMIT_EGF_RESPONSE_120_MCF10A,1/16,41/21728,0.02977805570311487,0.07122174147549123,0.031102961057241526,MAFF,1
GALLUZZI_PERMEABILIZE_MITOCHONDRIA,GALLUZZI_PERMEABILIZE_MITOCHONDRIA,1/16,41/21728,0.02977805570311487,0.07122174147549123,0.031102961057241526,BNIP3,1
KEGG_AMINOACYL_TRNA_BIOSYNTHESIS,KEGG_AMINOACYL_TRNA_BIOSYNTHESIS,1/16,41/21728,0.02977805570311487,0.07122174147549123,0.031102961057241526,YARS1,1
LIAO_HAVE_SOX4_BINDING_SITES,LIAO_HAVE_SOX4_BINDING_SITES,1/16,41/21728,0.02977805570311487,0.07122174147549123,0.031102961057241526,SLC2A1,1
LIN_MELANOMA_COPY_NUMBER_DN,LIN_MELANOMA_COPY_NUMBER_DN,1/16,41/21728,0.02977805570311487,0.07122174147549123,0.031102961057241526,KLF6,1
PIONTEK_PKD1_TARGETS_UP,PIONTEK_PKD1_TARGETS_UP,1/16,41/21728,0.02977805570311487,0.07122174147549123,0.031102961057241526,NDRG1,1
WP_BLADDER_CANCER,WP_BLADDER_CANCER,1/16,41/21728,0.02977805570311487,0.07122174147549123,0.031102961057241526,VEGFA,1
AMIT_EGF_RESPONSE_40_HELA,AMIT_EGF_RESPONSE_40_HELA,1/16,42/21728,0.030493855542131243,0.07164126061543745,0.03128616757820261,KLF6,1
BYSTROEM_CORRELATED_WITH_IL5_UP,BYSTROEM_CORRELATED_WITH_IL5_UP,1/16,42/21728,0.030493855542131243,0.07164126061543745,0.03128616757820261,PSMC5,1
KEGG_BLADDER_CANCER,KEGG_BLADDER_CANCER,1/16,42/21728,0.030493855542131243,0.07164126061543745,0.03128616757820261,VEGFA,1
KORKOLA_EMBRYONAL_CARCINOMA_UP,KORKOLA_EMBRYONAL_CARCINOMA_UP,1/16,42/21728,0.030493855542131243,0.07164126061543745,0.03128616757820261,GAPDH,1
PID_TCPTP_PATHWAY,PID_TCPTP_PATHWAY,1/16,42/21728,0.030493855542131243,0.07164126061543745,0.03128616757820261,VEGFA,1
PID_UPA_UPAR_PATHWAY,PID_UPA_UPAR_PATHWAY,1/16,42/21728,0.030493855542131243,0.07164126061543745,0.03128616757820261,VLDLR,1
REACTOME_TRNA_AMINOACYLATION,REACTOME_TRNA_AMINOACYLATION,1/16,42/21728,0.030493855542131243,0.07164126061543745,0.03128616757820261,YARS1,1
BLANCO_MELO_BETA_INTERFERON_TREATED_BRONCHIAL_EPITHELIAL_CELLS_UP,BLANCO_MELO_BETA_INTERFERON_TREATED_BRONCHIAL_EPITHELIAL_CELLS_UP,2/16,378/21728,0.030839018325627927,0.07222469009930722,0.031540954728032304,KLF6/MAFF,2
GOBERT_CORE_OLIGODENDROCYTE_DIFFERENTIATION,GOBERT_CORE_OLIGODENDROCYTE_DIFFERENTIATION,1/16,43/21728,0.03120916026920495,0.07222469009930722,0.031540954728032304,NDRG1,1
JOHANSSON_BRAIN_CANCER_EARLY_VS_LATE_DN,JOHANSSON_BRAIN_CANCER_EARLY_VS_LATE_DN,1/16,43/21728,0.03120916026920495,0.07222469009930722,0.031540954728032304,NDRG1,1
LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_DN,LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_DN,1/16,43/21728,0.03120916026920495,0.07222469009930722,0.031540954728032304,ARL4C,1
LUI_THYROID_CANCER_CLUSTER_2,LUI_THYROID_CANCER_CLUSTER_2,1/16,43/21728,0.03120916026920495,0.07222469009930722,0.031540954728032304,BNIP3L,1
PID_INTEGRIN3_PATHWAY,PID_INTEGRIN3_PATHWAY,1/16,43/21728,0.03120916026920495,0.07222469009930722,0.031540954728032304,VEGFA,1
VECCHI_GASTRIC_CANCER_EARLY_DN,VECCHI_GASTRIC_CANCER_EARLY_DN,2/16,384/21728,0.03174583602389322,0.07243384926478638,0.031632295788274464,BNIP3/VLDLR,2
WANG_TUMOR_INVASIVENESS_UP,WANG_TUMOR_INVASIVENESS_UP,2/16,384/21728,0.03174583602389322,0.07243384926478638,0.031632295788274464,GAPDH/PSMC5,2
IKEDA_MIR133_TARGETS_UP,IKEDA_MIR133_TARGETS_UP,1/16,44/21728,0.03192397020398452,0.07243384926478638,0.031632295788274464,NDRG1,1
KORKOLA_SEMINOMA_UP,KORKOLA_SEMINOMA_UP,1/16,44/21728,0.03192397020398452,0.07243384926478638,0.031632295788274464,GAPDH,1
MARTIN_NFKB_TARGETS_UP,MARTIN_NFKB_TARGETS_UP,1/16,44/21728,0.03192397020398452,0.07243384926478638,0.031632295788274464,VEGFA,1
PARENT_MTOR_SIGNALING_DN,PARENT_MTOR_SIGNALING_DN,1/16,44/21728,0.03192397020398452,0.07243384926478638,0.031632295788274464,VEGFA,1
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP,1/16,44/21728,0.03192397020398452,0.07243384926478638,0.031632295788274464,KLF6,1
WP_GENES_CONTROLLING_NEPHROGENESIS,WP_GENES_CONTROLLING_NEPHROGENESIS,1/16,44/21728,0.03192397020398452,0.07243384926478638,0.031632295788274464,VEGFA,1
LINDGREN_BLADDER_CANCER_CLUSTER_2B,LINDGREN_BLADDER_CANCER_CLUSTER_2B,2/16,389/21728,0.03250968019531614,0.07316021521251113,0.03194950414793193,NRN1/ARL4C,2
HALMOS_CEBPA_TARGETS_DN,HALMOS_CEBPA_TARGETS_DN,1/16,45/21728,0.0326382856659263,0.07316021521251113,0.03194950414793193,ARL4C,1
WANG_TARGETS_OF_MLL_CBP_FUSION_DN,WANG_TARGETS_OF_MLL_CBP_FUSION_DN,1/16,45/21728,0.0326382856659263,0.07316021521251113,0.03194950414793193,PSMC5,1
WP_NEPHROTIC_SYNDROME,WP_NEPHROTIC_SYNDROME,1/16,45/21728,0.0326382856659263,0.07316021521251113,0.03194950414793193,YARS1,1
ZHAN_V2_LATE_DIFFERENTIATION_GENES,ZHAN_V2_LATE_DIFFERENTIATION_GENES,1/16,45/21728,0.0326382856659263,0.07316021521251113,0.03194950414793193,KLF6,1
BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN,BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN,1/16,46/21728,0.03335210697429403,0.07368933139369432,0.032180572353190016,VEGFA,1
FIGUEROA_AML_METHYLATION_CLUSTER_1_DN,FIGUEROA_AML_METHYLATION_CLUSTER_1_DN,1/16,46/21728,0.03335210697429403,0.07368933139369432,0.032180572353190016,H2BC11,1
KEGG_PROTEASOME,KEGG_PROTEASOME,1/16,46/21728,0.03335210697429403,0.07368933139369432,0.032180572353190016,PSMC5,1
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_1,PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_1,1/16,46/21728,0.03335210697429403,0.07368933139369432,0.032180572353190016,MAFF,1
SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER,SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER,1/16,46/21728,0.03335210697429403,0.07368933139369432,0.032180572353190016,BNIP3,1
WP_HEART_DEVELOPMENT,WP_HEART_DEVELOPMENT,1/16,46/21728,0.03335210697429403,0.07368933139369432,0.032180572353190016,VEGFA,1
JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_UP,JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_UP,2/16,395/21728,0.03343600279851602,0.07368933139369432,0.032180572353190016,KLF6/H2BC11,2
HSIAO_HOUSEKEEPING_GENES,HSIAO_HOUSEKEEPING_GENES,2/16,399/21728,0.03405939020176097,0.07368933139369432,0.032180572353190016,GAPDH/NDRG1,2
HUANG_FOXA2_TARGETS_UP,HUANG_FOXA2_TARGETS_UP,1/16,47/21728,0.03406543444816257,0.07368933139369432,0.032180572353190016,MAFF,1
MCDOWELL_ACUTE_LUNG_INJURY_UP,MCDOWELL_ACUTE_LUNG_INJURY_UP,1/16,47/21728,0.03406543444816257,0.07368933139369432,0.032180572353190016,KLF6,1
MELLMAN_TUT1_TARGETS_DN,MELLMAN_TUT1_TARGETS_DN,1/16,47/21728,0.03406543444816257,0.07368933139369432,0.032180572353190016,BNIP3,1
NAKAMURA_METASTASIS,NAKAMURA_METASTASIS,1/16,47/21728,0.03406543444816257,0.07368933139369432,0.032180572353190016,NRN1,1
REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING,REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING,1/16,47/21728,0.03406543444816257,0.07368933139369432,0.032180572353190016,ARL4C,1
SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2,SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2,1/16,47/21728,0.03406543444816257,0.07368933139369432,0.032180572353190016,BNIP3,1
SMITH_LIVER_CANCER,SMITH_LIVER_CANCER,1/16,47/21728,0.03406543444816257,0.07368933139369432,0.032180572353190016,BNIP3,1
BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN,BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN,1/16,48/21728,0.03477826840641274,0.07470887287303478,0.03262581222336478,KLF6,1
LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_DN,LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_DN,1/16,48/21728,0.03477826840641274,0.07470887287303478,0.03262581222336478,VEGFA,1
WP_PLURIPOTENT_STEM_CELL_DIFFERENTIATION_PATHWAY,WP_PLURIPOTENT_STEM_CELL_DIFFERENTIATION_PATHWAY,1/16,48/21728,0.03477826840641274,0.07470887287303478,0.03262581222336478,VEGFA,1
REN_ALVEOLAR_RHABDOMYOSARCOMA_DN,REN_ALVEOLAR_RHABDOMYOSARCOMA_DN,2/16,407/21728,0.03532004799771564,0.0756663967184403,0.03304396862136969,KLF6/ARL4C,2
GUILLAUMOND_KLF10_TARGETS_UP,GUILLAUMOND_KLF10_TARGETS_UP,1/16,49/21728,0.03549060916773661,0.0756663967184403,0.03304396862136969,NDRG1,1
PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN,PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN,1/16,49/21728,0.03549060916773661,0.0756663967184403,0.03304396862136969,PSMC5,1
SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN,SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN,2/16,409/21728,0.03563808367371529,0.0756663967184403,0.03304396862136969,NDRG1/ARL4C,2
CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_UP,CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_UP,1/16,50/21728,0.036202457050633075,0.0756663967184403,0.03304396862136969,YARS1,1
KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP,KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP,1/16,50/21728,0.036202457050633075,0.0756663967184403,0.03304396862136969,VEGFA,1
OHGUCHI_LIVER_HNF4A_TARGETS_UP,OHGUCHI_LIVER_HNF4A_TARGETS_UP,1/16,50/21728,0.036202457050633075,0.0756663967184403,0.03304396862136969,VLDLR,1
REACTOME_CROSS_PRESENTATION_OF_SOLUBLE_EXOGENOUS_ANTIGENS_ENDOSOMES,REACTOME_CROSS_PRESENTATION_OF_SOLUBLE_EXOGENOUS_ANTIGENS_ENDOSOMES,1/16,50/21728,0.036202457050633075,0.0756663967184403,0.03304396862136969,PSMC5,1
REACTOME_HDMS_DEMETHYLATE_HISTONES,REACTOME_HDMS_DEMETHYLATE_HISTONES,1/16,50/21728,0.036202457050633075,0.0756663967184403,0.03304396862136969,H4C8,1
SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION,SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION,1/16,50/21728,0.036202457050633075,0.0756663967184403,0.03304396862136969,VLDLR,1
WONG_PROTEASOME_GENE_MODULE,WONG_PROTEASOME_GENE_MODULE,1/16,50/21728,0.036202457050633075,0.0756663967184403,0.03304396862136969,PSMC5,1
WP_HEPATITIS_C_AND_HEPATOCELLULAR_CARCINOMA,WP_HEPATITIS_C_AND_HEPATOCELLULAR_CARCINOMA,1/16,50/21728,0.036202457050633075,0.0756663967184403,0.03304396862136969,VEGFA,1
FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN,FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN,1/16,51/21728,0.036913812373411625,0.07663538676180309,0.03346713237669487,GAPDH,1
KOHOUTEK_CCNT1_TARGETS,KOHOUTEK_CCNT1_TARGETS,1/16,51/21728,0.036913812373411625,0.07663538676180309,0.03346713237669487,ARL4C,1
NATSUME_RESPONSE_TO_INTERFERON_BETA_DN,NATSUME_RESPONSE_TO_INTERFERON_BETA_DN,1/16,51/21728,0.036913812373411625,0.07663538676180309,0.03346713237669487,GAPDH,1
BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_DN,BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_DN,1/16,52/21728,0.03762467545418968,0.07759044182552895,0.03388421064295445,YARS1,1
FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_UP,FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_UP,1/16,52/21728,0.03762467545418968,0.07759044182552895,0.03388421064295445,NDRG1,1
KEGG_MTOR_SIGNALING_PATHWAY,KEGG_MTOR_SIGNALING_PATHWAY,1/16,52/21728,0.03762467545418968,0.07759044182552895,0.03388421064295445,VEGFA,1
RUTELLA_RESPONSE_TO_HGF_UP,RUTELLA_RESPONSE_TO_HGF_UP,2/16,422/21728,0.03773297484394865,0.07764124313788104,0.0339063958803133,NDRG1/TFG,2
HUPER_BREAST_BASAL_VS_LUMINAL_UP,HUPER_BREAST_BASAL_VS_LUMINAL_UP,1/16,53/21728,0.03833504661089415,0.07818664451628521,0.03414457592873164,NDRG1,1
SCHEIDEREIT_IKK_INTERACTING_PROTEINS,SCHEIDEREIT_IKK_INTERACTING_PROTEINS,1/16,53/21728,0.03833504661089415,0.07818664451628521,0.03414457592873164,TFG,1
TIEN_INTESTINE_PROBIOTICS_6HR_UP,TIEN_INTESTINE_PROBIOTICS_6HR_UP,1/16,53/21728,0.03833504661089415,0.07818664451628521,0.03414457592873164,GAPDH,1
WU_APOPTOSIS_BY_CDKN1A_VIA_TP53,WU_APOPTOSIS_BY_CDKN1A_VIA_TP53,1/16,53/21728,0.03833504661089415,0.07818664451628521,0.03414457592873164,VEGFA,1
BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP,BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP,2/16,428/21728,0.038715840062498785,0.07832697194139121,0.03420585775571191,KLF6/YARS1,2
MILI_PSEUDOPODIA_CHEMOTAXIS_DN,MILI_PSEUDOPODIA_CHEMOTAXIS_DN,2/16,428/21728,0.038715840062498785,0.07832697194139121,0.03420585775571191,KLF6/SLC2A1,2
BAKKER_FOXO3_TARGETS_UP,BAKKER_FOXO3_TARGETS_UP,1/16,54/21728,0.03904492616126187,0.07832697194139121,0.03420585775571191,KLF6,1
DEMAGALHAES_AGING_UP,DEMAGALHAES_AGING_UP,1/16,54/21728,0.03904492616126187,0.07832697194139121,0.03420585775571191,NDRG1,1
HENDRICKS_SMARCA4_TARGETS_UP,HENDRICKS_SMARCA4_TARGETS_UP,1/16,54/21728,0.03904492616126187,0.07832697194139121,0.03420585775571191,ARL4C,1
REACTOME_NEGATIVE_REGULATION_OF_NOTCH4_SIGNALING,REACTOME_NEGATIVE_REGULATION_OF_NOTCH4_SIGNALING,1/16,54/21728,0.03904492616126187,0.07832697194139121,0.03420585775571191,PSMC5,1
WIERENGA_STAT5A_TARGETS_GROUP2,WIERENGA_STAT5A_TARGETS_GROUP2,1/16,54/21728,0.03904492616126187,0.07832697194139121,0.03420585775571191,KLF6,1
MOOTHA_HUMAN_MITODB_6_2002,MOOTHA_HUMAN_MITODB_6_2002,2/16,431/21728,0.039211016510635445,0.07832697194139121,0.03420585775571191,BNIP3L/BNIP3,2
REACTOME_DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS,REACTOME_DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS,2/16,432/21728,0.03937662703449864,0.07832697194139121,0.03420585775571191,TFG/PSMC5,2
JOHNSTONE_PARVB_TARGETS_3_UP,JOHNSTONE_PARVB_TARGETS_3_UP,2/16,433/21728,0.039542512680479654,0.07832697194139121,0.03420585775571191,KLF6/ARL4C,2
LAU_APOPTOSIS_CDKN2A_UP,LAU_APOPTOSIS_CDKN2A_UP,1/16,55/21728,0.03975431442283972,0.07832697194139121,0.03420585775571191,BNIP3,1
REACTOME_AUF1_HNRNP_D0_BINDS_AND_DESTABILIZES_MRNA,REACTOME_AUF1_HNRNP_D0_BINDS_AND_DESTABILIZES_MRNA,1/16,55/21728,0.03975431442283972,0.07832697194139121,0.03420585775571191,PSMC5,1
REACTOME_DEGRADATION_OF_AXIN,REACTOME_DEGRADATION_OF_AXIN,1/16,55/21728,0.03975431442283972,0.07832697194139121,0.03420585775571191,PSMC5,1
REACTOME_REGULATION_OF_RUNX3_EXPRESSION_AND_ACTIVITY,REACTOME_REGULATION_OF_RUNX3_EXPRESSION_AND_ACTIVITY,1/16,55/21728,0.03975431442283972,0.07832697194139121,0.03420585775571191,PSMC5,1
REACTOME_SIGNALING_BY_ALK_IN_CANCER,REACTOME_SIGNALING_BY_ALK_IN_CANCER,1/16,55/21728,0.03975431442283972,0.07832697194139121,0.03420585775571191,TFG,1
WP_NRP1TRIGGERED_SIGNALING_PATHWAYS_IN_PANCREATIC_CANCER,WP_NRP1TRIGGERED_SIGNALING_PATHWAYS_IN_PANCREATIC_CANCER,1/16,55/21728,0.03975431442283972,0.07832697194139121,0.03420585775571191,VEGFA,1
GRYDER_PAX3FOXO1_ENHANCERS_KO_DOWN,GRYDER_PAX3FOXO1_ENHANCERS_KO_DOWN,2/16,438/21728,0.040376052411738736,0.07905233783083393,0.034522629383928166,NRN1/ARL4C,2
RICKMAN_HEAD_AND_NECK_CANCER_B,RICKMAN_HEAD_AND_NECK_CANCER_B,1/16,56/21728,0.04046321171298073,0.07905233783083393,0.034522629383928166,NRN1,1
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_DN,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_DN,1/16,56/21728,0.04046321171298073,0.07905233783083393,0.034522629383928166,ARL4C,1
WP_CCL18_SIGNALING_PATHWAY,WP_CCL18_SIGNALING_PATHWAY,1/16,56/21728,0.04046321171298073,0.07905233783083393,0.034522629383928166,SLC2A1,1
DELASERNA_MYOD_TARGETS_DN,DELASERNA_MYOD_TARGETS_DN,1/16,57/21728,0.04117161834885141,0.07959846214111273,0.03476112514102587,KLF6,1
JOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP,JOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP,1/16,57/21728,0.04117161834885141,0.07959846214111273,0.03476112514102587,KLF6,1
PID_SHP2_PATHWAY,PID_SHP2_PATHWAY,1/16,57/21728,0.04117161834885141,0.07959846214111273,0.03476112514102587,VEGFA,1
REACTOME_DEGRADATION_OF_DVL,REACTOME_DEGRADATION_OF_DVL,1/16,57/21728,0.04117161834885141,0.07959846214111273,0.03476112514102587,PSMC5,1
REACTOME_STABILIZATION_OF_P53,REACTOME_STABILIZATION_OF_P53,1/16,57/21728,0.04117161834885141,0.07959846214111273,0.03476112514102587,PSMC5,1
MITSIADES_RESPONSE_TO_APLIDIN_UP,MITSIADES_RESPONSE_TO_APLIDIN_UP,2/16,445/21728,0.04155444079122467,0.0801715614433607,0.03501140103867272,KLF6/MAFF,2
PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_UP,PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_UP,1/16,58/21728,0.041879534647426664,0.08046419907414482,0.03513919764467531,NRN1,1
WP_PROXIMAL_TUBULE_TRANSPORT,WP_PROXIMAL_TUBULE_TRANSPORT,1/16,58/21728,0.041879534647426664,0.08046419907414482,0.03513919764467531,SLC2A1,1
SENESE_HDAC1_TARGETS_UP,SENESE_HDAC1_TARGETS_UP,2/16,451/21728,0.04257500242625043,0.0804902235007224,0.03515056266762491,MAFF/VEGFA,2
AMIT_EGF_RESPONSE_240_HELA,AMIT_EGF_RESPONSE_240_HELA,1/16,59/21728,0.04258696092548997,0.0804902235007224,0.03515056266762491,NDRG1,1
BOYLAN_MULTIPLE_MYELOMA_C_DN,BOYLAN_MULTIPLE_MYELOMA_C_DN,1/16,59/21728,0.04258696092548997,0.0804902235007224,0.03515056266762491,KLF6,1
GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP,GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP,1/16,59/21728,0.04258696092548997,0.0804902235007224,0.03515056266762491,MAFF,1
ONDER_CDH1_TARGETS_3_DN,ONDER_CDH1_TARGETS_3_DN,1/16,59/21728,0.04258696092548997,0.0804902235007224,0.03515056266762491,ARL4C,1
REACTOME_CDT1_ASSOCIATION_WITH_THE_CDC6_ORC_ORIGIN_COMPLEX,REACTOME_CDT1_ASSOCIATION_WITH_THE_CDC6_ORC_ORIGIN_COMPLEX,1/16,59/21728,0.04258696092548997,0.0804902235007224,0.03515056266762491,PSMC5,1
REACTOME_E3_UBIQUITIN_LIGASES_UBIQUITINATE_TARGET_PROTEINS,REACTOME_E3_UBIQUITIN_LIGASES_UBIQUITINATE_TARGET_PROTEINS,1/16,59/21728,0.04258696092548997,0.0804902235007224,0.03515056266762491,H2BC11,1
REACTOME_METABOLISM_OF_POLYAMINES,REACTOME_METABOLISM_OF_POLYAMINES,1/16,59/21728,0.04258696092548997,0.0804902235007224,0.03515056266762491,PSMC5,1
SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP,SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP,2/16,453/21728,0.04291732915217538,0.08094975905125763,0.03535124459475294,NRN1/VLDLR,2
DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP,DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP,1/16,60/21728,0.04329389749963708,0.08100148564448227,0.03537383390781043,ARL4C,1
LEE_LIVER_CANCER_DENA_UP,LEE_LIVER_CANCER_DENA_UP,1/16,60/21728,0.04329389749963708,0.08100148564448227,0.03537383390781043,NDRG1,1
REACTOME_DEGRADATION_OF_GLI1_BY_THE_PROTEASOME,REACTOME_DEGRADATION_OF_GLI1_BY_THE_PROTEASOME,1/16,60/21728,0.04329389749963708,0.08100148564448227,0.03537383390781043,PSMC5,1
REACTOME_SCF_SKP2_MEDIATED_DEGRADATION_OF_P27_P21,REACTOME_SCF_SKP2_MEDIATED_DEGRADATION_OF_P27_P21,1/16,60/21728,0.04329389749963708,0.08100148564448227,0.03537383390781043,PSMC5,1
DASU_IL6_SIGNALING_UP,DASU_IL6_SIGNALING_UP,1/16,61/21728,0.04400034468627212,0.08182829633038181,0.03573490708620349,MAFF,1
LEE_LIVER_CANCER_MYC_TGFA_UP,LEE_LIVER_CANCER_MYC_TGFA_UP,1/16,61/21728,0.04400034468627212,0.08182829633038181,0.03573490708620349,NDRG1,1
REACTOME_DEFECTIVE_CFTR_CAUSES_CYSTIC_FIBROSIS,REACTOME_DEFECTIVE_CFTR_CAUSES_CYSTIC_FIBROSIS,1/16,61/21728,0.04400034468627212,0.08182829633038181,0.03573490708620349,PSMC5,1
REACTOME_SIGNALING_BY_INTERLEUKINS,REACTOME_SIGNALING_BY_INTERLEUKINS,2/16,463/21728,0.04464485441335745,0.08231636706328134,0.035948050498370375,VEGFA/PSMC5,2
DIRMEIER_LMP1_RESPONSE_EARLY,DIRMEIER_LMP1_RESPONSE_EARLY,1/16,62/21728,0.0447063028016097,0.08231636706328134,0.035948050498370375,KLF6,1
KEGG_GLYCOLYSIS_GLUCONEOGENESIS,KEGG_GLYCOLYSIS_GLUCONEOGENESIS,1/16,62/21728,0.0447063028016097,0.08231636706328134,0.035948050498370375,GAPDH,1
REACTOME_DECTIN_1_MEDIATED_NONCANONICAL_NF_KB_SIGNALING,REACTOME_DECTIN_1_MEDIATED_NONCANONICAL_NF_KB_SIGNALING,1/16,62/21728,0.0447063028016097,0.08231636706328134,0.035948050498370375,PSMC5,1
TENEDINI_MEGAKARYOCYTE_MARKERS,TENEDINI_MEGAKARYOCYTE_MARKERS,1/16,62/21728,0.0447063028016097,0.08231636706328134,0.035948050498370375,VEGFA,1
ANDERSEN_CHOLANGIOCARCINOMA_CLASS1,ANDERSEN_CHOLANGIOCARCINOMA_CLASS1,1/16,63/21728,0.04541177216167491,0.0829569381221148,0.03622779171621393,H4C8,1
HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP,HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP,1/16,63/21728,0.04541177216167491,0.0829569381221148,0.03622779171621393,KLF6,1
PHONG_TNF_TARGETS_UP,PHONG_TNF_TARGETS_UP,1/16,63/21728,0.04541177216167491,0.0829569381221148,0.03622779171621393,KLF6,1
PID_MYC_REPRESS_PATHWAY,PID_MYC_REPRESS_PATHWAY,1/16,63/21728,0.04541177216167491,0.0829569381221148,0.03622779171621393,NDRG1,1
BILBAN_B_CLL_LPL_UP,BILBAN_B_CLL_LPL_UP,1/16,64/21728,0.04611675308230323,0.08326137521474201,0.03636074121787169,BNIP3L,1
BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_UP,BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_UP,1/16,64/21728,0.04611675308230323,0.08326137521474201,0.03636074121787169,MAFF,1
GOLDRATH_IMMUNE_MEMORY,GOLDRATH_IMMUNE_MEMORY,1/16,64/21728,0.04611675308230323,0.08326137521474201,0.03636074121787169,SLC2A1,1
GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP,GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP,1/16,64/21728,0.04611675308230323,0.08326137521474201,0.03636074121787169,MAFF,1
REACTOME_ASYMMETRIC_LOCALIZATION_OF_PCP_PROTEINS,REACTOME_ASYMMETRIC_LOCALIZATION_OF_PCP_PROTEINS,1/16,64/21728,0.04611675308230323,0.08326137521474201,0.03636074121787169,PSMC5,1
WP_PROTEASOME_DEGRADATION,WP_PROTEASOME_DEGRADATION,1/16,64/21728,0.04611675308230323,0.08326137521474201,0.03636074121787169,PSMC5,1
ONDER_CDH1_TARGETS_2_DN,ONDER_CDH1_TARGETS_2_DN,2/16,473/21728,0.0463985526870243,0.08339753584614659,0.03642020338108717,NDRG1/ARL4C,2
AMIT_SERUM_RESPONSE_120_MCF10A,AMIT_SERUM_RESPONSE_120_MCF10A,1/16,65/21728,0.046821245879140494,0.08339753584614659,0.03642020338108717,MAFF,1
LEE_LIVER_CANCER_ACOX1_UP,LEE_LIVER_CANCER_ACOX1_UP,1/16,65/21728,0.046821245879140494,0.08339753584614659,0.03642020338108717,NDRG1,1
REACTOME_HEDGEHOG_LIGAND_BIOGENESIS,REACTOME_HEDGEHOG_LIGAND_BIOGENESIS,1/16,65/21728,0.046821245879140494,0.08339753584614659,0.03642020338108717,PSMC5,1
REACTOME_REGULATION_OF_HMOX1_EXPRESSION_AND_ACTIVITY,REACTOME_REGULATION_OF_HMOX1_EXPRESSION_AND_ACTIVITY,1/16,65/21728,0.046821245879140494,0.08339753584614659,0.03642020338108717,PSMC5,1
WP_ENDOCHONDRAL_OSSIFICATION,WP_ENDOCHONDRAL_OSSIFICATION,1/16,65/21728,0.046821245879140494,0.08339753584614659,0.03642020338108717,VEGFA,1
WP_ENDOCHONDRAL_OSSIFICATION_WITH_SKELETAL_DYSPLASIAS,WP_ENDOCHONDRAL_OSSIFICATION_WITH_SKELETAL_DYSPLASIAS,1/16,65/21728,0.046821245879140494,0.08339753584614659,0.03642020338108717,VEGFA,1
BRUNO_HEMATOPOIESIS,BRUNO_HEMATOPOIESIS,1/16,66/21728,0.04752525086764314,0.083846830428085245,0.036616413015894765,BNIP3,1
GAJATE_RESPONSE_TO_TRABECTEDIN_UP,GAJATE_RESPONSE_TO_TRABECTEDIN_UP,1/16,66/21728,0.04752525086764314,0.083846830428085245,0.036616413015894765,VLDLR,1
PID_INTEGRIN1_PATHWAY,PID_INTEGRIN1_PATHWAY,1/16,66/21728,0.04752525086764314,0.083846830428085245,0.036616413015894765,VEGFA,1
SWEET_KRAS_TARGETS_DN,SWEET_KRAS_TARGETS_DN,1/16,66/21728,0.04752525086764314,0.083846830428085245,0.036616413015894765,ARL4C,1
WP_ONCOSTATIN_M_SIGNALING_PATHWAY,WP_ONCOSTATIN_M_SIGNALING_PATHWAY,1/16,66/21728,0.04752525086764314,0.083846830428085245,0.036616413015894765,VEGFA,1
BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_RUXOLITINIB_UP,BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_RUXOLITINIB_UP,2/16,483/21728,0.048178000417470224,0.08455997984269362,0.036927849636385034,KLF6/MAFF,2
KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY,KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY,1/16,67/21728,0.048228768363078656,0.08455997984269362,0.036927849636385034,SLC2A1,1
TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_UP,TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_UP,1/16,67/21728,0.048228768363078656,0.08455997984269362,0.036927849636385034,MAFF,1
AMIT_EGF_RESPONSE_120_HELA,AMIT_EGF_RESPONSE_120_HELA,1/16,68/21728,0.04893179868052422,0.08455997984269362,0.036927849636385034,MAFF,1
CHIARETTI_ACUTE_LYMPHOBLASTIC_LEUKEMIA_ZAP70,CHIARETTI_ACUTE_LYMPHOBLASTIC_LEUKEMIA_ZAP70,1/16,68/21728,0.04893179868052422,0.08455997984269362,0.036927849636385034,SLC2A1,1
DANG_REGULATED_BY_MYC_UP,DANG_REGULATED_BY_MYC_UP,1/16,68/21728,0.04893179868052422,0.08455997984269362,0.036927849636385034,SLC2A1,1
MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_UP,MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_UP,1/16,68/21728,0.04893179868052422,0.08455997984269362,0.036927849636385034,H4C8,1
REACTOME_COPII_MEDIATED_VESICLE_TRANSPORT,REACTOME_COPII_MEDIATED_VESICLE_TRANSPORT,1/16,68/21728,0.04893179868052422,0.08455997984269362,0.036927849636385034,TFG,1
REACTOME_G1_S_DNA_DAMAGE_CHECKPOINTS,REACTOME_G1_S_DNA_DAMAGE_CHECKPOINTS,1/16,68/21728,0.04893179868052422,0.08455997984269362,0.036927849636385034,PSMC5,1
REACTOME_REGULATION_OF_RAS_BY_GAPS,REACTOME_REGULATION_OF_RAS_BY_GAPS,1/16,68/21728,0.04893179868052422,0.08455997984269362,0.036927849636385034,PSMC5,1
ZHONG_SECRETOME_OF_LUNG_CANCER_AND_ENDOTHELIUM,ZHONG_SECRETOME_OF_LUNG_CANCER_AND_ENDOTHELIUM,1/16,68/21728,0.04893179868052422,0.08455997984269362,0.036927849636385034,GAPDH,1
JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP,JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP,1/16,69/21728,0.04963434213486939,0.08482627900765893,0.037044144076620565,VLDLR,1
LEE_CALORIE_RESTRICTION_NEOCORTEX_UP,LEE_CALORIE_RESTRICTION_NEOCORTEX_UP,1/16,69/21728,0.04963434213486939,0.08482627900765893,0.037044144076620565,MAFF,1
PID_MTOR_4PATHWAY,PID_MTOR_4PATHWAY,1/16,69/21728,0.04963434213486939,0.08482627900765893,0.037044144076620565,BNIP3,1
PID_VEGFR1_2_PATHWAY,PID_VEGFR1_2_PATHWAY,1/16,69/21728,0.04963434213486939,0.08482627900765893,0.037044144076620565,VEGFA,1
REACTOME_REGULATION_OF_PTEN_STABILITY_AND_ACTIVITY,REACTOME_REGULATION_OF_PTEN_STABILITY_AND_ACTIVITY,1/16,69/21728,0.04963434213486939,0.08482627900765893,0.037044144076620565,PSMC5,1
ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_UP,ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_UP,1/16,69/21728,0.04963434213486939,0.08482627900765893,0.037044144076620565,VLDLR,1
FONTAINE_FOLLICULAR_THYROID_ADENOMA_DN,FONTAINE_FOLLICULAR_THYROID_ADENOMA_DN,1/16,70/21728,0.05033639904081333,0.08488035106369371,0.03706775766733449,BNIP3,1
KEGG_PANCREATIC_CANCER,KEGG_PANCREATIC_CANCER,1/16,70/21728,0.05033639904081333,0.08488035106369371,0.03706775766733449,VEGFA,1
SESTO_RESPONSE_TO_UV_C7,SESTO_RESPONSE_TO_UV_C7,1/16,70/21728,0.05033639904081333,0.08488035106369371,0.03706775766733449,YARS1,1
WP_HISTONE_MODIFICATIONS,WP_HISTONE_MODIFICATIONS,1/16,70/21728,0.05033639904081333,0.08488035106369371,0.03706775766733449,H4C8,1
WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY,WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY,1/16,70/21728,0.05033639904081333,0.08488035106369371,0.03706775766733449,PSMC5,1
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1,1/16,70/21728,0.05033639904081333,0.08488035106369371,0.03706775766733449,NDRG1,1
SENESE_HDAC3_TARGETS_UP,SENESE_HDAC3_TARGETS_UP,2/16,495/21728,0.05034673669897596,0.08488035106369371,0.03706775766733449,KLF6/ARL4C,2
BAE_BRCA1_TARGETS_UP,BAE_BRCA1_TARGETS_UP,1/16,71/21728,0.05103796971286756,0.08488035106369371,0.03706775766733449,VEGFA,1
BASSO_CD40_SIGNALING_DN,BASSO_CD40_SIGNALING_DN,1/16,71/21728,0.05103796971286756,0.08488035106369371,0.03706775766733449,ARL4C,1
GU_PDEF_TARGETS_UP,GU_PDEF_TARGETS_UP,1/16,71/21728,0.05103796971286756,0.08488035106369371,0.03706775766733449,VEGFA,1
HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP,HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP,1/16,71/21728,0.05103796971286756,0.08488035106369371,0.03706775766733449,VLDLR,1
REACTOME_ORC1_REMOVAL_FROM_CHROMATIN,REACTOME_ORC1_REMOVAL_FROM_CHROMATIN,1/16,71/21728,0.05103796971286756,0.08488035106369371,0.03706775766733449,PSMC5,1
REACTOME_PKMTS_METHYLATE_HISTONE_LYSINES,REACTOME_PKMTS_METHYLATE_HISTONE_LYSINES,1/16,71/21728,0.05103796971286756,0.08488035106369371,0.03706775766733449,H4C8,1
REACTOME_PLASMA_LIPOPROTEIN_ASSEMBLY_REMODELING_AND_CLEARANCE,REACTOME_PLASMA_LIPOPROTEIN_ASSEMBLY_REMODELING_AND_CLEARANCE,1/16,71/21728,0.05103796971286756,0.08488035106369371,0.03706775766733449,VLDLR,1
REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS,REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS,1/16,71/21728,0.05103796971286756,0.08488035106369371,0.03706775766733449,H4C8,1
REACTOME_GLYCOLYSIS,REACTOME_GLYCOLYSIS,1/16,72/21728,0.05173905446535376,0.0855861720924212,0.03737599393782006,GAPDH,1
WP_P53_TRANSCRIPTIONAL_GENE_NETWORK,WP_P53_TRANSCRIPTIONAL_GENE_NETWORK,1/16,72/21728,0.05173905446535376,0.0855861720924212,0.03737599393782006,SLC2A1,1
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_0,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_0,1/16,72/21728,0.05173905446535376,0.0855861720924212,0.03737599393782006,BNIP3,1
FURUKAWA_DUSP6_TARGETS_PCI35_DN,FURUKAWA_DUSP6_TARGETS_PCI35_DN,1/16,73/21728,0.052439653612405435,0.08597879602882022,0.03754745516231373,MAFF,1
HUANG_GATA2_TARGETS_DN,HUANG_GATA2_TARGETS_DN,1/16,73/21728,0.052439653612405435,0.08597879602882022,0.03754745516231373,SLC2A1,1
LINDVALL_IMMORTALIZED_BY_TERT_DN,LINDVALL_IMMORTALIZED_BY_TERT_DN,1/16,73/21728,0.052439653612405435,0.08597879602882022,0.03754745516231373,ARL4C,1
REACTOME_REGULATION_OF_RUNX2_EXPRESSION_AND_ACTIVITY,REACTOME_REGULATION_OF_RUNX2_EXPRESSION_AND_ACTIVITY,1/16,73/21728,0.052439653612405435,0.08597879602882022,0.03754745516231373,PSMC5,1
WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_DN,WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_DN,1/16,73/21728,0.052439653612405435,0.08597879602882022,0.03754745516231373,BNIP3,1
ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN,ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN,1/16,74/21728,0.05313976746796745,0.08636375518436741,0.037715569131104194,KLF6,1
LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_UP,LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_UP,1/16,74/21728,0.05313976746796745,0.08636375518436741,0.037715569131104194,BNIP3,1
PID_AVB3_INTEGRIN_PATHWAY,PID_AVB3_INTEGRIN_PATHWAY,1/16,74/21728,0.05313976746796745,0.08636375518436741,0.037715569131104194,VEGFA,1
REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1,REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1,1/16,74/21728,0.05313976746796745,0.08636375518436741,0.037715569131104194,PSMC5,1
SESTO_RESPONSE_TO_UV_C1,SESTO_RESPONSE_TO_UV_C1,1/16,74/21728,0.05313976746796745,0.08636375518436741,0.037715569131104194,BNIP3,1
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM3,SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM3,1/16,75/21728,0.05383939634579704,0.08726166489513716,0.03810769167947801,MAFF,1
HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_DN,HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_DN,1/16,76/21728,0.054538540559460724,0.08726166489513716,0.03810769167947801,NDRG1,1
KEGG_VEGF_SIGNALING_PATHWAY,KEGG_VEGF_SIGNALING_PATHWAY,1/16,76/21728,0.054538540559460724,0.08726166489513716,0.03810769167947801,VEGFA,1
LEIN_OLIGODENDROCYTE_MARKERS,LEIN_OLIGODENDROCYTE_MARKERS,1/16,76/21728,0.054538540559460724,0.08726166489513716,0.03810769167947801,NDRG1,1
MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_DN,MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_DN,1/16,76/21728,0.054538540559460724,0.08726166489513716,0.03810769167947801,ARL4C,1
THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP,THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP,1/16,76/21728,0.054538540559460724,0.08726166489513716,0.03810769167947801,VEGFA,1
WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA,WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA,1/16,76/21728,0.054538540559460724,0.08726166489513716,0.03810769167947801,VEGFA,1
WP_NUCLEOTIDE_EXCISION_REPAIR_IN_XERODERMA_PIGMENTOSUM,WP_NUCLEOTIDE_EXCISION_REPAIR_IN_XERODERMA_PIGMENTOSUM,1/16,76/21728,0.054538540559460724,0.08726166489513716,0.03810769167947801,H4C8,1
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6,1/16,76/21728,0.054538540559460724,0.08726166489513716,0.03810769167947801,ARL4C,1
KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_UP,KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_UP,1/16,77/21728,0.055237200422339816,0.08807581098269993,0.03846323415192771,NDRG1,1
REACTOME_RMTS_METHYLATE_HISTONE_ARGININES,REACTOME_RMTS_METHYLATE_HISTONE_ARGININES,1/16,77/21728,0.055237200422339816,0.08807581098269993,0.03846323415192771,H4C8,1
GUO_HEX_TARGETS_UP,GUO_HEX_TARGETS_UP,1/16,78/21728,0.05593537624762446,0.08842935120578449,0.03861762728474028,VEGFA,1
REACTOME_ABC_TRANSPORTER_DISORDERS,REACTOME_ABC_TRANSPORTER_DISORDERS,1/16,78/21728,0.05593537624762446,0.08842935120578449,0.03861762728474028,PSMC5,1
REACTOME_REGULATION_OF_INSULIN_SECRETION,REACTOME_REGULATION_OF_INSULIN_SECRETION,1/16,78/21728,0.05593537624762446,0.08842935120578449,0.03861762728474028,SLC2A1,1
SEKI_INFLAMMATORY_RESPONSE_LPS_UP,SEKI_INFLAMMATORY_RESPONSE_LPS_UP,1/16,78/21728,0.05593537624762446,0.08842935120578449,0.03861762728474028,MAFF,1
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16,1/16,78/21728,0.05593537624762446,0.08842935120578449,0.03861762728474028,GAPDH,1
CORRE_MULTIPLE_MYELOMA_UP,CORRE_MULTIPLE_MYELOMA_UP,1/16,79/21728,0.05663306834831905,0.08907709733430522,0.03890050189848856,MAFF,1
REACTOME_PROTEIN_UBIQUITINATION,REACTOME_PROTEIN_UBIQUITINATION,1/16,79/21728,0.05663306834831905,0.08907709733430522,0.03890050189848856,H2BC11,1
REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT,REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT,1/16,79/21728,0.05663306834831905,0.08907709733430522,0.03890050189848856,PSMC5,1
GRABARCZYK_BCL11B_TARGETS_UP,GRABARCZYK_BCL11B_TARGETS_UP,1/16,81/21728,0.05802700262701177,0.09065498053512949,0.03958957294240569,BNIP3,1
HINATA_NFKB_TARGETS_FIBROBLAST_UP,HINATA_NFKB_TARGETS_FIBROBLAST_UP,1/16,81/21728,0.05802700262701177,0.09065498053512949,0.03958957294240569,VEGFA,1
REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR,REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR,1/16,81/21728,0.05802700262701177,0.09065498053512949,0.03958957294240569,PSMC5,1
ROSS_LEUKEMIA_WITH_MLL_FUSIONS,ROSS_LEUKEMIA_WITH_MLL_FUSIONS,1/16,81/21728,0.05802700262701177,0.09065498053512949,0.03958957294240569,VLDLR,1
ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP,ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP,1/16,82/21728,0.05872324543007745,0.09112904976440113,0.03979660181408171,KLF6,1
RADMACHER_AML_PROGNOSIS,RADMACHER_AML_PROGNOSIS,1/16,82/21728,0.05872324543007745,0.09112904976440113,0.03979660181408171,SLC2A1,1
REACTOME_SIGNALING_BY_NOTCH4,REACTOME_SIGNALING_BY_NOTCH4,1/16,82/21728,0.05872324543007745,0.09112904976440113,0.03979660181408171,PSMC5,1
VANDESLUIS_COMMD1_TARGETS_GROUP_3_UP,VANDESLUIS_COMMD1_TARGETS_GROUP_3_UP,1/16,82/21728,0.05872324543007745,0.09112904976440113,0.03979660181408171,BNIP3L,1
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP,1/16,83/21728,0.05941900575868864,0.09190139557343842,0.04013388985455286,KLF6,1
NELSON_RESPONSE_TO_ANDROGEN_UP,NELSON_RESPONSE_TO_ANDROGEN_UP,1/16,83/21728,0.05941900575868864,0.09190139557343842,0.04013388985455286,NDRG1,1
HINATA_NFKB_TARGETS_KERATINOCYTE_UP,HINATA_NFKB_TARGETS_KERATINOCYTE_UP,1/16,84/21728,0.06011428392491014,0.09236101901045797,0.04033461016223494,VEGFA,1
NEMETH_INFLAMMATORY_RESPONSE_LPS_UP,NEMETH_INFLAMMATORY_RESPONSE_LPS_UP,1/16,84/21728,0.06011428392491014,0.09236101901045797,0.04033461016223494,SLC2A1,1
ONDER_CDH1_SIGNALING_VIA_CTNNB1,ONDER_CDH1_SIGNALING_VIA_CTNNB1,1/16,84/21728,0.06011428392491014,0.09236101901045797,0.04033461016223494,NDRG1,1
WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE,WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE,1/16,84/21728,0.06011428392491014,0.09236101901045797,0.04033461016223494,VEGFA,1
DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN,DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN,1/16,85/21728,0.06080908024061926,0.0925095515791716,0.040399475224570186,VLDLR,1
GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN,GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN,1/16,85/21728,0.06080908024061926,0.0925095515791716,0.040399475224570186,VEGFA,1
HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN,HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN,1/16,85/21728,0.06080908024061926,0.0925095515791716,0.040399475224570186,NDRG1,1
REACTOME_CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,REACTOME_CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,1/16,85/21728,0.06080908024061926,0.0925095515791716,0.040399475224570186,PSMC5,1
REACTOME_DEGRADATION_OF_BETA_CATENIN_BY_THE_DESTRUCTION_COMPLEX,REACTOME_DEGRADATION_OF_BETA_CATENIN_BY_THE_DESTRUCTION_COMPLEX,1/16,85/21728,0.06080908024061926,0.0925095515791716,0.040399475224570186,PSMC5,1
SASSON_RESPONSE_TO_FORSKOLIN_DN,SASSON_RESPONSE_TO_FORSKOLIN_DN,1/16,85/21728,0.06080908024061926,0.0925095515791716,0.040399475224570186,ARL4C,1
REACTOME_HEDGEHOG_ON_STATE,REACTOME_HEDGEHOG_ON_STATE,1/16,86/21728,0.06150339501750568,0.0929562712968164,0.04059456040071951,PSMC5,1
SASSON_RESPONSE_TO_GONADOTROPHINS_DN,SASSON_RESPONSE_TO_GONADOTROPHINS_DN,1/16,86/21728,0.06150339501750568,0.0929562712968164,0.04059456040071951,ARL4C,1
SASSON_RESPONSE_TO_GONADOTROPHINS_UP,SASSON_RESPONSE_TO_GONADOTROPHINS_UP,1/16,86/21728,0.06150339501750568,0.0929562712968164,0.04059456040071951,BNIP3L,1
WP_APOPTOSIS,WP_APOPTOSIS,1/16,86/21728,0.06150339501750568,0.0929562712968164,0.04059456040071951,BNIP3L,1
KAYO_CALORIE_RESTRICTION_MUSCLE_DN,KAYO_CALORIE_RESTRICTION_MUSCLE_DN,1/16,87/21728,0.062197228567072105,0.09339648561527979,0.040786804630084765,VLDLR,1
MARTIN_VIRAL_GPCR_SIGNALING_UP,MARTIN_VIRAL_GPCR_SIGNALING_UP,1/16,87/21728,0.062197228567072105,0.09339648561527979,0.040786804630084765,VEGFA,1
REACTOME_POTENTIAL_THERAPEUTICS_FOR_SARS,REACTOME_POTENTIAL_THERAPEUTICS_FOR_SARS,1/16,87/21728,0.062197228567072105,0.09339648561527979,0.040786804630084765,VEGFA,1
REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS,REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS,1/16,87/21728,0.062197228567072105,0.09339648561527979,0.040786804630084765,PSMC5,1
HOEBEKE_LYMPHOID_STEM_CELL_DN,HOEBEKE_LYMPHOID_STEM_CELL_DN,1/16,88/21728,0.06289058120063484,0.09352958229838003,0.040844928748725404,MAFF,1
KANG_IMMORTALIZED_BY_TERT_UP,KANG_IMMORTALIZED_BY_TERT_UP,1/16,88/21728,0.06289058120063484,0.09352958229838003,0.040844928748725404,BNIP3,1
MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_DEPENDENT,MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_DEPENDENT,1/16,88/21728,0.06289058120063484,0.09352958229838003,0.040844928748725404,ARL4C,1
REACTOME_APC_C_MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS,REACTOME_APC_C_MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS,1/16,88/21728,0.06289058120063484,0.09352958229838003,0.040844928748725404,PSMC5,1
SASSON_RESPONSE_TO_FORSKOLIN_UP,SASSON_RESPONSE_TO_FORSKOLIN_UP,1/16,88/21728,0.06289058120063484,0.09352958229838003,0.040844928748725404,BNIP3L,1
SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER,SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER,1/16,88/21728,0.06289058120063484,0.09352958229838003,0.040844928748725404,NDRG1,1
FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN,FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN,1/16,89/21728,0.06358345322932157,0.09380833799174948,0.04096666302951855,GAPDH,1
LI_DCP2_BOUND_MRNA,LI_DCP2_BOUND_MRNA,1/16,89/21728,0.06358345322932157,0.09380833799174948,0.04096666302951855,PSMC5,1
WNT_SIGNALING,WNT_SIGNALING,1/16,89/21728,0.06358345322932157,0.09380833799174948,0.04096666302951855,GAPDH,1
WP_ALLOGRAFT_REJECTION,WP_ALLOGRAFT_REJECTION,1/16,89/21728,0.06358345322932157,0.09380833799174948,0.04096666302951855,VEGFA,1
WP_PANCREATIC_ADENOCARCINOMA_PATHWAY,WP_PANCREATIC_ADENOCARCINOMA_PATHWAY,1/16,89/21728,0.06358345322932157,0.09380833799174948,0.04096666302951855,VEGFA,1
REACTOME_SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,REACTOME_SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,1/16,91/21728,0.0649677567156498,0.09554687516976706,0.04172589262745047,PSMC5,1
WP_APOPTOSIS_MODULATION_AND_SIGNALING,WP_APOPTOSIS_MODULATION_AND_SIGNALING,1/16,91/21728,0.0649677567156498,0.09554687516976706,0.04172589262745047,BNIP3,1
GAVIN_FOXP3_TARGETS_CLUSTER_P6,GAVIN_FOXP3_TARGETS_CLUSTER_P6,1/16,92/21728,0.06565918879461441,0.09610682523880469,0.041970426176202134,NRN1,1
REACTOME_GLUCOSE_METABOLISM,REACTOME_GLUCOSE_METABOLISM,1/16,92/21728,0.06565918879461441,0.09610682523880469,0.041970426176202134,GAPDH,1
REACTOME_PCP_CE_PATHWAY,REACTOME_PCP_CE_PATHWAY,1/16,92/21728,0.06565918879461441,0.09610682523880469,0.041970426176202134,PSMC5,1
REACTOME_MAPK6_MAPK4_SIGNALING,REACTOME_MAPK6_MAPK4_SIGNALING,1/16,93/21728,0.06635014151134944,0.09681278509832118,0.04227872307492476,PSMC5,1
SEAVEY_EPITHELIOID_HEMANGIOENDOTHELIOMA,SEAVEY_EPITHELIOID_HEMANGIOENDOTHELIOMA,1/16,93/21728,0.06635014151134944,0.09681278509832118,0.04227872307492476,MAFF,1
REACTOME_POST_TRANSLATIONAL_MODIFICATION_SYNTHESIS_OF_GPI_ANCHORED_PROTEINS,REACTOME_POST_TRANSLATIONAL_MODIFICATION_SYNTHESIS_OF_GPI_ANCHORED_PROTEINS,1/16,94/21728,0.06704061517605098,0.09751362207425597,0.04258478277970571,NRN1,1
ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP,ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP,1/16,94/21728,0.06704061517605098,0.09751362207425597,0.04258478277970571,BNIP3L,1
CROONQUIST_IL6_DEPRIVATION_DN,CROONQUIST_IL6_DEPRIVATION_DN,1/16,95/21728,0.06773061009872772,0.09836307695089096,0.042955744811811504,H2BC11,1
REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3,1/16,96/21728,0.06842012658920127,0.09920918355434184,0.043325244632964624,PSMC5,1
CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN,CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN,1/16,97/21728,0.06910916495710862,0.10005195800342714,0.04369328928234965,H2BC11,1
QI_PLASMACYTOMA_DN,QI_PLASMACYTOMA_DN,1/16,98/21728,0.06979772551190011,0.10073450898140482,0.04399136338230588,VEGFA,1
TAKAO_RESPONSE_TO_UVB_RADIATION_DN,TAKAO_RESPONSE_TO_UVB_RADIATION_DN,1/16,98/21728,0.06979772551190011,0.10073450898140482,0.04399136338230588,NDRG1,1
REACTOME_SLC_TRANSPORTER_DISORDERS,REACTOME_SLC_TRANSPORTER_DISORDERS,1/16,99/21728,0.07048580856283904,0.10156961233899788,0.044356058020093216,SLC2A1,1
REACTOME_CLEC7A_DECTIN_1_SIGNALING,REACTOME_CLEC7A_DECTIN_1_SIGNALING,1/16,100/21728,0.07117341441900404,0.10224292349974574,0.0446500970365269,PSMC5,1
REACTOME_UCH_PROTEINASES,REACTOME_UCH_PROTEINASES,1/16,100/21728,0.07117341441900404,0.10224292349974574,0.0446500970365269,PSMC5,1
REACTOME_TNFR2_NON_CANONICAL_NF_KB_PATHWAY,REACTOME_TNFR2_NON_CANONICAL_NF_KB_PATHWAY,1/16,101/21728,0.07186054338928771,0.10291139547107869,0.04494202274996065,PSMC5,1
WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN,WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN,1/16,101/21728,0.07186054338928771,0.10291139547107869,0.04494202274996065,ARL4C,1
REACTOME_INTERLEUKIN_1_SIGNALING,REACTOME_INTERLEUKIN_1_SIGNALING,1/16,102/21728,0.07254719578239655,0.10373466515572263,0.04530154955189794,PSMC5,1
MIKKELSEN_IPS_WITH_HCP_H3K27ME3,MIKKELSEN_IPS_WITH_HCP_H3K27ME3,1/16,103/21728,0.07323337190685264,0.10439411540638902,0.0455895354258845,NRN1,1
REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT,REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT,1/16,103/21728,0.07323337190685264,0.10439411540638902,0.0455895354258845,PSMC5,1
GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN,GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN,1/16,105/21728,0.07460429658296197,0.106185256486179,0.04637173746277101,ARL4C,1
REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION,REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION,1/16,106/21728,0.07528904575073125,0.10666906023920397,0.04658301745927126,PSMC5,1
REACTOME_SIGNALING_BY_VEGF,REACTOME_SIGNALING_BY_VEGF,1/16,106/21728,0.07528904575073125,0.10666906023920397,0.04658301745927126,VEGFA,1
WP_7Q1123_COPY_NUMBER_VARIATION_SYNDROME,WP_7Q1123_COPY_NUMBER_VARIATION_SYNDROME,1/16,106/21728,0.07528904575073125,0.10666906023920397,0.04658301745927126,GAPDH,1
HELLER_SILENCED_BY_METHYLATION_DN,HELLER_SILENCED_BY_METHYLATION_DN,1/16,107/21728,0.07597331988207834,0.10698519097203141,0.04672107364363895,MAFF,1
KIM_MYCN_AMPLIFICATION_TARGETS_DN,KIM_MYCN_AMPLIFICATION_TARGETS_DN,1/16,107/21728,0.07597331988207834,0.10698519097203141,0.04672107364363895,NDRG1,1
PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN,PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN,1/16,107/21728,0.07597331988207834,0.10698519097203141,0.04672107364363895,NRN1,1
SERVITJA_ISLET_HNF1A_TARGETS_DN,SERVITJA_ISLET_HNF1A_TARGETS_DN,1/16,107/21728,0.07597331988207834,0.10698519097203141,0.04672107364363895,VLDLR,1
BOUDOUKHA_BOUND_BY_IGF2BP2,BOUDOUKHA_BOUND_BY_IGF2BP2,1/16,108/21728,0.07665711928459851,0.1076214927323864,0.04699895043326766,NDRG1,1
REACTOME_INTEGRATION_OF_ENERGY_METABOLISM,REACTOME_INTEGRATION_OF_ENERGY_METABOLISM,1/16,108/21728,0.07665711928459851,0.1076214927323864,0.04699895043326766,SLC2A1,1
GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP,GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP,1/16,109/21728,0.07734044426570152,0.10841681613077193,0.0473462729246225,BNIP3L,1
BRUECKNER_TARGETS_OF_MIRLET7A3_UP,BRUECKNER_TARGETS_OF_MIRLET7A3_UP,1/16,110/21728,0.07802329513261286,0.10888062839558607,0.04754882251848984,NDRG1,1
SUNG_METASTASIS_STROMA_UP,SUNG_METASTASIS_STROMA_UP,1/16,110/21728,0.07802329513261286,0.10888062839558607,0.04754882251848984,BNIP3L,1
WP_BURN_WOUND_HEALING,WP_BURN_WOUND_HEALING,1/16,110/21728,0.07802329513261286,0.10888062839558607,0.04754882251848984,VEGFA,1
REACTOME_INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,REACTOME_INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,1/16,111/21728,0.07870567219237179,0.10966796365543696,0.047892656541904756,VEGFA,1
ROPERO_HDAC2_TARGETS,ROPERO_HDAC2_TARGETS,1/16,112/21728,0.07938757575183542,0.11045227930690145,0.04823517188425256,BNIP3L,1
REACTOME_HEDGEHOG_OFF_STATE,REACTOME_HEDGEHOG_OFF_STATE,1/16,113/21728,0.08006900611767398,0.11123358933712793,0.04857637465380473,PSMC5,1
WP_GASTRIN_SIGNALING_PATHWAY,WP_GASTRIN_SIGNALING_PATHWAY,1/16,114/21728,0.08074996359637465,0.1120119076493807,0.04891627092220005,VEGFA,1
DAZARD_RESPONSE_TO_UV_SCC_DN,DAZARD_RESPONSE_TO_UV_SCC_DN,1/16,115/21728,0.08143044849423997,0.1124515717301409,0.0491082748594649,ARL4C,1
LAIHO_COLORECTAL_CANCER_SERRATED_UP,LAIHO_COLORECTAL_CANCER_SERRATED_UP,1/16,115/21728,0.08143044849423997,0.1124515717301409,0.0491082748594649,BNIP3L,1
MARZEC_IL2_SIGNALING_UP,MARZEC_IL2_SIGNALING_UP,1/16,115/21728,0.08143044849423997,0.1124515717301409,0.0491082748594649,VEGFA,1
ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN,ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN,1/16,116/21728,0.08211046111738751,0.11322215143675425,0.04944479163243012,KLF6,1
DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_DN,DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_DN,1/16,117/21728,0.08279000177175222,0.11382092095434972,0.049706277866860986,GAPDH,1
WHITEFORD_PEDIATRIC_CANCER_MARKERS,WHITEFORD_PEDIATRIC_CANCER_MARKERS,1/16,117/21728,0.08279000177175222,0.11382092095434972,0.049706277866860986,GAPDH,1
DAIRKEE_CANCER_PRONE_RESPONSE_BPA_E2,DAIRKEE_CANCER_PRONE_RESPONSE_BPA_E2,1/16,118/21728,0.08346907076308296,0.11458475986411389,0.050039850893470794,GAPDH,1
RODRIGUES_DCC_TARGETS_DN,RODRIGUES_DCC_TARGETS_DN,1/16,119/21728,0.08414766839694643,0.1151755697232541,0.05029786109738298,KLF6,1
TSENG_IRS1_TARGETS_UP,TSENG_IRS1_TARGETS_UP,1/16,119/21728,0.08414766839694643,0.1151755697232541,0.05029786109738298,YARS1,1
HOOI_ST7_TARGETS_DN,HOOI_ST7_TARGETS_DN,1/16,120/21728,0.084825794978725,0.1155922727463389,0.05047983780324466,NDRG1,1
REACTOME_SYNTHESIS_OF_DNA,REACTOME_SYNTHESIS_OF_DNA,1/16,120/21728,0.084825794978725,0.1155922727463389,0.05047983780324466,PSMC5,1
REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX2,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX2,1/16,120/21728,0.084825794978725,0.1155922727463389,0.05047983780324466,PSMC5,1
MCBRYAN_PUBERTAL_BREAST_5_6WK_UP,MCBRYAN_PUBERTAL_BREAST_5_6WK_UP,1/16,122/21728,0.08618063620663652,0.11726632023425027,0.05121090436727128,NDRG1,1
KARLSSON_TGFB1_TARGETS_UP,KARLSSON_TGFB1_TARGETS_UP,1/16,123/21728,0.08685735146261586,0.11766952139752923,0.051386984730091595,KLF6,1
REACTOME_METABOLISM_OF_WATER_SOLUBLE_VITAMINS_AND_COFACTORS,REACTOME_METABOLISM_OF_WATER_SOLUBLE_VITAMINS_AND_COFACTORS,1/16,123/21728,0.08685735146261586,0.11766952139752923,0.051386984730091595,SLC2A1,1
TOOKER_GEMCITABINE_RESISTANCE_DN,TOOKER_GEMCITABINE_RESISTANCE_DN,1/16,123/21728,0.08685735146261586,0.11766952139752923,0.051386984730091595,YARS1,1
KAYO_AGING_MUSCLE_DN,KAYO_AGING_MUSCLE_DN,1/16,124/21728,0.08753359688620299,0.11806857254418078,0.05156125275579584,VLDLR,1
REACTOME_CYTOPROTECTION_BY_HMOX1,REACTOME_CYTOPROTECTION_BY_HMOX1,1/16,124/21728,0.08753359688620299,0.11806857254418078,0.05156125275579584,PSMC5,1
REACTOME_TCR_SIGNALING,REACTOME_TCR_SIGNALING,1/16,124/21728,0.08753359688620299,0.11806857254418078,0.05156125275579584,PSMC5,1
MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_DN,MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_DN,1/16,125/21728,0.08820937278186236,0.11846352813540995,0.05173373222791836,ARL4C,1
RASHI_RESPONSE_TO_IONIZING_RADIATION_2,RASHI_RESPONSE_TO_IONIZING_RADIATION_2,1/16,125/21728,0.08820937278186236,0.11846352813540995,0.05173373222791836,KLF6,1
RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_UP,RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_UP,1/16,125/21728,0.08820937278186236,0.11846352813540995,0.05173373222791836,VLDLR,1
ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION,ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION,1/16,126/21728,0.0888846794538748,0.11885444169048387,0.05190444651864371,MAFF,1
AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_UP,AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_UP,1/16,126/21728,0.0888846794538748,0.11885444169048387,0.05190444651864371,ARL4C,1
WIERENGA_STAT5A_TARGETS_GROUP1,WIERENGA_STAT5A_TARGETS_GROUP1,1/16,126/21728,0.0888846794538748,0.11885444169048387,0.05190444651864371,NDRG1,1
MANNE_COVID19_ICU_VS_HEALTHY_DONOR_PLATELETS_UP,MANNE_COVID19_ICU_VS_HEALTHY_DONOR_PLATELETS_UP,1/16,128/21728,0.09023388634317142,0.12031184845756189,0.05254090478239715,SLC2A1,1
WP_OVERVIEW_OF_PROINFLAMMATORY_AND_PROFIBROTIC_MEDIATORS,WP_OVERVIEW_OF_PROINFLAMMATORY_AND_PROFIBROTIC_MEDIATORS,1/16,128/21728,0.09023388634317142,0.12031184845756189,0.05254090478239715,VEGFA,1
DANG_MYC_TARGETS_UP,DANG_MYC_TARGETS_UP,1/16,130/21728,0.09158121998468216,0.12193310207429704,0.0532489159466928,GAPDH,1
PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_UP,PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_UP,1/16,131/21728,0.09225418509627781,0.12230269109906543,0.053410317687318735,NDRG1,1
REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS,REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS,1/16,131/21728,0.09225418509627781,0.12230269109906543,0.053410317687318735,PSMC5,1
WP_ADIPOGENESIS,WP_ADIPOGENESIS,1/16,131/21728,0.09225418509627781,0.12230269109906543,0.053410317687318735,KLF6,1
REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,1/16,132/21728,0.09292668280607341,0.12284325020517965,0.05364638308642715,VEGFA,1
WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY,WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY,1/16,132/21728,0.09292668280607341,0.12284325020517965,0.05364638308642715,SLC2A1,1
WP_TGFBETA_SIGNALING_PATHWAY,WP_TGFBETA_SIGNALING_PATHWAY,1/16,133/21728,0.09359871341707093,0.12355562738412777,0.05395748246697958,KLF6,1
VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN,VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN,1/16,134/21728,0.09427027723208992,0.12426536544230034,0.05426742932768335,VEGFA,1
REACTOME_FCERI_MEDIATED_NF_KB_ACTIVATION,REACTOME_FCERI_MEDIATED_NF_KB_ACTIVATION,1/16,136/21728,0.09561200568455586,0.12585523585144373,0.05496173525726615,PSMC5,1
PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN,PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN,1/16,138/21728,0.09695187058238264,0.12743815283350013,0.05565300458359523,KLF6,1
PECE_MAMMARY_STEM_CELL_UP,PECE_MAMMARY_STEM_CELL_UP,1/16,139/21728,0.09762110495341958,0.12795534660561209,0.05587886620140728,GAPDH,1
REACTOME_PTEN_REGULATION,REACTOME_PTEN_REGULATION,1/16,139/21728,0.09762110495341958,0.12795534660561209,0.05587886620140728,PSMC5,1
REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS,REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS,1/16,140/21728,0.09828987434156822,0.1284690188577117,0.056103189950339166,PSMC5,1
REACTOME_INTERLEUKIN_1_FAMILY_SIGNALING,REACTOME_INTERLEUKIN_1_FAMILY_SIGNALING,1/16,140/21728,0.09828987434156822,0.1284690188577117,0.056103189950339166,PSMC5,1
LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN,LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN,1/16,141/21728,0.09895817904837434,0.12897919965855534,0.05632598896159687,ARL4C,1
WELCSH_BRCA1_TARGETS_DN,WELCSH_BRCA1_TARGETS_DN,1/16,141/21728,0.09895817904837434,0.12897919965855534,0.05632598896159687,NDRG1,1
MANNE_COVID19_NONICU_VS_HEALTHY_DONOR_PLATELETS_UP,MANNE_COVID19_NONICU_VS_HEALTHY_DONOR_PLATELETS_UP,1/16,143/21728,0.1002933956232328,0.13035332092207289,0.056926075947139367,SLC2A1,1
MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3,MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3,1/16,143/21728,0.1002933956232328,0.13035332092207289,0.056926075947139367,NDRG1,1
BLANCO_MELO_COVID19_BRONCHIAL_EPITHELIAL_CELLS_SARS_COV_2_INFECTION_UP,BLANCO_MELO_COVID19_BRONCHIAL_EPITHELIAL_CELLS_SARS_COV_2_INFECTION_UP,1/16,144/21728,0.10096030809346823,0.13085358367421582,0.05714454368712919,MAFF,1
WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,1/16,144/21728,0.10096030809346823,0.13085358367421582,0.05714454368712919,SLC2A1,1
BROWNE_HCMV_INFECTION_24HR_DN,BROWNE_HCMV_INFECTION_24HR_DN,1/16,145/21728,0.1016267570867273,0.1311677754888497,0.05728175313430937,BNIP3L,1
DAZARD_UV_RESPONSE_CLUSTER_G6,DAZARD_UV_RESPONSE_CLUSTER_G6,1/16,145/21728,0.1016267570867273,0.1311677754888497,0.05728175313430937,VLDLR,1
GREGORY_SYNTHETIC_LETHAL_WITH_IMATINIB,GREGORY_SYNTHETIC_LETHAL_WITH_IMATINIB,1/16,145/21728,0.1016267570867273,0.1311677754888497,0.05728175313430937,GAPDH,1
BASSO_B_LYMPHOCYTE_NETWORK,BASSO_B_LYMPHOCYTE_NETWORK,1/16,146/21728,0.10229274290364865,0.1312969092871175,0.05733814663740953,NDRG1,1
BROCKE_APOPTOSIS_REVERSED_BY_IL6,BROCKE_APOPTOSIS_REVERSED_BY_IL6,1/16,146/21728,0.10229274290364865,0.1312969092871175,0.05733814663740953,MAFF,1
PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN,PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN,1/16,146/21728,0.10229274290364865,0.1312969092871175,0.05733814663740953,KLF6,1
REACTOME_BETA_CATENIN_INDEPENDENT_WNT_SIGNALING,REACTOME_BETA_CATENIN_INDEPENDENT_WNT_SIGNALING,1/16,146/21728,0.10229274290364865,0.1312969092871175,0.05733814663740953,PSMC5,1
REACTOME_MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,REACTOME_MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,1/16,149/21728,0.10428792430005374,0.13367291954482027,0.0583757645471368,PSMC5,1
REACTOME_SIGNALING_BY_HEDGEHOG,REACTOME_SIGNALING_BY_HEDGEHOG,1/16,150/21728,0.10495206041438698,0.13415359788505665,0.05858567965715383,PSMC5,1
WHITFIELD_CELL_CYCLE_S,WHITFIELD_CELL_CYCLE_S,1/16,150/21728,0.10495206041438698,0.13415359788505665,0.05858567965715383,H4C8,1
HUANG_GATA2_TARGETS_UP,HUANG_GATA2_TARGETS_UP,1/16,152/21728,0.10627894791502568,0.1356628110937329,0.05924476210422774,NDRG1,1
WILCOX_RESPONSE_TO_PROGESTERONE_UP,WILCOX_RESPONSE_TO_PROGESTERONE_UP,1/16,153/21728,0.1069416999002577,0.13632128778494387,0.05953232281896937,KLF6,1
FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP,FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP,1/16,154/21728,0.10760399110774765,0.13697737139641952,0.059818838461458156,KLF6,1
REACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,REACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,1/16,155/21728,0.10826582183650801,0.13763107214284856,0.06010431349250986,TFG,1
REACTOME_SARS_COV_INFECTIONS,REACTOME_SARS_COV_INFECTIONS,1/16,156/21728,0.10892719238537063,0.13809348980003272,0.06030625405287274,VEGFA,1
RUIZ_TNC_TARGETS_UP,RUIZ_TNC_TARGETS_UP,1/16,156/21728,0.10892719238537063,0.13809348980003272,0.06030625405287274,BNIP3L,1
BROWNE_HCMV_INFECTION_14HR_UP,BROWNE_HCMV_INFECTION_14HR_UP,1/16,157/21728,0.10958810305298772,0.138364298820643,0.06042451797407845,H2BC11,1
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS,BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS,1/16,157/21728,0.10958810305298772,0.138364298820643,0.06042451797407845,SLC2A1,1
NIKOLSKY_BREAST_CANCER_8Q23_Q24_AMPLICON,NIKOLSKY_BREAST_CANCER_8Q23_Q24_AMPLICON,1/16,157/21728,0.10958810305298772,0.138364298820643,0.06042451797407845,NDRG1,1
WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS,WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS,1/16,158/21728,0.11024855413783063,0.13900904652161256,0.0607060831565572,MAFF,1
REACTOME_CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,REACTOME_CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,1/16,160/21728,0.11156807875218411,0.14048192277072843,0.061349297035765034,PSMC5,1
MULLIGHAN_NPM1_SIGNATURE_3_DN,MULLIGHAN_NPM1_SIGNATURE_3_DN,1/16,161/21728,0.11222715287773866,0.14092936112387208,0.061544696044340694,ARL4C,1
WP_INSULIN_SIGNALING,WP_INSULIN_SIGNALING,1/16,161/21728,0.11222715287773866,0.14092936112387208,0.061544696044340694,SLC2A1,1
MANNE_COVID19_ICU_VS_HEALTHY_DONOR_PLATELETS_DN,MANNE_COVID19_ICU_VS_HEALTHY_DONOR_PLATELETS_DN,1/16,162/21728,0.11288576861260902,0.1409932614703919,0.061572601708372136,NRN1,1
PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN,PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN,1/16,162/21728,0.11288576861260902,0.1409932614703919,0.061572601708372136,ARL4C,1
REACTOME_S_PHASE,REACTOME_S_PHASE,1/16,162/21728,0.11288576861260902,0.1409932614703919,0.061572601708372136,PSMC5,1
SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM,SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM,1/16,162/21728,0.11288576861260902,0.1409932614703919,0.061572601708372136,YARS1,1
BROWNE_HCMV_INFECTION_6HR_DN,BROWNE_HCMV_INFECTION_6HR_DN,1/16,164/21728,0.11420162610041307,0.14206314882196155,0.062039827922476413,ARL4C,1
LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN,LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN,1/16,164/21728,0.11420162610041307,0.14206314882196155,0.062039827922476413,YARS1,1
VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP,VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP,1/16,164/21728,0.11420162610041307,0.14206314882196155,0.062039827922476413,VEGFA,1
IBRAHIM_NRF1_DOWN,IBRAHIM_NRF1_DOWN,1/16,166/21728,0.11551565359403071,0.14312219831142922,0.0625023211772916,KLF6,1
KEGG_ALZHEIMERS_DISEASE,KEGG_ALZHEIMERS_DISEASE,1/16,166/21728,0.11551565359403071,0.14312219831142922,0.0625023211772916,GAPDH,1
REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR,REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR,1/16,166/21728,0.11551565359403071,0.14312219831142922,0.0625023211772916,PSMC5,1
KIM_WT1_TARGETS_8HR_UP,KIM_WT1_TARGETS_8HR_UP,1/16,167/21728,0.11617198183549682,0.14355206277408927,0.06269004556264109,MAFF,1
YAMAZAKI_TCEB3_TARGETS_UP,YAMAZAKI_TCEB3_TARGETS_UP,1/16,167/21728,0.11617198183549682,0.14355206277408927,0.06269004556264109,VEGFA,1
IBRAHIM_NRF2_DOWN,IBRAHIM_NRF2_DOWN,1/16,168/21728,0.11682785346903135,0.1439790810348753,0.06287652699458597,KLF6,1
WHITFIELD_CELL_CYCLE_G2,WHITFIELD_CELL_CYCLE_G2,1/16,168/21728,0.11682785346903135,0.1439790810348753,0.06287652699458597,KLF6,1
ONDER_CDH1_TARGETS_1_DN,ONDER_CDH1_TARGETS_1_DN,1/16,170/21728,0.11813822809811936,0.1452083121523904,0.06341333958560608,ARL4C,1
REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,1/16,170/21728,0.11813822809811936,0.1452083121523904,0.06341333958560608,MAFF,1
REACTOME_REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,REACTOME_REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,1/16,172/21728,0.1194467798511405,0.1466225022511354,0.0640309248714691,PSMC5,1
CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP,CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP,1/16,173/21728,0.12010037288891995,0.1470358127188888,0.06421142002809913,KLF6,1
MOHANKUMAR_HOXA1_TARGETS_DN,MOHANKUMAR_HOXA1_TARGETS_DN,1/16,173/21728,0.12010037288891995,0.1470358127188888,0.06421142002809913,KLF6,1
BLANCO_MELO_COVID19_SARS_COV_2_LOW_MOI_INFECTION_A594_ACE2_EXPRESSING_CELLS_UP,BLANCO_MELO_COVID19_SARS_COV_2_LOW_MOI_INFECTION_A594_ACE2_EXPRESSING_CELLS_UP,1/16,174/21728,0.12075351109508015,0.14764065651677782,0.06447555893711374,MAFF,1
CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP,CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP,1/16,175/21728,0.1214061947650471,0.148243353607847,0.06473876036640323,VLDLR,1
JINESH_BLEBBISHIELD_TRANSFORMED_STEM_CELL_SPHERES_UP,JINESH_BLEBBISHIELD_TRANSFORMED_STEM_CELL_SPHERES_UP,1/16,176/21728,0.12205842419407142,0.14884391281484663,0.06500102816891556,KLF6,1
VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP,VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP,1/16,177/21728,0.12271019967722385,0.1494423429139944,0.0652623661772775,ARL4C,1
MANNE_COVID19_COMBINED_COHORT_VS_HEALTHY_DONOR_PLATELETS_UP,MANNE_COVID19_COMBINED_COHORT_VS_HEALTHY_DONOR_PLATELETS_UP,1/16,179/21728,0.12401238998530673,0.15063285066278093,0.0657822680412553,SLC2A1,1
REACTOME_APOPTOSIS,REACTOME_APOPTOSIS,1/16,179/21728,0.12401238998530673,0.15063285066278093,0.0657822680412553,PSMC5,1
BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN,BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN,1/16,182/21728,0.125962278219939,0.15260182008890782,0.06664212878202078,H4C8,1
JISON_SICKLE_CELL_DISEASE_UP,JISON_SICKLE_CELL_DISEASE_UP,1/16,182/21728,0.125962278219939,0.15260182008890782,0.06664212878202078,BNIP3L,1
LI_AMPLIFIED_IN_LUNG_CANCER,LI_AMPLIFIED_IN_LUNG_CANCER,1/16,183/21728,0.1266113362143919,0.15298869792572356,0.0668110806504124,VEGFA,1
WU_CELL_MIGRATION,WU_CELL_MIGRATION,1/16,183/21728,0.1266113362143919,0.15298869792572356,0.0668110806504124,ARL4C,1
DOANE_RESPONSE_TO_ANDROGEN_UP,DOANE_RESPONSE_TO_ANDROGEN_UP,1/16,184/21728,0.12725994232349236,0.15357246615890885,0.06706601573409701,NDRG1,1
LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP,LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP,1/16,185/21728,0.12790809684089033,0.15395423329227784,0.06723273572768487,PSMC5,1
WANG_CISPLATIN_RESPONSE_AND_XPC_UP,WANG_CISPLATIN_RESPONSE_AND_XPC_UP,1/16,185/21728,0.12790809684089033,0.15395423329227784,0.06723273572768487,PSMC5,1
ALCALAY_AML_BY_NPM1_LOCALIZATION_DN,ALCALAY_AML_BY_NPM1_LOCALIZATION_DN,1/16,186/21728,0.12855580006005862,0.15413408586012198,0.06731127842121934,VEGFA,1
REACTOME_FC_EPSILON_RECEPTOR_FCERI_SIGNALING,REACTOME_FC_EPSILON_RECEPTOR_FCERI_SIGNALING,1/16,186/21728,0.12855580006005862,0.15413408586012198,0.06731127842121934,PSMC5,1
REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,1/16,186/21728,0.12855580006005862,0.15413408586012198,0.06731127842121934,TFG,1
REACTOME_SUMOYLATION,REACTOME_SUMOYLATION,1/16,187/21728,0.1292030522742933,0.15471023549747637,0.06756288641847596,H4C8,1
REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS,REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS,1/16,189/21728,0.13049620486025815,0.15605731715247365,0.06815116504503443,SLC2A1,1
BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP,BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP,1/16,190/21728,0.13114210581769514,0.15662789472177746,0.06840033968680165,NDRG1,1
REACTOME_SEPARATION_OF_SISTER_CHROMATIDS,REACTOME_SEPARATION_OF_SISTER_CHROMATIDS,1/16,191/21728,0.1317875569416116,0.15719646894834904,0.06864863945679944,PSMC5,1
BURTON_ADIPOGENESIS_6,BURTON_ADIPOGENESIS_6,1/16,193/21728,0.13307711085835383,0.15853088430879636,0.0692313866366681,BNIP3,1
KARLSSON_TGFB1_TARGETS_DN,KARLSSON_TGFB1_TARGETS_DN,1/16,195/21728,0.13436486894766042,0.1598597415172165,0.06981170653825812,BNIP3L,1
ZHENG_FOXP3_TARGETS_IN_THYMUS_UP,ZHENG_FOXP3_TARGETS_IN_THYMUS_UP,1/16,198/21728,0.1362931440108075,0.1619462709885139,0.0707229064548297,KLF6,1
KEGG_FOCAL_ADHESION,KEGG_FOCAL_ADHESION,1/16,199/21728,0.1369350069785651,0.1622248034320373,0.07084454324107801,VEGFA,1
MCBRYAN_PUBERTAL_BREAST_4_5WK_DN,MCBRYAN_PUBERTAL_BREAST_4_5WK_DN,1/16,199/21728,0.1369350069785651,0.1622248034320373,0.07084454324107801,VEGFA,1
EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP,EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP,1/16,200/21728,0.13757642273816095,0.1622248034320373,0.07084454324107801,KLF6,1
FISCHER_G1_S_CELL_CYCLE,FISCHER_G1_S_CELL_CYCLE,1/16,200/21728,0.13757642273816095,0.1622248034320373,0.07084454324107801,H4C8,1
MEBARKI_HCC_PROGENITOR_WNT_UP,MEBARKI_HCC_PROGENITOR_WNT_UP,1/16,200/21728,0.13757642273816095,0.1622248034320373,0.07084454324107801,ARL4C,1
REACTOME_MITOTIC_G2_G2_M_PHASES,REACTOME_MITOTIC_G2_G2_M_PHASES,1/16,200/21728,0.13757642273816095,0.1622248034320373,0.07084454324107801,PSMC5,1
WELCSH_BRCA1_TARGETS_UP,WELCSH_BRCA1_TARGETS_UP,1/16,201/21728,0.138217391580422,0.16277378094750206,0.07108428500996858,BNIP3,1
WP_FOCAL_ADHESION,WP_FOCAL_ADHESION,1/16,202/21728,0.1388579137959981,0.16332084157501425,0.07132318966240982,VEGFA,1
BLANCO_MELO_HUMAN_PARAINFLUENZA_VIRUS_3_INFECTION_A594_CELLS_UP,BLANCO_MELO_HUMAN_PARAINFLUENZA_VIRUS_3_INFECTION_A594_CELLS_UP,1/16,204/21728,0.14013761950882409,0.16461735557492246,0.07188938509113563,KLF6,1
TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN,TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN,1/16,206/21728,0.1414155421983373,0.16590849957023643,0.07245323540669354,MAFF,1
GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN,GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN,1/16,207/21728,0.1420538356341159,0.16644691852078225,0.0726883661870476,PSMC5,1
REACTOME_PROGRAMMED_CELL_DEATH,REACTOME_PROGRAMMED_CELL_DEATH,1/16,208/21728,0.14269168418343325,0.16698345891831784,0.07292267659205125,PSMC5,1
GROSS_HYPOXIA_VIA_ELK3_UP,GROSS_HYPOXIA_VIA_ELK3_UP,1/16,209/21728,0.14332908813571354,0.1675181281989196,0.07315616986908355,ARL4C,1
CHANDRAN_METASTASIS_UP,CHANDRAN_METASTASIS_UP,1/16,210/21728,0.14396604778020528,0.16783981449752575,0.07329665220229971,VEGFA,1
MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3,MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3,1/16,210/21728,0.14396604778020528,0.16783981449752575,0.07329665220229971,NDRG1,1
BHAT_ESR1_TARGETS_NOT_VIA_AKT1_UP,BHAT_ESR1_TARGETS_NOT_VIA_AKT1_UP,1/16,211/21728,0.14460256340598454,0.16815937198089428,0.07343620486915191,SLC2A1,1
WANG_TUMOR_INVASIVENESS_DN,WANG_TUMOR_INVASIVENESS_DN,1/16,211/21728,0.14460256340598454,0.16815937198089428,0.07343620486915191,BNIP3L,1
SHEPARD_BMYB_MORPHOLINO_UP,SHEPARD_BMYB_MORPHOLINO_UP,1/16,212/21728,0.1452386353019509,0.1686876765459455,0.07366691863678428,BNIP3L,1
KIM_WT1_TARGETS_UP,KIM_WT1_TARGETS_UP,1/16,216/21728,0.14777849135957866,0.17120903867876278,0.07476801258090254,MAFF,1
LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER,LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER,1/16,216/21728,0.14777849135957866,0.17120903867876278,0.07476801258090254,VEGFA,1
BOQUEST_STEM_CELL_DN,BOQUEST_STEM_CELL_DN,1/16,218/21728,0.14904576450809504,0.17203292221829874,0.07512780745694762,NRN1,1
BROWNE_HCMV_INFECTION_1HR_DN,BROWNE_HCMV_INFECTION_1HR_DN,1/16,218/21728,0.14904576450809504,0.17203292221829874,0.07512780745694762,H2BC11,1
REACTOME_SIGNALING_BY_ROBO_RECEPTORS,REACTOME_SIGNALING_BY_ROBO_RECEPTORS,1/16,218/21728,0.14904576450809504,0.17203292221829874,0.07512780745694762,PSMC5,1
VANOEVELEN_MYOGENESIS_SIN3A_TARGETS,VANOEVELEN_MYOGENESIS_SIN3A_TARGETS,1/16,220/21728,0.15031127080685758,0.17327808609784326,0.07567157798056905,NDRG1,1
PHONG_TNF_RESPONSE_VIA_P38_COMPLETE,PHONG_TNF_RESPONSE_VIA_P38_COMPLETE,1/16,225/21728,0.15346732166877797,0.17669686663601233,0.0771645799170426,ARL4C,1
DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP,DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP,1/16,228/21728,0.15535567344982548,0.1786493989608898,0.07801726247724883,YARS1,1
KONDO_EZH2_TARGETS,KONDO_EZH2_TARGETS,1/16,229/21728,0.1559842459719094,0.1791502230964504,0.07823597537673936,H4C8,1
BENPORATH_MYC_TARGETS_WITH_EBOX,BENPORATH_MYC_TARGETS_WITH_EBOX,1/16,230/21728,0.15661237993462607,0.17964930603131396,0.07845392788345722,GAPDH,1
DELYS_THYROID_CANCER_DN,DELYS_THYROID_CANCER_DN,1/16,233/21728,0.15849415332171202,0.18158342504018365,0.07929856923828348,NRN1,1
REACTOME_HIV_INFECTION,REACTOME_HIV_INFECTION,1/16,234/21728,0.15912053590123554,0.18185204102998345,0.07941587544979996,PSMC5,1
REACTOME_NEDDYLATION,REACTOME_NEDDYLATION,1/16,234/21728,0.15912053590123554,0.18185204102998345,0.07941587544979996,PSMC5,1
HOSHIDA_LIVER_CANCER_SUBCLASS_S1,HOSHIDA_LIVER_CANCER_SUBCLASS_S1,1/16,235/21728,0.15974648134766578,0.18211883868628237,0.07953238758418638,SLC2A1,1
JAATINEN_HEMATOPOIETIC_STEM_CELL_DN,JAATINEN_HEMATOPOIETIC_STEM_CELL_DN,1/16,235/21728,0.15974648134766578,0.18211883868628237,0.07953238758418638,ARL4C,1
BROWNE_HCMV_INFECTION_20HR_UP,BROWNE_HCMV_INFECTION_20HR_UP,1/16,236/21728,0.16037198994574153,0.18238383170300015,0.07964811162165956,VEGFA,1
REACTOME_MITOTIC_METAPHASE_AND_ANAPHASE,REACTOME_MITOTIC_METAPHASE_AND_ANAPHASE,1/16,236/21728,0.16037198994574153,0.18238383170300015,0.07964811162165956,PSMC5,1
LEE_RECENT_THYMIC_EMIGRANT,LEE_RECENT_THYMIC_EMIGRANT,1/16,237/21728,0.16099706198002728,0.182870591820643,0.0798606826802944,YARS1,1
SENESE_HDAC1_AND_HDAC2_TARGETS_DN,SENESE_HDAC1_AND_HDAC2_TARGETS_DN,1/16,238/21728,0.16162169773491653,0.18335566686797375,0.08007251785863193,H4C8,1
SENESE_HDAC1_AND_HDAC2_TARGETS_UP,SENESE_HDAC1_AND_HDAC2_TARGETS_UP,1/16,243/21728,0.1647383422601335,0.18666322541807556,0.0815169484867957,MAFF,1
UDAYAKUMAR_MED1_TARGETS_DN,UDAYAKUMAR_MED1_TARGETS_DN,1/16,244/21728,0.16536036630127116,0.18713953649704831,0.0817249563876629,NDRG1,1
BLUM_RESPONSE_TO_SALIRASIB_UP,BLUM_RESPONSE_TO_SALIRASIB_UP,1/16,245/21728,0.16598195604895227,0.18761419636227492,0.08193224319359783,MAFF,1
REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,1/16,249/21728,0.1684639777629341,0.19018804302190126,0.08305625744490924,SLC2A1,1
RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN,RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN,1/16,250/21728,0.1690834002852023,0.19065540153665583,0.08326035570736444,TFG,1
KOBAYASHI_EGFR_SIGNALING_24HR_DN,KOBAYASHI_EGFR_SIGNALING_24HR_DN,1/16,253/21728,0.17093907339237036,0.1925139078982035,0.08407197656625268,MAFF,1
BROWNE_HCMV_INFECTION_4HR_DN,BROWNE_HCMV_INFECTION_4HR_DN,1/16,254/21728,0.1715567672142898,0.19274174331096966,0.08417147365553916,KLF6,1
PLASARI_TGFB1_TARGETS_10HR_DN,PLASARI_TGFB1_TARGETS_10HR_DN,1/16,254/21728,0.1715567672142898,0.19274174331096966,0.08417147365553916,BNIP3L,1
KAAB_HEART_ATRIUM_VS_VENTRICLE_UP,KAAB_HEART_ATRIUM_VS_VENTRICLE_UP,1/16,256/21728,0.17279086072656935,0.19389349305230513,0.08467444966553707,NDRG1,1
JAEGER_METASTASIS_DN,JAEGER_METASTASIS_DN,1/16,259/21728,0.1746387698832017,0.19549430452546585,0.0853735336233035,SLC2A1,1
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1,SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1,1/16,259/21728,0.1746387698832017,0.19549430452546585,0.0853735336233035,KLF6,1
REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,1/16,261/21728,0.17586855852243777,0.19663376181785816,0.08587114144722707,VEGFA,1
KAAB_HEART_ATRIUM_VS_VENTRICLE_DN,KAAB_HEART_ATRIUM_VS_VENTRICLE_DN,1/16,262/21728,0.17648280844388187,0.19684620941817593,0.08596391858665806,BNIP3,1
RIZKI_TUMOR_INVASIVENESS_3D_DN,RIZKI_TUMOR_INVASIVENESS_3D_DN,1/16,262/21728,0.17648280844388187,0.19684620941817593,0.08596391858665806,GAPDH,1
DURCHDEWALD_SKIN_CARCINOGENESIS_DN,DURCHDEWALD_SKIN_CARCINOGENESIS_DN,1/16,265/21728,0.1783229839764603,0.1981841067427008,0.08654818636109325,KLF6,1
KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION,KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION,1/16,265/21728,0.1783229839764603,0.1981841067427008,0.08654818636109325,VEGFA,1
MCLACHLAN_DENTAL_CARIES_UP,MCLACHLAN_DENTAL_CARIES_UP,1/16,265/21728,0.1783229839764603,0.1981841067427008,0.08654818636109325,MAFF,1
SENESE_HDAC1_TARGETS_DN,SENESE_HDAC1_TARGETS_DN,1/16,266/21728,0.178935518676007,0.19862698723843838,0.08674159492604216,BNIP3L,1
CAIRO_HEPATOBLASTOMA_DN,CAIRO_HEPATOBLASTOMA_DN,1/16,267/21728,0.1795476252691106,0.1990683348264452,0.08693433406100433,KLF6,1
HOLLMANN_APOPTOSIS_VIA_CD40_DN,HOLLMANN_APOPTOSIS_VIA_CD40_DN,1/16,268/21728,0.18015930403504365,0.19950815530372373,0.08712640629756539,TFG,1
MCBRYAN_PUBERTAL_BREAST_4_5WK_UP,MCBRYAN_PUBERTAL_BREAST_4_5WK_UP,1/16,269/21728,0.18077055525291164,0.1999464544394541,0.08731781415516089,SLC2A1,1
TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP,TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP,1/16,271/21728,0.18199177616002205,0.2010575812815482,0.08780304990176503,KLF6,1
MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN,MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN,1/16,272/21728,0.18260174640662863,0.2014915822417971,0.08799258072038554,SLC2A1,1
KUMAR_PATHOGEN_LOAD_BY_MACROPHAGES,KUMAR_PATHOGEN_LOAD_BY_MACROPHAGES,1/16,274/21728,0.18382040787808795,0.20259541390839145,0.08847463062015735,MAFF,1
BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D,BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D,1/16,279/21728,0.18685961357017156,0.20570073712113784,0.0898307438652882,GAPDH,1
BOYLAN_MULTIPLE_MYELOMA_C_D_DN,BOYLAN_MULTIPLE_MYELOMA_C_D_DN,1/16,280/21728,0.18746618013191696,0.20612395161424046,0.09001556416910456,ARL4C,1
BHAT_ESR1_TARGETS_VIA_AKT1_UP,BHAT_ESR1_TARGETS_VIA_AKT1_UP,1/16,281/21728,0.1880723224816877,0.20630155468440448,0.09009312449352966,SLC2A1,1
FOURNIER_ACINAR_DEVELOPMENT_LATE_2,FOURNIER_ACINAR_DEVELOPMENT_LATE_2,1/16,281/21728,0.1880723224816877,0.20630155468440448,0.09009312449352966,ARL4C,1
HELLER_SILENCED_BY_METHYLATION_UP,HELLER_SILENCED_BY_METHYLATION_UP,1/16,283/21728,0.18928333565279354,0.2073848116715377,0.09056618930755672,ARL4C,1
BLANCO_MELO_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_A594_CELLS_UP,BLANCO_MELO_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_A594_CELLS_UP,1/16,286/21728,0.19109668073703323,0.20912466948580993,0.0913259956352505,MAFF,1
GENTILE_UV_HIGH_DOSE_DN,GENTILE_UV_HIGH_DOSE_DN,1/16,289/21728,0.1929062228431938,0.21060820564527513,0.09197386476115124,ARL4C,1
HADDAD_B_LYMPHOCYTE_PROGENITOR,HADDAD_B_LYMPHOCYTE_PROGENITOR,1/16,289/21728,0.1929062228431938,0.21060820564527513,0.09197386476115124,H4C8,1
GRADE_COLON_AND_RECTAL_CANCER_UP,GRADE_COLON_AND_RECTAL_CANCER_UP,1/16,290/21728,0.19350855972618775,0.2110175598424233,0.09215263219071346,VEGFA,1
IVANOVA_HEMATOPOIESIS_MATURE_CELL,IVANOVA_HEMATOPOIESIS_MATURE_CELL,1/16,292/21728,0.19471196941627522,0.21183201362051982,0.09250830903346205,BNIP3L,1
MANALO_HYPOXIA_DN,MANALO_HYPOXIA_DN,1/16,292/21728,0.19471196941627522,0.21183201362051982,0.09250830903346205,YARS1,1
HELLER_HDAC_TARGETS_DN,HELLER_HDAC_TARGETS_DN,1/16,293/21728,0.19531304277368078,0.21223712376343767,0.09268522305912376,MAFF,1
REACTOME_TRANSLATION,REACTOME_TRANSLATION,1/16,295/21728,0.19651392788774225,0.21304313677549624,0.09303721376879091,YARS1,1
WANG_SMARCE1_TARGETS_UP,WANG_SMARCE1_TARGETS_UP,1/16,295/21728,0.19651392788774225,0.21304313677549624,0.09303721376879091,VLDLR,1
WEST_ADRENOCORTICAL_TUMOR_UP,WEST_ADRENOCORTICAL_TUMOR_UP,1/16,298/21728,0.19831210567554536,0.21474169669417278,0.09377898505814036,GAPDH,1
DAZARD_RESPONSE_TO_UV_NHEK_DN,DAZARD_RESPONSE_TO_UV_NHEK_DN,1/16,300/21728,0.19950879414467926,0.21553452964640554,0.09412521995674471,VLDLR,1
DURAND_STROMA_S_UP,DURAND_STROMA_S_UP,1/16,300/21728,0.19950879414467926,0.21553452964640554,0.09412521995674471,NDRG1,1
AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP,AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP,1/16,303/21728,0.2013006872407488,0.21696520064972694,0.09475000255234219,NDRG1,1
WALLACE_PROSTATE_CANCER_RACE_UP,WALLACE_PROSTATE_CANCER_RACE_UP,1/16,303/21728,0.2013006872407488,0.21696520064972694,0.09475000255234219,ARL4C,1
REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION,REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION,1/16,305/21728,0.20249319275613853,0.21799731192308183,0.09520073172684496,TFG,1
REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS,REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS,1/16,307/21728,0.2036840289142655,0.2190252361905428,0.09564963241079737,PSMC5,1
JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_DN,JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_DN,1/16,308/21728,0.204278821666115,0.21915693237705747,0.0957071449241914,KLF6,1
REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,1/16,308/21728,0.204278821666115,0.21915693237705747,0.0957071449241914,PSMC5,1
HORIUCHI_WTAP_TARGETS_UP,HORIUCHI_WTAP_TARGETS_UP,1/16,309/21728,0.20487319789642988,0.21954079405067775,0.09587477961605143,VLDLR,1
CHANDRAN_METASTASIS_DN,CHANDRAN_METASTASIS_DN,1/16,313/21728,0.20724654304484214,0.2218279030514573,0.09687357381444088,KLF6,1
HELLER_HDAC_TARGETS_UP,HELLER_HDAC_TARGETS_UP,1/16,317/21728,0.20961324559889394,0.22410264045596034,0.09786696526264149,H4C8,1
DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP,DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP,1/16,323/21728,0.21315088251877168,0.2276225764987573,0.09940414241381758,SLC2A1,1
REACTOME_MAPK_FAMILY_SIGNALING_CASCADES,REACTOME_MAPK_FAMILY_SIGNALING_CASCADES,1/16,327/21728,0.21550105442431156,0.22986779138593233,0.10038464120188743,PSMC5,1
YANG_BCL3_TARGETS_UP,YANG_BCL3_TARGETS_UP,1/16,333/21728,0.21901397634658348,0.2333466935127778,0.10190389859621082,VLDLR,1
NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON,NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON,1/16,334/21728,0.21959802759119484,0.23370065321631747,0.10205847491865044,PSMC5,1
WONG_EMBRYONIC_STEM_CELL_CORE,WONG_EMBRYONIC_STEM_CELL_CORE,1/16,335/21728,0.22018166933928063,0.23405336672033497,0.10221250701829511,SLC2A1,1
BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_CALU3_CELLS_UP,BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_CALU3_CELLS_UP,1/16,339/21728,0.22251214672357533,0.2359900253251176,0.10305825742986649,KLF6,1
DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP,DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP,1/16,339/21728,0.22251214672357533,0.2359900253251176,0.10305825742986649,NRN1,1
PHONG_TNF_RESPONSE_NOT_VIA_P38,PHONG_TNF_RESPONSE_NOT_VIA_P38,1/16,341/21728,0.22367493539638483,0.23695244297699214,0.10347855098246596,KLF6,1
NABA_SECRETED_FACTORS,NABA_SECRETED_FACTORS,1/16,343/21728,0.224836093572775,0.23791094051942438,0.10389713259979402,VEGFA,1
WP_PI3KAKT_SIGNALING_PATHWAY,WP_PI3KAKT_SIGNALING_PATHWAY,1/16,345/21728,0.22599562338685342,0.23886553360250568,0.10431400911633926,VEGFA,1
SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP,SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP,1/16,353/21728,0.23061750161146677,0.24347331228150304,0.10632625366195404,ARL4C,1
IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN,IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN,1/16,357/21728,0.23291872584631257,0.24562338361974778,0.10726520269238081,KLF6,1
COLINA_TARGETS_OF_4EBP1_AND_4EBP2,COLINA_TARGETS_OF_4EBP1_AND_4EBP2,1/16,359/21728,0.23406691666168722,0.2462744882789634,0.10754954399659815,NRN1,1
PEREZ_TP63_TARGETS,PEREZ_TP63_TARGETS,1/16,359/21728,0.23406691666168722,0.2462744882789634,0.10754954399659815,NDRG1,1
KOYAMA_SEMA3B_TARGETS_DN,KOYAMA_SEMA3B_TARGETS_DN,1/16,364/21728,0.23693034851810202,0.24900494159093844,0.10874194931092483,KLF6,1
GOLDRATH_ANTIGEN_RESPONSE,GOLDRATH_ANTIGEN_RESPONSE,1/16,366/21728,0.2380729087238278,0.24992269151098667,0.10914273619751573,GAPDH,1
RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN,RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN,1/16,368/21728,0.23921386492376517,0.25083668547938315,0.10954188283752554,GAPDH,1
YAGI_AML_WITH_T_8_21_TRANSLOCATION,YAGI_AML_WITH_T_8_21_TRANSLOCATION,1/16,371/21728,0.24092229631000417,0.25234299207187794,0.11019969594790499,VLDLR,1
REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1/16,374/21728,0.24262713049496865,0.2538421387816583,0.11085438229462166,PSMC5,1
JINESH_BLEBBISHIELD_TRANSFORMED_STEM_CELL_SPHERES_DN,JINESH_BLEBBISHIELD_TRANSFORMED_STEM_CELL_SPHERES_DN,1/16,375/21728,0.24319461040093826,0.2541493225811607,0.11098853129962213,MAFF,1
REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,1/16,377/21728,0.24432837454882528,0.2547603725632695,0.11125538048645504,PSMC5,1
ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN,ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN,1/16,377/21728,0.24432837454882528,0.2547603725632695,0.11125538048645504,SLC2A1,1
STEIN_ESRRA_TARGETS_UP,STEIN_ESRRA_TARGETS_UP,1/16,385/21728,0.2488475272362537,0.2588907009812146,0.11305911964356584,VEGFA,1
WANG_SMARCE1_TARGETS_DN,WANG_SMARCE1_TARGETS_DN,1/16,385/21728,0.2488475272362537,0.2588907009812146,0.11305911964356584,BNIP3,1
WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP,WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP,1/16,392/21728,0.25278098940519,0.2626884190011381,0.11471760584782008,VEGFA,1
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7,PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7,1/16,399/21728,0.25669513476642114,0.26645758955619553,0.11636362520319339,KLF6,1
PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN,PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN,1/16,403/21728,0.25892315050600245,0.2684700376196316,0.11724247332527014,BNIP3L,1
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP,SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP,1/16,405/21728,0.26003480904856546,0.26932176651458567,0.11761442843479525,TFG,1
KUMAR_TARGETS_OF_MLL_AF9_FUSION,KUMAR_TARGETS_OF_MLL_AF9_FUSION,1/16,407/21728,0.26114490411385893,0.2701699788379722,0.11798484783645567,GAPDH,1
ZHOU_INFLAMMATORY_RESPONSE_LPS_UP,ZHOU_INFLAMMATORY_RESPONSE_LPS_UP,1/16,409/21728,0.2622534377544109,0.27101468845890125,0.11835373758697482,MAFF,1
YAGI_AML_WITH_INV_16_TRANSLOCATION,YAGI_AML_WITH_INV_16_TRANSLOCATION,1/16,411/21728,0.2633604120202474,0.27182192713164294,0.11870626355000288,ARL4C,1
PEDRIOLI_MIR31_TARGETS_DN,PEDRIOLI_MIR31_TARGETS_DN,1/16,412/21728,0.2639133150275973,0.27182192713164294,0.11870626355000288,KLF6,1
RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP,RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP,1/16,412/21728,0.2639133150275973,0.27182192713164294,0.11870626355000288,NDRG1,1
LIM_MAMMARY_STEM_CELL_DN,LIM_MAMMARY_STEM_CELL_DN,1/16,416/21728,0.26612103885121163,0.2737919335409361,0.11956657714752772,KLF6,1
SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1,SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1,1/16,421/21728,0.2688719643048184,0.2763158171371777,0.12066877222982468,BNIP3,1
SWEET_LUNG_CANCER_KRAS_DN,SWEET_LUNG_CANCER_KRAS_DN,1/16,423/21728,0.2699696252331423,0.2771369604163231,0.12102737041774543,VEGFA,1
OSMAN_BLADDER_CANCER_DN,OSMAN_BLADDER_CANCER_DN,1/16,427/21728,0.27216031383682104,0.27907709529344743,0.12187463893826823,H4C8,1
THUM_SYSTOLIC_HEART_FAILURE_UP,THUM_SYSTOLIC_HEART_FAILURE_UP,1/16,430/21728,0.2737992841806912,0.2804478319201782,0.12247324783265497,VEGFA,1
BOCHKIS_FOXA2_TARGETS,BOCHKIS_FOXA2_TARGETS,1/16,433/21728,0.27543479402441196,0.2817477382052365,0.12304092469262257,BNIP3,1
ODONNELL_TFRC_TARGETS_UP,ODONNELL_TFRC_TARGETS_UP,1/16,434/21728,0.2759791961514655,0.2817477382052365,0.12304092469262257,KLF6,1
RIGGI_EWING_SARCOMA_PROGENITOR_UP,RIGGI_EWING_SARCOMA_PROGENITOR_UP,1/16,434/21728,0.2759791961514655,0.2817477382052365,0.12304092469262257,H4C8,1
GARY_CD5_TARGETS_DN,GARY_CD5_TARGETS_DN,1/16,440/21728,0.2792375644474646,0.28476094484312875,0.12435681007781829,PSMC5,1
GRYDER_PAX3FOXO1_TOP_ENHANCERS,GRYDER_PAX3FOXO1_TOP_ENHANCERS,1/16,441/21728,0.2797792874354784,0.2850001962021119,0.12446129257918911,ARL4C,1
MOOTHA_MITOCHONDRIA,MOOTHA_MITOCHONDRIA,1/16,450/21728,0.2846376466614846,0.2896312895853703,0.126483718795789,BNIP3L,1
MARTENS_BOUND_BY_PML_RARA_FUSION,MARTENS_BOUND_BY_PML_RARA_FUSION,1/16,456/21728,0.28785946520900507,0.292588810201486,0.1277752857617651,NDRG1,1
MEBARKI_HCC_PROGENITOR_FZD8CRD_DN,MEBARKI_HCC_PROGENITOR_FZD8CRD_DN,1/16,459/21728,0.2894652684143134,0.2938990909064364,0.12834749319303315,VEGFA,1
HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP,HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP,1/16,461/21728,0.2905339173089333,0.2946617215985684,0.12868053858376685,H4C8,1
DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN,DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN,1/16,466/21728,0.2931989510073669,0.29703998530003983,0.12971914058588405,KLF6,1
GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN,GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN,1/16,467/21728,0.2937308302653806,0.29725431895994897,0.12981274137883436,BNIP3,1
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2,CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2,1/16,470/21728,0.2953242175280879,0.29854125693471195,0.13037475490002734,ARL4C,1
KIM_WT1_TARGETS_DN,KIM_WT1_TARGETS_DN,1/16,472/21728,0.2963846027462992,0.2992871723052945,0.13070050060973046,ARL4C,1
JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_UP,JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_UP,1/16,476/21728,0.2985008869615752,0.30109654684819753,0.1314906653091607,MAFF,1
SWEET_LUNG_CANCER_KRAS_UP,SWEET_LUNG_CANCER_KRAS_UP,1/16,482/21728,0.30166412724875935,0.30395690563175753,0.13273980112094677,GAPDH,1
SMID_BREAST_CANCER_NORMAL_LIKE_UP,SMID_BREAST_CANCER_NORMAL_LIKE_UP,1/16,484/21728,0.30271556558935575,0.3046855150400457,0.1330579892132686,ARL4C,1
MATSUDA_NATURAL_KILLER_DIFFERENTIATION,MATSUDA_NATURAL_KILLER_DIFFERENTIATION,1/16,485/21728,0.30324072803289603,0.3048834188673104,0.13314441499990304,KLF6,1
LIU_PROSTATE_CANCER_DN,LIU_PROSTATE_CANCER_DN,1/16,491/21728,0.30638392391674996,0.3077102612497229,0.13437891399857455,VEGFA,1
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5,CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5,1/16,493/21728,0.3074286983900094,0.30842576443884184,0.13469137852649063,ARL4C,1
ZHENG_BOUND_BY_FOXP3,ZHENG_BOUND_BY_FOXP3,1/16,496/21728,0.3089930941522667,0.3096604658459001,0.1352305800257164,KLF6,1
PILON_KLF1_TARGETS_UP,PILON_KLF1_TARGETS_UP,1/16,497/21728,0.3095138227926947,0.3098477104116728,0.13531235084901774,BNIP3,1
RODWELL_AGING_KIDNEY_UP,RODWELL_AGING_KIDNEY_UP,1/16,500/21728,0.3110738022716385,0.3110738022716385,0.13584779250746465,ARL4C,1
